UNIVERSITY OF PITTSBURGH – OF THE COMMONWEALTH … · CONSOLIDATED FINANCIAL STATEMENTS The accompanying notes are an integral part of these consolidated financial statements. 1

UNIVERSITY OF PITTSBURGH – OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION

Consolidated Financial Statements and Independent Auditors’ Reports Required by Title 2 U.S. Code of Federal Regulations Part 200, Uniform

Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, and Related Information

Year ended June 30, 2019


June 30, 2019

Table of Contents

Page

Independent Auditors’ Report

Consolidated Balance Sheets 1

Consolidated Statement of Activities 2

Consolidated Statements of Cash Flows 4

Notes to Consolidated Financial Statements 5

Schedule of Expenditures of Federal Awards 34

Notes to Schedule of Expenditures of Federal Awards 62

Independent Auditors’ Report on Internal Control Over Financial Reporting and on Compliance and Other Matters Based on an Audit of Financial Statements Performed in Accordance With Government Auditing Standards 64

Independent Auditors’ Report on Compliance for Each Major Federal Program; Report on Internal Control Over Compliance; and Report on Schedule of Expenditures of Federal Awards Required by the Uniform Guidance 66

Schedule of Findings and Questioned Costs 68

KPMG LLP is a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity.

KPMG LLPBNY Mellon CenterSuite 3400500 Grant StreetPittsburgh, PA 15219-2598

Independent Auditors’ Report

The Board of Trustees of the University of Pittsburgh – Of the Commonwealth System of Higher Education:

Report on the Financial Statements

We have audited the accompanying consolidated financial statements of the University of Pittsburgh – Of the Commonwealth System of Higher Education (the University), which comprise the consolidated balance sheets as of June 30, 2019 and 2018, and the related consolidated statements of activities, and cash flows for the years then ended, and the related notes to the consolidated financial statements.

Management’s Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of these consolidated financial statements in accordance with U.S. generally accepted accounting principles; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

Auditors’ Responsibility

Our responsibility is to express an opinion on these consolidated financial statements based on our audit. We conducted our audit in accordance with auditing standards generally accepted in the United States of America and the standards applicable to financial audits contained in Government Auditing Standards, issued by the Comptroller General of the United States. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the consolidated financial statements. The procedures selected depend on the auditors’ judgment, including the assessment of the risks of material misstatement of the consolidated financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the consolidated financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Opinion

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of the University of Pittsburgh – Of the Commonwealth System of Higher Education as of June 30, 2019 and 2018, and the changes in its net assets and its cash flows for the years then ended in accordance with U.S. generally accepted accounting principles.

Emphasis of Matter

As discussed in Note 1 to the consolidated financial statements, in 2019, the University of Pittsburgh – Of the Commonwealth System of Higher Education adopted Accounting Standards Update (ASU) 2016-14, Presentation of Financial Statements of Not-for-Profit Entities; ASU 2014-09, Revenue from Contracts with Customers (Topic 606), as amended; ASU 2018-08, Clarifying the Scope and the Accounting Guidance for Contributions Received and Contributions Made; and ASU 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. Our opinion is not modified with respect to these matters.

Other Reporting Required by Government Auditing Standards In accordance with Government Auditing Standards, we have also issued our report dated October 16, 2019 on our consideration of the University’s internal control over financial reporting and on our tests of its compliance with certain provisions of laws, regulations, contracts, and grant agreements and other matters. The purpose of that report is solely to describe the scope of our testing of internal control over financial reporting and compliance and the results of that testing, and not to provide an opinion on the effectiveness of the University’s internal control over financial reporting or on compliance. That report is an integral part of an audit performed in accordance with Government Auditing Standards in considering the University’s internal control over financial reporting and compliance.

Pittsburgh, Pennsylvania October 16, 2019

CONSOLIDATED FINANCIAL STATEMENTS

The accompanying notes are an integral part of these consolidated financial statements.

1

UNIVERSITY OF PITTSBURGH CONSOLIDATED BALANCE SHEETS JUNE 30, 2019 AND 2018 (in thousands of dollars)

2019 2018

ASSETS:Cash and cash equivalents (Notes 1, 2 and 6) $ 10,521 $ 45,809 Operating investments (Notes 1, 2, 5 and 6) 469,630 382,935 Inventories and deferred charges 35,656 23,556 Accounts and notes receivable, net (Notes 2 and 3) 266,984 229,576 Contributions receivable, net (Notes 1 and 4) 55,663 60,161 Student loans receivable, net 36,811 40,611 Foundation assets (Note 1) 30,903 29,697 Endowment investments (Notes 5 and 6) 4,342,563 4,226,330 Endowed funds held by third parties (Note 6) 23,677 23,591 Property, plant, and equipment, net (Note 7) 1,929,919 1,834,129

TOTAL ASSETS $ 7,202,327 $ 6,896,395

LIABILITIES: Accounts payable and accrued expenses $ 106,235 $ 99,001 Accrued payroll and related liabilities 81,987 80,804

Deferred student and other revenue (Note 1) 48,101 52,955

Advanced receipt of grant funds (Note 1) 73,708 68,321

Refundable U.S. government student loans 32,978 34,373

Other liabilities (Notes 6 and 9) 138,004 90,375

Pension and postretirement obligations (Note 10) 622,845 550,588

Conditional asset remediation obligation (Note 7) 30,022 29,764

Bonds and notes payable (Note 8) 899,687 833,420

TOTAL LIABILITIES 2,033,567 1,839,601

NET ASSETS:

Without donor restrictions (Notes 1 and 11)

Endowment designated for financial aid 1,704,446 1,683,220

Other designated endowments 947,923 934,324

Net invested in plant and other 763,467 729,390

Total without donor restrictions 3,415,836 3,346,934

With donor restrictions (Notes 1 and 11)

Endowments 1,663,466 1,607,760

Other 89,458 102,100

Total with donor restrictions 1,752,924 1,709,860

TOTAL NET ASSETS 5,168,760 5,056,794

TOTAL LIABILITIES AND NET ASSETS $ 7,202,327 $ 6,896,395



2

UNIVERSITY OF PITTSBURGH CONSOLIDATED STATEMENT OF ACTIVITIES FOR THE YEAR ENDED JUNE 30, 2019 COMPARED TO SUMMARY INFORMATION FOR THE YEAR ENDED JUNE 30, 2018 (in thousands of dollars)

2019

OPERATING REVENUES:

Without Donor

Restrictions

With Donor

Restrictions Total 2018 Tuition and fees (net of tuition discounts of $206.0 million and $192.7 million) $ 639,561 $ - $ 639,561 $ 628,481Commonwealth appropriation 174,675 - 174,675 169,680 Commonwealth construction grants - 8,781 8,781 21,582 Research grants and contracts 859,690 - 859,690 808,082 Contributions for operations 33,216 17,831 51,047 77,638 Endowment distributions and investment income 157,031 - 157,031 143,535 Sales and services, educational and other 292,912 - 292,912 256,877 Sales and services, auxiliary 151,020 - 151,020 151,688 Rental revenue 18,253 - 18,253 18,444 Net assets released from restrictions 42,037 (42,037) - -

Total operating revenues 2,368,395 (15,425) 2,352,970 2,276,007

OPERATING EXPENSES: Salaries and wages 1,055,046 - 1,055,046 1,005,074

Fringe benefits 300,091 - 300,091 286,230 Total compensation 1,355,137 - 1,355,137 1,291,304 Supplies 122,669 - 122,669 112,032 Business and professional 374,303 - 374,303 350,407 Facilities 103,357 - 103,357 95,105 Depreciation 184,835 - 184,835 177,210

Interest 30,137 - 30,137 30,171 Rent 52,507 - 52,507 50,083 Other 42,301 - 42,301 46,912

Total operating expenses (Note 13) 2,265,246 - 2,265,246 2,153,224

Change in net assets from operating activities 103,149 (15,425) 87,724 122,783

OTHER ACTIVITIES: Investment gains, net of endowment distributions for operations 44,111 27,464 71,575 206,836 Contributions for endowment - 31,025 31,025 24,297

Change in fair value of interest rate swaps (Note 9) (20,765) - (20,765) 20,526 Deferred tax benefit (Note 1) 11,355 - 11,355 - Other components of net periodic benefit cost (Note 10) (22,241) - (22,241) (22,437) Nonperiodic changes in benefit plans (Note 10) (46,707) - (46,707) 29,719

Total other activities (34,247) 58,489 24,242 258,941

CHANGE IN NET ASSETS 68,902 43,064 111,966 381,724

NET ASSETS, BEGINNING OF YEAR 3,346,934 1,709,860 5,056,794 4,675,070

NET ASSETS, END OF YEAR $ 3,415,836 $ 1,752,924 $ 5,168,760 $ 5,056,794


3

UNIVERSITY OF PITTSBURGH CONSOLIDATED STATEMENT OF ACTIVITIES FOR THE YEAR ENDED JUNE 30, 2018 (in thousands of dollars)

2018

OPERATING REVENUES:

Without Donor

Restrictions

With Donor

Restrictions Total Tuition and fees (net of tuition discounts of $192.7 million) $ 628,481 $ - $ 628,481Commonwealth appropriation 169,680 - 169,680Commonwealth construction grants - 21,582 21,582Research grants and contracts 808,082 - 808,082Contributions for operations 31,627 46,011 77,638Endowment distributions and investment income 143,535 - 143,535Sales and services, educational and other 256,877 - 256,877Sales and services, auxiliary 151,688 - 151,688Rental revenue 18,444 - 18,444Net assets released from restrictions 29,894 (29,894) -

Total operating revenues 2,238,308 37,699 2,276,007

OPERATING EXPENSES: Salaries and wages 1,005,074 - 1,005,074

Fringe benefits 286,230 - 286,230 Total compensation 1,291,304 - 1,291,304Supplies 112,032 - 112,032Business and professional 350,407 - 350,407Facilities 95,105 - 95,105Depreciation 177,210 - 177,210

Interest 30,171 - 30,171 Rent 50,083 - 50,083 Other 46,912 - 46,912

Total operating expenses (Note 13) 2,153,224 - 2,153,224

Change in net assets from operating activities 85,084 37,699 122,783

OTHER ACTIVITIES: Investment gains, net of endowment distributions for operations 140,366 66,470 206,836 Contributions for endowment - 24,297 24,297

Change in fair value of interest rate swaps (Note 9) 20,526 - 20,526Deferred tax benefit (Note 1) - - -Other components of net periodic benefit cost (Note 10) (22,437) - (22,437)Nonperiodic changes in benefit plans (Note 10) 29,719 - 29,719

Total other activities 168,174 90,767 258,941

CHANGE IN NET ASSETS 253,258 128,466 381,724

NET ASSETS, BEGINNING OF YEAR 3,093,676 1,581,394 4,675,070

NET ASSETS, END OF YEAR $ 3,346,934 $ 1,709,860 $ 5,056,794



4

UNIVERSITY OF PITTSBURGH CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED JUNE 30, 2019 AND 2018 (in thousands of dollars)

2019 2018

CASH AND CASH EQUIVALENTS: End of year $ 10,521 $ 45,809 Beginning of year 45,809 22,494 CHANGE IN CASH AND CASH EQUIVALENTS $ (35,288) $ 23,315

CASH FLOWS FROM OPERATING ACTIVITIES: Change in net assets $ 111,966 $ 381,724

Adjustments to reconcile change in net assets to net cash provided by operating activities:

Depreciation 184,835 177,210 Deferred tax benefit (11,355) - Other components of net periodic benefit cost 22,241 22,437 Nonperiodic changes in benefit plans 46,707 (29,719) Amortization of debt issuance costs and bond premiums, net 279 66 Loss on disposal of plant assets 2,301 1,719 Investment gains (200,369) (321,918) Change in fair value of interest rate swaps 20,765 (20,526) Contributions restricted for long-term investment (41,341) (47,453) Changes in operating assets and liabilities:

Accounts, notes, contributions, and loans receivable, net (35,414) (67,891) Other assets (745) (2,632)Accounts payable and accrued expenses 7,720 (355) Pension and postretirement obligations 3,309 3,784 Conditional asset remediation obligation 258 (880) Other liabilities 3,522 (1,404) Government student loans and deferred revenue (862) 4,012

Net cash provided by operating activities 113,817 98,174

CASH FLOWS FROM INVESTING ACTIVITIES: Expended for property, plant, and equipment - University (249,620) (208,380) Expended for property, plant, and equipment - commonwealth (8,781) (21,582)

Change in accounts payable for property, plant, and equipment (486) 3,324Purchases/sales of operating investments, net (76,910) 133,065Purchases of endowment investments (4,135,729) (2,411,292) Proceeds from sales/maturities of endowment investments 4,210,040 2,482,201

Change in endowed funds held by third parties, excluding gains (46) (43) Change in foundation assets (1,206) (1,804)

Net cash used for investing activities (262,738) (24,511)

CASH FLOWS FROM FINANCING ACTIVITIES: Principal repayment of debt including bond refundings (43,600) (106,025)

Proceeds from issuance of debt 109,588 - Contributions restricted for long-term investment 47,645 55,677

Net cash provided by (used for) financing activities 113,633 (50,348)

CHANGE IN CASH AND CASH EQUIVALENTS $ (35,288) $ 23,315

Supplemental disclosure of cash flow information: Cash paid for interest (excluding fees) $ 30,282 $ 30,401

Noncash investing activity for property, plant, and equipment - accounts payable and capital lease obligations $ 52,637 $ 28,598

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

5

NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING AND REPORTING PRACTICES

Organization Founded in 1787, the University of Pittsburgh (the University) is one of the oldest institutions of higher education in the United States. The University’s mission is to provide high-quality undergraduate and graduate programs in the arts and sciences and professional fields; engage in research, artistic, and scholarly activities that advance learning through the extension of the frontiers of knowledge and creative endeavor; cooperate with industrial and governmental institutions to transfer knowledge in science, technology, and health care; offer continuing educational programs adapted to the personal enrichment, professional upgrading, and career advancement interests and needs of adult Pennsylvanians; and make available to local communities and public agencies the expertise of the University in ways that are consistent with the primary teaching and research functions and contribute to social, intellectual, and economic development in the commonwealth, the nation, and the world.

The University’s main campus in the City of Pittsburgh comprises 16 schools and several academic centers educating nearly 29,000 students in various undergraduate, graduate, and doctorate-professional programs. Four regional campuses with a total enrollment approximating 5,600 students are located throughout western Pennsylvania.

Relationship with the Commonwealth of Pennsylvania The University derives its corporate existence under the laws of the Commonwealth of Pennsylvania (the commonwealth) by reason of the act of the General Assembly of the commonwealth establishing an “Academy or Public School in the town of Pittsburgh” on February 28, 1787 and from the act of February 18, 1819

incorporating the “Western University of Pennsylvania.” In 1908, the University’s name was changed to the “University of Pittsburgh” by order of the Court of Common Pleas of Allegheny County. In 1966, the Pennsylvania State Legislature enacted the “University of Pittsburgh-Commonwealth Act,” which changed the name of the University to the “University of Pittsburgh – of the Commonwealth System of Higher Education” and established the University as an instrumentality of the commonwealth to serve as a state-related institution in the Commonwealth System of Higher Education. The University is a Pennsylvania nonprofit corporation subject to the Nonprofit Corporation Law of 1988.

The entire management, control, and conduct of the instructional, administrative, and financial affairs of the University are vested in the Board of Trustees. The Board of Trustees is comprised of fifty-two members (thirty-six voting members), including twelve commonwealth trustees and sixteen special trustees elected by the board. Special trustees may attend all meetings of the board and are entitled to and exercise all rights, responsibilities, and privileges of trusteeship, except the right to vote at board meetings.

Funding from the Commonwealth of Pennsylvania As a state-related institution, the University receives an annual appropriation from the commonwealth. There is no assurance that such appropriation will continue to be made, or will be made, at current levels or at levels requested by the University. In addition, the commonwealth also funds certain capital projects in support of the University’s mission, as well as support for sponsored research programs, as presented in the following table:

2019 2018 Commonwealth appropriation: (in thousands of dollars)

General support $ 148,536 $ 144,210 Rural Education Outreach 2,846 2,763 Supplemental funds – Academic Medical Centers

and general support 23,293 22,707 Total commonwealth appropriation 174,675 169,680

Commonwealth construction grants 8,781 21,582 Commonwealth sponsored research programs 13,918 12,703 Total $ 197,374 $ 203,965


6

Basis of Presentation The consolidated financial statements include the accounts of the University, which do not include the net assets or activities of the University of Pittsburgh Medical Center (UPMC) or the University of Pittsburgh Physicians (UPP) clinical practice plans, as they are separate legal entities not controlled by the University. The University does have the right to designate one-third of the members of the UPMC Board of Directors and any Executive Committee thereof.

The other activities section of the Consolidated Statements of Activities includes investment gains, net of endowment distributions for operations; contributions for endowment; change in fair value of interest rate swaps; deferred tax benefit; other components of net periodic benefit cost; and nonperiodic changes in pension and postretirement benefit plans. Endowment distributions for operations represent those distributions not reinvested in the endowment (see Note 12).

Basis of Accounting The consolidated financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America (GAAP) as promulgated by the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 958, Not-for-Profit Entities.

The University’s net assets have been classified in accordance with the presence or absence of donor-imposed restrictions and are reported as follows:

Net assets without donor restrictions - Includesrevenues, gains, and losses, which are free fromdonor restriction and are available for the generaloperating purposes of the University. All Universityexpenses are reported as a reduction in net assetswithout donor restrictions. This class of net assetsincludes contributions and endowment distributionswhose donor-imposed restrictions have been metwithin the fiscal year as well as endowment fundsdesignated by the University’s Board of Trustees ormanagement. Restrictions are considered to bereleased if unrestricted resources are used for apurpose for which restricted resources are available.Contributions for capital construction or acquisitionare reported as net assets without donor restrictiononce the asset is placed into service.

Net assets with donor restrictions - Includes donor-imposed restrictions that may be met by theUniversity through the passage of time or through theuse of such funds in accordance with the donor’swishes. These funds include endowed contributionsand pledges requiring that the original corpus bemaintained in perpetuity. The distributions generatedby these contributions may be either expended orreinvested in the endowment in accordance withdonor restrictions and endowment contribution andspending policies. This net asset category alsoincludes donor restricted funds to be used asrevolving student loan funds in perpetuity.

Donor restricted contributions are reported as increases in net assets with donor restrictions. When a restriction expires, net assets are reclassified from net assets with donor restrictions to net assets without donor restrictions in the Consolidated Statements of Activities.

Estimates Preparation of the consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates.

Revenue Recognition – Contracts with Customers and Accounts Receivable In May 2014, FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606), which, along with related amendments, replaces the existing revenue recognition requirements in GAAP. The core principle of Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration it expects to be entitled in exchange. In addition, Topic 606 requires disclosures about the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. Topic 606 also requires that tuition, fees, and auxiliary student revenues be presented in the Consolidated Statements of Activities at the transaction price, net of student aid (tuition discounts). Previously, such revenues were presented gross – at published rates – followed by a reduction for student aid. Accordingly, the University’s 2018 Consolidated Statement of Activities has been revised to conform to the 2019 presentation.

7

The following table presents the University’s net revenue subject to Topic 606:

2019 2018 (in thousands of dollars)

Net tuition and fees $ 639,561 $ 628,481 Sales and services, educational and other 292,912 256,877 Sales and services, auxiliary 151,020 151,688 Total $ 1,083,493 $ 1,037,046

Revenues are recognized when control of the promised goods or services is transferred to the institutions’ students or customers, in an amount that reflects the consideration the University expects to be entitled to in exchange for those goods or services. The University uses the portfolio approach, a practical expedient, to evaluate if a contract exists and to assess collectability at the time of contract inception based on historical experience. Contracts are subsequently reviewed for collectability periodically.

Tuition and fees include tuition from undergraduate, graduate and doctorate-professional programs (net of discounts), and various academic related fees. The University recognizes this revenue as the academic services are rendered and the performance obligation is met, which occurs ratably over the applicable period of instruction or academic term. Undergraduate programs totaled 71.7% and 71.6% of net tuition and fees in 2019 and 2018, respectively.

Tuition discounts are recorded to the extent that either institutional financial aid or aid funded by contributions, endowment distributions, and grant activities are awarded. Tuition discounts awarded in 2019 and 2018 were $206.0 million and $192.7 million, respectively. The portion of tuition discounts attributable to institutional funds in 2019 and 2018 were $174.1 million and $163.9 million, respectively. Tuition discounts attributable to contributions, donor-restricted endowment distributions, and grant activities were $31.9 million and $28.8 million in 2019 and 2018, respectively. Such discounts are reflected within net tuition and fees.

Sales and services, education and other includes revenues from UPMC and UPP to support teaching, research, and community service functions at the University, and revenues from activities to provide students an enhanced

educational experience including athletics, student services, and the study abroad program. UPMC and UPP revenue comprises 62.2% and 57.5% of this total in 2019 and 2018, respectively. Revenue is recognized for these activities as performance obligations are met.

Sales and services, auxiliary includes revenues from activities conducted primarily to provide goods or services for students, faculty, and staff. Housing and meal plan revenue in 2019 and 2018 comprised 84.1% and 84.2%, respectively, and are recognized as performance obligations are met, which occurs ratably over the academic term. The remaining revenue consists primarily of book store and parking operations, which is generally recognized at the point of sale.

Students are invoiced prior to the start of the term and payment is generally due within three weeks of the start of classes. Student charges are comprised of all educational related items including tuition and educational materials. Receivables related to sales and services are invoiced based upon contractual terms with students and others.

The University maintains allowances for doubtful accounts to reflect management’s best estimate of probable losses inherent in receivable balances. Management determines the allowances for doubtful accounts based on known troubled accounts, the age of the receivable, the anticipated source of payment, historical allowance considerations, and other currently available evidence. Consideration is also given to any specific known risk areas among the existing accounts receivable balances. Receivables are written off when management determines they will not be collected. Recoveries of receivables previously written off are recorded when received.


8

The University has no significant contract assets or deferred contract costs at June 30, 2019 and June 30, 2018.

The University recognizes a contract liability, or deferred revenue, for payments received in advance of providing services under certain contracts. Contract liabilities include advanced receipt of student tuition and fees, athletic ticket sales, and housing and food service revenue. These contract liabilities are recorded in deferred student and other revenue on the Consolidated Balance Sheets. Revenue recognized related to contract liabilities in 2019 and 2018 was $43.2 million and $41.5 million, respectively.

Revenue Recognition - Contributions In June 2018, FASB issued ASU No. 2018-08, Not-for-Profit Entities (Topic 958), Clarifying the Scope and Accounting Guidance for Contributions Received and Contributions Made. The FASB issued this ASU to reduce diversity in reporting by clarifying (1) whether transactions should be accounted for as contributions within the scope of Topic 958 or as exchange transactions subject to other guidance and (2) whether a contribution is conditional.

Commonwealth appropriation revenue is provided by the commonwealth to support the general operations of the University, which allows for a reduction in tuition rates for Pennsylvania resident students. The reduction in rates in 2019 and 2018 amounted to $273.9 million and $256.6 million, respectively. Funds are to be spent in accordance with applicable laws and revenue is recognized ratably over the fiscal year as the funds are expended.

Commonwealth construction grants are provided by the commonwealth to fund certain capital projects in support of the University’s mission. This revenue is classified as with donor restrictions until the capital project is completed and placed in service, at such time the net assets are released from restrictions.

The University conducts sponsored program activity with various sponsors, including agencies and departments of the federal government, the commonwealth, local government entities, companies, and foundations. Sponsored activity in 2019 and 2018 was $859.7 million and $808.1 million, respectively, with approximately 66%

of the funding awarded through the National Institutes of Health. Most University sponsored activity is conducted on a cost-reimbursable basis with the University recognizing revenue as the related expenses have been incurred. Certain sponsors, however, provide funding in advance of related expenses, and such funding is recorded as advanced receipt of grant funds on the Consolidated Balance Sheets with revenue recognized as the related expenses are incurred. There is no assurance that sponsored awards will continue to be made at current levels.

The University initially records at fair value unconditional pledges (which are agreements with donors involving non-reciprocal transfers of cash or other assets) as net assets with donor restrictions or without donor restrictions depending on the nature of the donor-imposed restrictions. Contributions whose restrictions are met in the same fiscal year in which they are received are combined and reported with net assets without donor restrictions. Contributions receivable are discounted at a risk-adjusted rate commensurate with the donor’s payment plan.

Conditional pledges of cash or other assets are recognized as contribution revenues and receivables when the conditions surrounding the pledge are substantially met.

Cash and Cash Equivalents and Operating Investments Cash equivalents consist of operating investments with original maturities of 90 days or less. Operating investments include U.S. Treasury instruments and other high-quality, liquid securities that at the time of purchase are rated A3/P-1 or better by Moody’s Investors Service or A-/A-1 or better by Standard & Poor’s Ratings Services. Operating investments, together with cash, are utilized to fund the University’s short-term operating needs and are invested with the expectation that such securities can be liquidated at their current value in a short time frame. Cash and cash equivalents that are part of endowment investments are shown therewith, as such funds are utilized for endowment purposes rather than University operating needs.

9

Foundation Assets The University’s foundation assets represent the Bradford Educational Foundation (BEF). The BEF is a 509(a)(3) Type III supporting organization whose sole purpose is to receive, administer, and distribute property for the benefit of the University of Pittsburgh Bradford campus. The BEF is governed by an independent board of directors, with the majority of members being non-University members. Although the University does not exercise control of the BEF, all assets held by the BEF are held for the financial benefit of the University. As such, the consolidated financial statements include the net assets and annual change in net assets of the BEF.

Endowment Investments The University’s endowment investments are reported at fair value. The fair value of direct University holdings in publicly traded securities and exchange traded funds are based upon quoted or published market prices. The fair value of all other investments, which consist of indirect holdings in both privately and publicly traded assets, is determined using net asset value (NAV) per share or unit of interest. Used as a practical expedient for the estimated fair value, NAV per share or its equivalent is provided by the fund manager and reviewed by the University. Indirect holdings of private assets primarily consist of University interests in funds investing in nonmarketable alternatives, real assets, and/or distressed securities, whereas indirect holdings of publicly traded assets primarily consist of University interests in marketable alternatives or other commingled funds. Nonmarketable alternatives are private equity or equity-like holdings, such as mezzanine and subordinated debt interests, in venture, buyout, or recapitalized companies or properties. Real assets are physical assets, or financial assets associated with such physical assets, whose income streams and/or fair values tend to rise with inflation; they include real estate, natural resources, commodities, and other hard assets. Marketable alternatives consist of absolute return-oriented strategies, distressed debt, long/short equity, and other hedging strategies. In the case of indirect holdings, changes in market conditions, economic environment, regulatory environment, currency exchange rates, interest rates, and commodity prices may significantly impact the NAV of the funds holding the investments and, consequently, the fair value of the University’s interest in such funds and could materially affect the amounts reported in the consolidated financial statements. Although a secondary market exists for these investments, it is not active, and individual transactions are typically not observable. When transactions do occur in this limited secondary market, they may occur at

discounts to the reported NAV. It is therefore possible that if the University were to sell these investments in the secondary market, a buyer may require a discount to the reported NAV, and the discount could be significant. The University attempts to manage these risks through diversification, ongoing due diligence of fund managers, maintaining adequate liquidity, and continuously monitoring economic and market conditions.

Dividend income is recognized net of applicable withholding taxes on the ex-dividend date. Noncash dividends are recorded at the fair value of the securities received. Interest income and expenses are recorded net of management fees and applicable withholding taxes on the accrual basis of accounting.

Government Loan Funds U.S. government student loans are recorded as liabilities because these funds are refundable to the federal government under certain conditions. Student loan funds donated by private groups, organizations, or individuals are recorded as net assets with donor restrictions since such funds operate on a revolving fund basis with principal and interest payments remaining in the fund for future lending.

Derivative Financial Instruments The University records derivatives at fair value on the Consolidated Balance Sheets with changes in fair value reflected in the Consolidated Statements of Activities (see Note 9).

Split-Interest Agreements These agreements with donors consist primarily of charitable gift annuities, pooled income funds, and irrevocable charitable remainder trusts for which the University serves as trustee. Assets are invested and payments are made to donors and/or other beneficiaries in accordance with the respective agreements. Endowment investments include $31.2 million and $24.1 million at June 30, 2019 and 2018, respectively, for the split-interest agreements. Other liabilities include $15.6 million and $12.9 million at June 30, 2019 and 2018, respectively, for the split-interest agreements.

The University maintains separate and distinct reserve funds adequate to meet future payments of all outstanding charitable gift annuities administered by the University. The University complies with applicable state annuity reserve requirements.


10

Property, Plant, and Equipment, Net Property, plant, and equipment is recorded at cost, or if acquired by contribution, at fair value as of the date of the contribution. Depreciation is calculated using the straight-line method. Useful lives generally range from 15 to 40 years for buildings and improvements and 5 to 10 years for furnishings and equipment. As assets are retired, sold, or otherwise disposed, the cost and related accumulated depreciation are removed from the accounts, and gains or losses are recognized in the Consolidated Statements of Activities. Costs associated with the construction of new facilities and renovation and expansion of existing facilities are capitalized within construction in progress until such projects are placed in service. The University capitalizes software and certain implementation costs and generally depreciates such assets over 5 to 10 years. Works of art, historical treasures, and similar assets include a variety of paintings, sculptures, photographs, antiques, and furnishings, as well as scholarly papers and archives. These assets are used for public exhibition, the preservation of artifacts and antiques for future generations, and scholarly research. Due to their nature, these assets are not depreciated. Library books, which include hard copy publications, periodicals, and electronic publications with rights to archival content, are depreciated over a period of 7 years. Maintenance and repairs are expensed as incurred.

Insurance Liabilities The University is self-insured through an agreement with UPMC to provide medical coverage for its employees. A liability for estimated incurred but unreported claims of $8.2 million and $7.5 million has been recorded at June 30, 2019 and 2018, respectively, based upon management’s analysis of claims history. This liability is reflected in accrued payroll and related liabilities on the Consolidated Balance Sheets.

The University is also self-insured for other activities, including workers’ compensation, unemployment compensation, and certain litigation claims. Liabilities have been established for these programs generally based on third-party administrators’ estimates using the University’s historical loss experience. The self-insurance accrual is subject to periodic adjustment by the University based on actual loss experience factors. Liabilities for these other self-insured obligations aggregated $6.0 million and $9.3 million at June 30, 2019 and 2018, respectively, and are included in accrued payroll and related liabilities on the Consolidated Balance Sheets.

Recent Accounting Pronouncements In March 2017, FASB issued the Accounting Standards Update (ASU) No. 2016-14, Not-for-Profit Entities (NFP's)(Topic 958): Presentation of Financial Statements for Not-for-Profit Entities. The ASU is effective in the current fiscal year and has been adopted in 2019 including the required reclassification of the 2018 activities. ASU 2016-14 reduces the number of net assets classes from three to two, increases disclosure regarding liquidity (Note 2), and requires expenses to be reported by their natural and functional classifications in one location (Note 13). With respect to the net asset classes, and as a result of the adoption of ASU 2016-14, as of June 30, 2018 previously reported unrestricted net assets ($3.37 billion) were reduced by $19.5 million and reclassified to without donor restrictions and temporarily restricted net assets ($924.2 million) and permanently restricted net assets ($766.1 million) were combined and increased by $19.5 million and reclassified to with donor restrictions as of June 30, 2018. The change relates to the timing of release of the commonwealth construction grant revenue to align with when the constructed assets are placed into service.

In March 2017, FASB issued the ASU No. 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost. This ASU requires presentation of the service cost component of the net periodic benefit cost within the same line item or items as other compensation costs arising from services rendered by relevant employees during the period, and presentation of the other cost components of net periodic benefit cost separately and outside of the change in net assets from operating activities. The ASU is effective in fiscal year 2020, but the University has elected early adoption in the current year and applied the expense reclassification retrospectively (see Note 10).

In May 2014, FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) and in June 2018, FASB issued ASU No. 2018-08, Not-for-Profit Entities (Topic 958), Clarifying the Scope and Accounting Guidance for Contributions Received and Contributions Made. Both ASU’s, and related amendments to ASU 2014-09, are effective for fiscal year 2019 and have been adopted in the current year. The University is using the modified retrospective approach for adopting Topic 606. The ASU had minimal impact on the recognition of University revenue. See Revenue Recognition – Contracts with Customers and Accounts Receivable; and Revenue Recognition – Contributions within this note for details.

11

In February 2016, FASB issued ASU No. 2016-02, Leases (Topic 842). The ASU is effective for fiscal year 2020 and will require lessees to report most leases as assets and liabilities on the balance sheet, while lessor accounting will remain substantially unchanged. The ASU requires a modified retrospective transition approach for existing leases, whereby the new rules will be applied to the earliest year presented. The University is currently finalizing the implementation of this ASU (see Note 15 for the disclosure of lease commitments).

Tax-Exempt Status The University is exempt from federal income tax under Section 501(c)(3) of the United States Internal Revenue Code. Accordingly, it is not subject to income taxes except to the extent it has taxable income from activities that are not related to its exempt purpose. The University annually reviews its tax positions and has determined that there are no material uncertain tax positions that require recognition in the consolidated financial statements. No provision for income taxes was required for 2019 or 2018.

The University’s federal net operating loss carryforwards as of June 30, 2019 are approximately $54.1 million and expire in years ranging from 2029 to 2037. Because management believes it is more likely than not that unrelated business activities will generate sufficient taxable income in the future in which all or part of these operating loss carryforwards will become deductible, a deferred tax benefit (included in inventories and deferred charges on the Consolidated Balance Sheets) of $11.4 million was recognized as of June 30, 2019. Previously, a full valuation allowance was recorded.

Reclassifications Certain 2018 operating expense line items include reclassifications related to the presentation of internal cost recovery to conform with the 2019 presentation. In addition, the 2018 student wellness fee was reclassified from sales and services, educational and other to net tuition and fees to conform with the 2019 presentation.


12

NOTE 2: LIQUIDITY AND AVAILABILITY OF FINANCIAL ASSETS

As of June 30, the following financial assets could be made available within one year of the balance sheet date to meet general expenditures:


Cash and cash equivalents $ 10,521 $ 45,809 Operating investments 448,012 360,951 Accounts and notes receivable 266,984 229,576 Payout on designated endowment – financial aid 66,629 59,515 Payout on endowments - other 79,385 76,629 Financial assets available within one year $ 871,531 $ 772,480

The University regularly monitors liquidity required to meet all general and capital expenditures, liabilities, and contractual obligations, while striving to maximize the investment of its available funds. For purposes of analyzing resources available to meet general operating needs over a twelve-month period, the University considers all expenditures related to its ongoing activities of teaching, research, and public service mission. This includes operating expenses, principal and interest payments on debt, and capital-related expenditures. Resources not available to meet general expenditures within one year may include those with external limitations imposed by donors, laws, or contracts or internal limitations imposed by management restrictions.

The University has various sources of liquidity including cash and cash equivalents, operating investments, and lines of credit. Operating investments consist of high-quality securities which are utilized to fund the University's short-term operating needs and are invested with the expectation that such securities can be liquidated at their current value in a short time frame.

Accounts and notes receivable consist of amounts due from students; sponsors of research, instruction, and public service initiatives; UPMC; the commonwealth; and

various other entities. All amounts are expected to be converted to cash within twelve months. Student loan receivables are not included as principal and interest on these loans are used solely to make new loans and are, therefore, not available to meet current operating needs.

The University maintains a management designated endowment fund, the payout from which is used to support student financial aid.

Payout on other endowments represents distributions on endowments which are expected to be available for use in the next twelve months. These funds are primarily available to the academic units in which the endowments were directed and are used to support scholarships, chairs and other initiatives.

To help manage unanticipated liquidity needs, the University has four general unsecured credit facilities aggregating $100.0 million at June 30, 2019. No draws were made against the facilities during 2019. Termination dates on the lines of credit available at June 30, 2019 range from October 2019 to March 2020. It is management’s intention to extend each credit facility.

13

NOTE 3: ACCOUNTS AND NOTES RECEIVABLE, NET

NOTE 4: CONTRIBUTIONS RECEIVABLE, NET

Contributions receivable, net, at June 30 consists of the following:


Amounts due in: Less than one year $ 17,890 $ 18,268 One to five years 32,026 34,905 Greater than five years 10,816 14,061

Gross contributions receivable 60,732 67,234 Less:

Allowance for uncollectible pledges (1,392) (765) Unamortized discounts (3,677) (6,308) Total contributions receivable, net $ 55,663 $ 60,161

At June 30, 2019 and 2018, the five largest outstanding pledge balances represented 55% and 61%, respectively, of the University’s net contributions receivable.

The University has been named a beneficiary in the wills of numerous donors or has received conditional pledges

totaling $283.5 million and $271.8 million at June 30, 2019 and 2018, respectively. These bequests are considered intentions to give and do not fall within the definition of an unconditional pledge, and hence, are not recognized in the consolidated financial statements.

Accounts and notes receivable, net, at June 30 consists of the following:


Sponsored grant receivables, net $ 134,557 $ 120,480 Commonwealth appropriation receivable 63,500 51,285 Hospitals and affiliated organizations receivables, net 33,278 18,202 Other receivables, net 16,320 14,148 Plant construction receivables due from commonwealth 11,833 17,491 Student receivables, net 7,496 7,970 Total accounts and notes receivable, net $ 266,984 $ 229,576


14

NOTE 5: ENDOWMENT AND OPERATING INVESTMENTS

Investments at June 30 consist of the following:


Endowment investments: Pooled $ 4,299,208 $ 4,188,409

Nonpooled 43,355 37,921 Subtotal endowment investments 4,342,563 4,226,330

Operating investments (Note 1) 469,630 382,935 Total endowment and operating investments $ 4,812,193 $ 4,609,265

Composition of endowment investments: Cash and cash equivalents $ 48,408 $ 101,225 Domestic equities 678,766 674,604 International equities 883,225 844,240 U.S. government and government agencies’

securities, bank acceptances and certificates, and commercial paper 235,709 249,614

Corporate bonds and other obligations 74,151 108,862 Alternative investment funds, partnerships, and exchange traded funds:

Marketable alternatives 854,520 830,639 Nonmarketable alternatives 884,248 745,331

Real assets 683,536 671,815 Total endowment investments $ 4,342,563 $ 4,226,330

Composition of operating investments: U.S. government and government agencies’ securities,

repurchase agreements, and commercial paper $ 260,809 $ 210,301 Corporate bonds and other obligations 185,103 148,909

Other 23,718 23,725 Total operating investments $ 469,630 $ 382,935

Unless precluded by size or donor restrictions, individual endowment fund assets are pooled and collectively managed on a unitized basis. Each endowment fund subscribes to or disposes of units in the pool using fair value per unit at the beginning of the month such subscription or disposition occurs to account for the transaction.

The philosophies and policies employed in the management of the endowment are long-term by definition, as they are based on the expectation that the endowment will continue to provide financial support to

the University in perpetuity. Accordingly, the University’s investment policy is intended to optimize long-term total return — income plus capital appreciation — relative to the level of risk taken.

The University’s investment policy contemplates the effects of its spending policy. The endowment spending policy balances the need for reliable and predictable earnings distributions to support current University activities with the desire to maintain the purchasing power of endowment assets so that they can continue providing financial support for future generations.

15

The following table summarizes the University’s investments at June 30, 2019 and 2018, for which NAV was used as a practical expedient to estimate fair value:

Fair Value Determined Using NAV

Unfunded Commitments Redemption

Redemption Notice

Asset Class 2019 2018 at June 30, 2019 Frequency Period (in thousands of dollars)

International equities $ 179,209 $ 139,647 $ - 30-90 days 30-120 days

Marketable alternatives: Redeemable within one year 654,700 711,582 - 30-365 days 30-180 daysRedeemable beyond one year 53,811 18,882 - 1-3 years 60-90 daysNonredeemable 32,745 29,725 95,143 NA NA

Total marketable alternatives 741,256 760,189 95,143

Nonmarketable alternatives 884,248 745,331 668,849 NA NA

Real assets: Redeemable - 61,914 - Daily NA Nonredeemable 657,914 585,947 439,305 NA NA

Total real assets 657,914 647,861 439,305 Total $ 2,462,627 $ 2,293,028 $ 1,203,297

Descriptions follow for each asset class set forth in the table above:

International Equities A portion of the University’s investments in emerging market equities includes interests in two funds that hold publicly traded emerging market equities.

Marketable Alternatives The University’s investments in marketable alternatives are interests in commingled funds that hold various combinations of long and short positions predominantly in publicly traded equities, fixed income, and financial derivatives. Funds that are nonredeemable typically have investment periods of three or more years during which committed capital may be called and invested. The University’s interests in the nonredeemable funds are considered to be illiquid in that they are not easily transferable and typically achieve liquidity over multi-year periods when and if the fund managers distribute proceeds realized from the underlying fund assets.

Nonmarketable Alternatives The University’s investments in nonmarketable alternatives are interests in commingled, private equity funds, including venture capital. These funds are invested

in equity and equity-like securities of mostly nonpublicly traded companies over investment periods of typically three to five years during which committed capital may be called and invested. The University’s interests in private equity funds are considered to be illiquid in that they are not easily transferable and typically achieve liquidity over multi-year periods when and if the fund managers distribute proceeds realized from underlying fund assets.

Real Assets The University’s investments in real assets are interests in commingled funds that hold various combinations of publicly and nonpublicly traded physical assets (such as real estate, natural resources, commodities, and utilities), the financial assets and derivatives associated with such physical assets, and the equity and equity-like securities of companies engaged in physical asset ownership, operations and/or services. Funds that are nonredeemable typically have investment periods of three or more years during which committed capital may be called and invested. The University’s interests in the nonredeemable funds are considered to be illiquid in that they are not easily transferable and typically achieve liquidity over multi-year periods when and if the fund managers distribute proceeds realized from the underlying fund assets.


16

NOTE 6: FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The three levels of the fair value hierarchy are as follows:

Level 1 – Unadjusted quoted or published prices inactive markets for identical assets or liabilities thatare available at the measurement date.

Level 2 – Inputs other than quoted or publishedprices included within Level 1 that are observable forthe asset or liability, either directly or indirectly.

Level 3 – Unobservable inputs for the asset orliability that are used to measure fair value whenobservable inputs are not available. These inputs aredeveloped based upon the best information availablein such circumstances.

In the event that changes in the inputs used in the fair value measurement of an asset or liability result in a transfer of the fair value measurement into a different level, such transfers are recognized at the end of the reporting period.

The following tables summarize the inputs used in valuing the University’s assets and liabilities carried at fair value, excluding investments stated at NAV as a practical expedient, at June 30, 2019 and 2018:

2019 Level 1 Level 2 Level 3 Total

Assets (in thousands of dollars) Cash and cash equivalents $ 9,485 $ 1,036 $ - $ 10,521Endowment investments:

Cash and cash equivalents 39,175 9,233 - 48,408Domestic equities 678,766 - - 678,766International equities 696,058 5,417 2,541 704,016U.S. government, corporate bonds,

and other obligations 268,449 29,850 11,561 309,860Marketable alternatives 23,270 89,994 - 113,264Real assets 25,622 - - 25,622

Subtotal endowment investments(1) 1,731,340 134,494 14,102 1,879,936 Operating investments:

U.S. government, corporate bonds, and other obligations 378,037 67,875 - 445,912

Other 2,100 - 21,618 23,718 Endowed funds held by third parties - - 23,677 23,677Total assets $ 2,120,962 $ 203,405 $ 59,397 $ 2,383,764 Liabilities

Interest rate swaps $ - $ 77,554 $ - $ 77,554

17

2018 Level 1 Level 2 Level 3 Total

Assets (in thousands of dollars) Cash and cash equivalents $ 31,428 $ 14,381 $ - $ 45,809Endowment investments:

Cash and cash equivalents 80,475 20,750 - 101,225Domestic equities 664,575 10,029 - 674,604International equities 701,706 - 2,887 704,593U.S. government, corporate bonds,

and other obligations 288,141 59,585 10,750 358,476Marketable alternatives 70,450 - - 70,450 Real assets 23,954 - - 23,954

Subtotal endowment investments(1) 1,829,301 90,364 13,637 1,933,302 Operating investments:

U.S. government, corporate bonds, and other obligations 300,452 58,758 - 359,210

Other 1,741 - 21,984 23,725 Endowed funds held by third parties - - 23,591 23,591Total assets $ 2,162,922 $ 163,503 $ 59,212 $ 2,385,637 Liabilities

Interest rate swaps $ - $ 56,789 $ - $ 56,789

(1) The subtotals of endowment investments within the fair value tables above exclude investments of $2,462,627 and$2,293,028 as of June 30, 2019 and 2018, respectively, which are measured at NAV as a practical expedient and are notclassified in the fair value hierarchy (see Note 5).

The following table summarizes the change in the Level 3 activity for the years ended June 30, 2019 and 2018:

U.S. Government Other Operating and

International Equities Corporate and Other

Endowed Funds Held by Third Parties Total

(in thousands of dollars)

Fair Value - June 30, 2017 $ 4,301 $ 9,348 $ 41,657 $ 55,306 Capital calls/purchases - 1,175 3,366 4,541 Distributions/sales (1,340) - (1,155) (2,495) Realized gains 144 - - 144 Unrealized (losses) gains (218) 227 1,707 1,716

Fair Value - June 30, 2018 $ 2,887 $ 10,750 $ 45,575 $ 59,212 Capital calls/purchases - 1,300 1,070 2,370 Distributions/sales (448) (800) (982) (2,230)Realized gains 107 65 - 172Unrealized (losses) gains (5) 246 (368) (127)

Fair Value - June 30, 2019 $ 2,541 $ 11,561 $ 45,295 $ 59,397

Realized and unrealized gains (losses) for Level 3 activity are reported in other activities in the Consolidated Statements of Activities. An unrealized loss of

$0.2 million and an unrealized gain of $1.0 million were recognized related to these investments held at June 30, 2019 and 2018, respectively.


18

NOTE 7: PROPERTY, PLANT, AND EQUIPMENT, NET

Property, plant, and equipment, net, at June 30 is summarized below:


Land $ 75,658 $ 63,849 Buildings and improvements 3,465,813 3,247,659 Equipment 804,690 783,323 Library books 308,705 297,372 Works of art, historical treasures, and similar assets 21,690 21,555 Construction in progress 151,790 185,442 Subtotal 4,828,346 4,599,200 Less: Accumulated depreciation (2,898,427) (2,765,071) Total property, plant, and equipment, net $ 1,929,919 $ 1,834,129

The amount capitalized in property, plant, and equipment related to expenditures funded by the commonwealth on behalf of the University totaled $779.9 million and $757.5 million at June 30, 2019 and 2018, respectively. The net book value of these items was $330.1 million and $333.9 million at June 30, 2019 and 2018, respectively.

The University has recognized a liability for conditional asset retirement obligations. The University performed an analysis of such obligations and determined that asbestos remediation costs represented the primary source of the liability. The University reviewed facilities on all campuses and estimated the timing, method, and cost of remediation. The resulting liability for conditional asset remediation obligations recognized at June 30, 2019 and 2018 was $30.0 million and $29.8 million, respectively.

19

NOTE 8: BONDS AND NOTES PAYABLE

Bonds and notes payable at June 30 are reported based upon outstanding principal and consists of the following:

Range of Years Outstanding Principal Remaining 2019 Effective (in thousands of dollars) to Maturity Interest Rates 2019 2018

Variable-rate bonds and notes: Series 2017-C1, taxable 12-20 2.03%-2.63% $ 55,000 $ 55,000 Series 2017-C2, taxable 20-22 2.00%-2.58% 55,000 55,000 Series 2017-C3, taxable 13-18 2.08%-2.72% 50,000 50,000 Series 2014-B1/B2, tax-exempt 6-16 1.35%-1.90% 46,000 46,000 Series 2018 PANTHERTM Notes, due September 15, 2021 1.52%-2.54% 110,000 -

Total variable-rate bonds and notes 316,000 206,000

Fixed-rate bonds: Series 2017-A, taxable 3 mos.-17 1.43%-3.65% 434,900 477,500 Series 2017-B, taxable 3 mos.-11 1.41%-3.60% 102,335 103,335 Series 2014-A, tax-exempt 17-25 3.51%-3.65% 49,000 49,000 Noninterest-bearing promissory note 171 171

Total fixed-rate bonds 586,406 630,006

Unamortized net premium 1,274 1,335 Debt issuance costs (3,993) (3,921) Total bonds and notes payable $ 899,687 $ 833,420

The principal payments of bonds and notes payable for the next five years ending June 30 in millions of dollars are:

2020 $ 42.6 2021 $ 41.8 2022 $ 151.2 2023 $ 39.4 2024 $ 40.8


20

The foregoing principal payments do not include $206.0 million of variable-rate demand bonds (VRDBs) in commercial paper (CP) mode, all of which have final maturity dates between 2030 and 2041. These bonds bear short-term rates that are fixed over staggered periods of approximately 90 days each and are remarketed at the expiry of their respective rate periods.

Liquidity support for the $206.0 million of outstanding VRDBs in CP mode is provided by the University. In the event that the University receives notice of an optional tender on its VRDBs in CP mode, the tendered bonds will be purchased with remarketing proceeds. If the remarketing proceeds are insufficient to purchase all tendered bonds, the University would have a current obligation to meet the shortfall. As an additional source of liquidity for this situation, the University entered into a $40.0 million unsecured standby liquidity agreement with a financial institution that matures in June 2020. Since the University commenced providing self-liquidity in October 2009, there have been no failed remarketings.

On January 17, 2017, the University issued $512.5 million fixed-rate Taxable University Refunding Bonds (Series 2017-A). The proceeds were used to fund an escrow account that was irrevocably placed with a trustee to meet the principal and interest payments of the Series 2000-A/B/C ($124.4 million), Series 2002-A ($20.0 million), and Series 2002-B ($14.5 million) fixed-rate bonds until their first call date of September 15, 2019; Series 2009-A/B ($290.3 million) fixed-rate bonds, which were called on March 15, 2019; and to redeem $15.0 million tax-exempt Series 2002-B VRDBs in CP mode. The Series 2017-A bonds were issued at par.

On March 21, 2017, the University issued $104.4 million fixed-rate Taxable University Refunding Bonds (Series 2017-B). The proceeds were used to fund an escrow account that was irrevocably placed with a trustee to meet the principal and interest payments of the Series 2005-A ($35.0 million) and Series 2007-B ($60.0 million) fixed-rate bonds until their respective first call date. The Series 2017-B bonds were issued at par.

On May 4, 2017, the University issued $160.0 million in Taxable University Refunding Bonds (Series 2017-C); such bonds were issued as VRDBs in CP mode. The proceeds were used to redeem $159.6 million tax-exempt Series 2005-A/B/C and Series 2007-B VRDBs at their CP maturity date.

In August 2018, the University issued its Pitt Asset Notes – Tax-Exempt Higher Education Registered Series of2018 (Series 2018 PANTHERS™ Notes) in the amount of$110.0 million to reimburse the University for priorcapital and equipment expenditures. These three-yearfloating rate notes will mature on September 15, 2021.

Interest costs incurred in 2019 and 2018 were $30.1 million and $30.2 million, respectively. Included in these amounts are net swap payments and capitalized interest associated with various construction projects. Capitalized interest for 2019 and 2018 was $0.9 million and $0.5 million, respectively.

21

NOTE 9: DERIVATIVE AND OTHER FINANCIAL INSTRUMENTS

The University does not issue or trade derivative financial instruments except as described herein. University financial assets are invested on its behalf with various investment managers, some of whom are authorized to employ derivative instruments, including swaps, futures, forwards, and options. These derivatives are generally used for managing interest rate or foreign currency risk or to attain or hedge a specific financial market position. Additionally, the University has entered into various interest rate swap agreements to hedge its interest rate risk associated with certain debt obligations.

The University may be exposed to financial loss should a derivative counterparty fail to perform pursuant to the instrument. Counterparties are typically financial institutions or exchanges. Counterparty risks are mitigated by using creditworthy counterparties, settling positions periodically, and requiring collateral to be posted at predetermined levels of exposure.

Not including University derivative instruments held by various alternative investment funds, the University invested in futures contracts with gross notional values of $92.2 million and $59.8 million at June 30, 2019 and 2018, respectively. When the University uses futures to replicate an investment position, it posts the required collateral. Futures contracts are marked-to-market daily based on settlement prices established by the board of trade or exchange on which they are traded. Gains and losses are realized when the contracts expire or are closed. There were unrealized gains of $1.5 million and unrealized losses of $0.7 million on these future contracts at June 30, 2019 and June 30, 2018, respectively.

The University liabilities arising from variable-to-fixed interest rate swap agreements associated with certain University debt obligations had an aggregated fair value of $77.6 million and $56.8 million at June 30, 2019 and 2018, respectively, and are included in other liabilities on the Consolidated Balance Sheets (see also Note 6). The fair value represents the estimated amount the University would be required to pay to terminate these agreements as of the respective fiscal year-end. The University recorded in the Consolidated Statements of Activities an unrealized loss of $20.8 million in 2019 and an unrealized gain of $20.5 million in 2018, due to changes in fair value of the swaps.

The aggregate notional amount of the swap agreements associated with University debt was $320.3 million and $335.3 million at June 30, 2019 and 2018, respectively. These swaps were entered into for the sole purpose of hedging interest payable on certain University VRDBs. The variable interest rates received by the University under the swap agreements are either 67% or 70% of one- or three-month London Interbank Offered Rates (LIBOR), while the fixed rates paid by the University range from 3.25% to 5.14%. Net swap payments made or received by the University are reported in interest expense in the Consolidated Statements of Activities. No collateral was called or posted during 2019 or 2018 with respect to these swap agreements. Furthermore, the University does not anticipate posting collateral pursuant to these swap agreements since there are no collateral thresholds applicable to the University given the University’s current credit ratings.


22

NOTE 10: PENSION AND POSTRETIREMENT OBLIGATIONS

Pension The University provides retirement benefits under contributory or noncontributory plans to substantially all employees. The University’s contributory plan provides for participant directed investment in certain investments managed by the Teachers Insurance and Annuity Association (TIAA) and College Retirement Equities Fund (CREF) and in certain investment funds of the Vanguard Group. The plan requires three years of service for vesting of the University contribution. Employees hired before January 1, 1995 were immediately vested. University contributions to this plan in 2019 and 2018 were $86.3 million and $82.5 million, respectively.

The noncontributory plan is a defined-benefit pension plan that covers employees who do not participate in the contributory plan. The plan was amended to freeze new entrants effective November 3, 2015. The plan provides for vesting after five years with pension benefits accruing at 2.1% of base salary or the Social Security wage base, whichever is lower. Pension benefits are payable upon normal retirement at age 65 or early retirement at age 55, in accordance with the conditions and pension eligibility criteria described in the plan. University contributions to this plan in 2019 and 2018 were $4.9 million and $6.7 million, respectively.

Postretirement The University also provides postretirement medical and life insurance benefits to eligible employees and their spouses upon retirement through a contributory benefit plan.

Though funding is not required, the University has elected to fund its postretirement liability via a Board designated endowment fund, which is managed within the University’s pooled endowment investments (see Notes 5 and 12). The fair value of this fund at June 30, 2019 and 2018 was $479.5 million and $455.0 million, respectively, and is included in endowment investments on the Consolidated Balance Sheets. Although the University has established this endowment for the postretirement plan, payments to beneficiaries of this plan are currently made through non-endowed operating funds.

Under the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, the federal government provides a subsidy to employers equal to 28% of the employer’s qualifying prescription drug costs for retirees if the plan offered by the employer is at least actuarially equivalent to Medicare Part D. The University is qualified for and receives the subsidy via a reduction in premiums charged by its provider.

23

The University uses a measurement date of June 30 for plan assets and the benefit obligations. Information related to the benefit obligation, assets, and funded status of the defined-benefit pension plan and the postretirement benefit plan as of and for the years ended June 30, 2019 and 2018 is summarized in the table below:

Defined-Benefit Plan Postretirement Plan 2019 2018 2019 2018

(in thousands of dollars)

Service cost $ 7,151 $ 8,089 $ 19,099 $ 19,224

Other components of net periodic benefit cost:Interest cost $ 6,950 $ 6,069 $ 22,179 $ 20,237 Expected return on plan assets (10,480) (9,393) - - Actuarial loss 1,287 1,887 2,305 3,637 Total $ (2,243) $ (1,437) $ 24,484 $ 23,874

Funded status: Benefit obligation at beginning of year $ 164,979 $ 156,877 $ 531,620 $ 528,040 Service cost 7,151 8,089 19,099 19,224 Interest cost 6,950 6,069 22,179 20,237 Actuarial loss (gains) 24,610 (4,783) 24,170 (19,003) Benefits paid (1,499) (1,273) (18,034) (16,878) Benefit obligation at end of year $ 202,191 $ 164,979 $ 579,034 $ 531,620

Fair value of plan assets at beginning of year $ 146,011 $ 130,831 Actual return on plan assets 8,961 9,801 Actual plan contributions 4,907 6,652 Benefits paid (1,499) (1,273) Fair value of plan assets at end of year $ 158,380 $ 146,011

Funded status – liability recognized on Consolidated Balance Sheets:

Pension and postretirement obligations $ (43,811) $ (18,968) $ (579,034) $ (531,620)

Accumulated benefit obligation $ 193,323 $ 157,471

Estimated 2020 employer contribution to the defined-benefit plan: (in thousands of dollars) $ 6,728


24

Defined-Benefit Plan Postretirement Plan 2019 2018 2019 2018

Weighted-average assumptions used to determine the benefit obligation (liability) at June 30: Discount rate 3.8% 4.25% 3.7% 4.25%Rate of compensation increase 3.0% 3.0% - -Assumed health care trend cost:

Initial trend – pre-age 65 retirees - - 6.75% 7.0%Initial trend – post-age 65 retirees - - 6.0% 6.0%Ultimate trend - - 4.5% 4.5%Year to reach ultimate - - 2029 2026

Weighted-average assumptions used to determine the net periodic cost (expense) for the years ended June 30:Discount rate 4.25% 3.9% 4.25% 3.9%Rate of compensation increase 3.0% 3.0% - -Expected long-term return on plan assets 7.25% 7.25% - -Assumed health care trend cost:

Initial trend – pre-age 65 retirees - - 7.0% 7.0%Initial trend – post-age 65 retirees - - 6.0% 7.0%Ultimate trend - - 4.5% 4.5%Year to reach ultimate - - 2026 2025

Estimated future benefit payments: Defined-Benefit

Plan Postretirement

Plan (in thousands of dollars)

2020 $ 4,452 $ 18,369 2021 $ 4,829 $ 21,340 2022 $ 5,226 $ 22,846 2023 $ 5,703 $ 24,513 2024 $ 6,152 $ 26,019 2025 – 2029 $ 38,260 $ 153,856

25

A one-percentage point change in assumed health care cost trend rates would have the following effects on the postretirement plan:

Increase Decrease (in millions of dollars)

Revised Amount

Percent Change

Revised Amount

Percent Change

Service and interest cost (medical component only) $ 39.3 2.2% $ 37.6 2.3% Total periodic benefit cost $ 45.3 3.9% $ 41.7 4.3% Benefit obligation for health care benefits $ 546.1 3.1% $ 510.6 3.6% Total benefit obligation $ 595.2 2.8% $ 559.9 3.3%

Pension Assets Assets related to the University’s defined-benefit pension plan are segregated in a trust managed by a third-party investment manager. The fair value of these assets at June 30, 2019 and 2018 was $158.4 million and $146.0 million, respectively. The fund is invested through common collective trust funds in domestic and international equities and fixed-income securities using the S&P 500 Index as a benchmark for domestic equities, the MSCI EAFE Index for international equities, and the Barclays Intermediate Government/Credit Bond Index for the fixed-income securities. Common collective trust funds are similar to mutual funds; however, they are generally not registered with the U.S. Securities and Exchange Commission and participation is not open to the public but limited to institutional investors. The specific investment objective is to meet or exceed the investment policy benchmark over the long term. Plan investment valuations are determined using NAV per share available at the measurement date, as published by the fund manager. The plan has no unfunded commitments. Pension plan assets are Level 1 in the fair value hierarchy.

The long-term investment strategy for pension plan assets is to meet present and future benefit obligations to all participants and beneficiaries; cover reasonable expenses incurred to provide such benefits, including expenses incurred in the administration of the trust and the plan; provide sufficient liquidity to meet benefit and expense payment requirements on a timely basis; and provide a total return that, over the long term, maximizes the ratio of trust assets to liabilities by maximizing investment return, at an appropriate level of risk. The expected return on plan assets is based on a weighted average of the individual expected return for each asset category in the plan’s portfolio. Expected return comprises inflation plus the real rate of return for each asset class.

Over the long term, asset allocation is believed to be the single greatest determinant of risk and return. Asset allocation will deviate from the target percentages due to market movement, cash flows, and investment manager performance. Material deviations from the asset allocation target can alter the expected return and risk of the trust. However, frequent rebalancing to the asset allocation targets may result in significant transaction costs, which can impair the trust’s ability to meet its investment objective.

The target allocation for both fiscal years and the fair value of the University’s pension plan assets at June 30, by asset category, were as follows:

Target Allocation 2019 2018

Asset class: (in thousands of dollars) Equity securities:

Stock index and small cap 35% $ 55,096 $ 50,326 International 35% 55,525 51,049 Debt securities 30% 47,475 44,136

Cash and cash equivalents - 284 500 Total pension plan assets $ 158,380 $ 146,011


26

NOTE 11: NET ASSETS

Net assets at June 30 consist of the following: 2019

Without Donor Restrictions

With Donor Restrictions Total

(in thousands of dollars) Endowments – instruction and academic support $ - $ 1,084,845 $ 1,084,845 Endowments – financial aid - 374,395 374,395 Endowments – other - 204,226 204,226 Endowment designated for financial aid 1,704,446 - 1,704,446Endowment designated for postretirement benefits 479,494 - 479,494Endowments designated for schools and other 468,429 - 468,429

Total endowment net assets 2,652,369 1,663,466 4,315,835

Net invested in plant and other 763,467 - 763,467Pledges, loan funds, and other - 89,458 89,458Total net assets $ 3,415,836 $ 1,752,924 $ 5,168,760

2018 Without Donor

Restrictions With Donor Restrictions Total

(in thousands of dollars) Endowments – instruction and academic support $ - $ 1,047,947 $ 1,047,947 Endowments – financial aid - 363,959 363,959 Endowments – other - 195,854 195,854 Endowment designated for financial aid 1,683,220 - 1,683,220Endowment designated for postretirement benefits 454,963 - 454,963Endowments designated for schools and other 479,361 - 479,361

Total endowment net assets 2,617,544 1,607,760 4,225,304

Net invested in plant and other 729,390 - 729,390Pledges, loan funds, and other - 102,100 102,100Total net assets $ 3,346,934 $ 1,709,860 $ 5,056,794

Endowments with donor restrictions require the original corpus be maintained in perpetuity. The distributions generated by these funds may be either expended or reinvested in the endowment, in accordance with donor restrictions and the endowment contribution and spending policy (see Note 12). Expendable funds are made available for the schools to use for instruction, academic support, scholarships, fellowships, chairs and other academic initiatives in accordance with donor wishes and University policy. The principal of endowment funds with donor restrictions was $771.8 million and $738.4 million as of June 30, 2019 and 2018, respectively. Pledges, loan funds, and other includes endowed and non-endowed pledges and student loan funds restricted by donors.

The endowment designated for financial aid was established exclusively to provide financial aid to students. During 2019 and 2018, the endowment distributed $66.6 million and $59.5 million, respectively (Note 2).

The endowment designated for postretirement benefits was established by the Board of Trustees to support the University’s postretirement health and life insurance

benefits for employees. Distributions from this endowment totaled $18.3 million and $16.9 million in 2019 and 2018, respectively, and were returned to principal. Postretirement liabilities of $579.0 million as of June 30, 2019 and $531.6 million as of June 30, 2018 are reported in pension and postretirement liabilities on the Consolidated Balance Sheets.

Endowments designated for schools and other include both Board and management designated endowments. Endowments designated to the schools support scholarships, fellowships, chairs, and other academic initiatives. Endowments designated by management support self-insurance liabilities and other general purposes. Cash not yet invested in the consolidated endowment pool as of June 30 is included in endowments designated for schools and other.

Invested in plant and other primarily includes the value of University property net of debt and other capital-related liabilities. Other capital-related liabilities include the valuation of the University’s interest rate swap agreements and the conditional asset retirement obligation (see Note 7).

27

NOTE 12: ENDOWMENT NET ASSETS

The commonwealth has not adopted The Uniform Prudent Management of Institutional Funds Act of 2006 (UPMIFA) and, instead, enacted in December 1998 Pennsylvania Act 141 (codified as Title 15 of the Pennsylvania Consolidated Statutes §5548(c) and referred to herein as Title 15) to govern the investment of restricted funds held in trust by Pennsylvania nonprofit corporations. Title 15 permits Pennsylvania nonprofit corporations to elect a total return approach for determining income distributions from restricted funds held in trust, whereby income is defined as a stipulated percentage of the value of the assets held; the stipulated percentage must be determined at least annually and may be no less than 2% nor more than 7%, and the value of the assets held must be averaged over a period of three or more preceding years. A resolution to elect a total return approach for determining endowment income distributions for the University’s consolidated investment pool was passed by the University’s Board of Trustees on

October 21, 1999. The University’s endowment income distribution is determined annually using a stipulated percentage of 4.25% of the endowment’s three-year average fair value, provided that such distribution is not less than the amount distributed in the previous year.

Employing the total return approach, the University records the original value of an endowed contribution as net assets with donor restrictions, along with any endowment income distributions that are reinvested in the endowment. Non-endowed funds that lack third-party donor restrictions but function as endowments (designated endowments) are classified as net assets without donor restrictions. Gains and losses attributable to donor-restricted endowed funds and designated endowment funds are recorded as net assets with donor restrictions and without donor restrictions, respectively.

The change in endowment net assets for the years ended June 30, 2019 and 2018 was as follows:

Without Donor

Restrictions

With Donor

Restrictions Total (in thousands of dollars)

Endowment net assets – June 30, 2017 $ 2,439,453 $ 1,515,088 $ 3,954,541 Endowment return:

Endowment earnings 15,285 1,495 16,780 Gains 262,111 64,054 326,165 Total endowment return 277,396 65,549 342,945 Contributions 270 27,123 27,393 Distributions for operations (136,144) - (136,144)Net transfers 36,569 - 36,569

Endowment net assets – June 30, 2018 2,617,544 1,607,760 4,225,304 Endowment return:

Endowment earnings 15,603 1,657 17,260 Gains 165,017 22,559 187,576 Total endowment return 180,620 24,216 204,836 Contributions 136 31,490 31,626 Distributions for operations (146,014) - (146,014)Net transfers 83 - 83

Endowment net assets – June 30, 2019 $ 2,652,369 $ 1,663,466 $ 4,315,835

Approximately 99% of the University’s endowment funds are collectively managed in a broadly diversified pool of assets called the consolidated investment pool. The Investment Committee of the Board of Trustees provides

general oversight, policy guidance, and performance review of the consolidated investment pool and approves asset allocation and spending policies.


28

NOTE 13: FUNCTIONAL EXPENSES

The University accounts for expenses according to major classes of program services or functions. Functional expenses for the years ended June 30 consist of the following:

2019 Program Services

Academics Research

and Related Student Services

Auxiliary Enterprises

Support Services

Total

(in thousands of dollars) Salaries and wages $ 495,462 $ 373,335 $ 76,385 $ 20,881 $ 88,983 $ 1,055,046 Fringe benefits 136,459 105,269 24,981 7,359 26,023 300,091 Total compensation 631,921 478,604 101,366 28,240 115,006 1,355,137 Supplies 33,995 71,021 9,109 2,750 5,794 122,669 Business and professional 60,505 187,642 40,909 45,106 40,141 374,303 Facilities 45,541 22,463 8,526 19,608 7,219 103,357 Depreciation 79,570 46,784 16,793 26,445 15,243 184,835 Interest 12,032 7,126 2,535 6,067 2,377 30,137 Rent 19,110 26,451 2,851 1,104 2,991 52,507 Other 1,570 19,157 4,421 23,340 (6,187) 42,301 Total operating expenses 884,244 859,248 186,510 152,660 182,584 2,265,246 Other components of net periodic benefit cost 10,445 7,871 1,610 440 1,875 22,241 Total $ 894,689 $ 867,119 $ 188,120 $ 153,100 $ 184,459 $ 2,287,487

2018 Program Services

Academics Research and Related

Student Services

Auxiliary Enterprises

Support Services

Total

(in thousands of dollars) Salaries and wages $ 483,087 $ 350,628 $ 70,194 $ 18,926 $ 82,239 $ 1,005,074 Fringe benefits 133,217 98,486 22,966 6,739 24,822 286,230 Total compensation 616,304 449,114 93,160 25,665 107,061 1,291,304 Supplies 31,156 66,594 7,294 1,945 5,043 112,032 Business and professional 61,109 179,210 38,298 41,491 30,299 350,407 Facilities 43,879 21,808 7,193 17,789 4,436 95,105 Depreciation 77,438 44,260 15,178 26,454 13,880 177,210 Interest 11,998 6,914 2,346 6,614 2,299 30,171 Rent 18,497 26,821 2,542 13 2,210 50,083 Other 4,060 15,978 6,321 23,740 (3,187) 46,912 Total operating expenses 864,441 810,699 172,332 143,711 162,041 2,153,224 Other components of net periodic benefit cost 10,785 7,829 1,566 422 1,835 22,437 Total $ 875,226 $ 818,528 $ 173,898 $ 144,133 $ 163,876 $ 2,175,661

Costs related to the operation and maintenance of property, including depreciation of property and equipment and interest on related debt, are allocated to program services and support services based upon salary effort.

Academics includes instructional, academic support, and library costs. Research and related includes sponsored programs related to research and development as well as public service activity such as clinical trials. Student

services represents expenses supporting the well-being and development of students outside of direct instruction. Student admissions, registration, counseling, and advising, as well as intercollegiate athletics are included in student services. Auxiliary enterprises consists of costs to provide services to students, faculty, and staff, such as student housing, meal plans, parking, and book store activity. Support services consists of institution-wide functions in support of the University’s academic, research, and public service mission.

29

NOTE 14: RELATED PARTIES

The University has relationships and affiliation agreements with separately incorporated entities including UPMC and affiliated hospitals and UPP. These relationships include a common paymaster arrangement for certain University School of Medicine (SOM) faculty with academic and clinical responsibilities; contractual

obligations for UPMC and UPP to support certain educational and research functions at the University; and property rental agreements. There is no guarantee these agreements will be renewed in future periods. Transactions with all related entities are conducted in the ordinary course of business and are discussed below.

The following summarizes the significant related party transactions between the University and UPMC for the years ended June 30, 2019 and 2018:

Service Agreement Location on the Consolidated

Financial Statements 2019 2018 (in thousands of dollars)

Common paymaster arrangement(a) Net on balance sheet $ 119,196 $ 113,878 Facilities-related services, mail, telephone,

printing, and other services(a) Net on balance sheet 16,491 15,249

Net balance sheet transactions with UPMC $ 135,687 $ 129,127

UPMC dean’s tax, Children’s Hospital of Pittsburgh, and other academic support(b)

Sales and services, educational and other $ 104,178 $ 84,642

UPMC academic affiliation agreement(c) Sales and services, educational and other 31,000 30,500

UPMC Hillman Cancer Center research support payments(d)

Sales and services, educational and other 17,237 10,039

Rental revenue(e) Rental revenue 10,209 10,226 Cost sharing for Medical and Health Sciences Foundation(f)

Sales and services, educational and other 3,657 3,644

UPMC Enterprises Contributions for operations 2,250 - Institute for Personalized Medicine Sales and services, educational

and other 1,880 1,946

Revenues from UPMC $ 170,411 $ 140,997

Health insurance coverage for University employees(g) Fringe benefits $ 130,608 $ 124,970 WPIC and UPMC Hillman Cancer Center research services(h) Primarily compensation 27,007 26,258 Rental expense paid to UPMC(e) Rent 23,999 23,332

Expenses paid to UPMC $ 181,614 $ 174,560

(a) Certain University SOM faculty and staff provide clinical services through their University appointments to UPMC,UPP, and affiliated hospitals. The University invoices these entities monthly for reimbursement of the clinical portion ofthe associated compensation costs. SOM faculty members, having both a University academic appointment and aseparate, external appointment for clinical responsibilities, participate in the common paymaster arrangement forpurposes of determining appropriate FICA taxation. In addition to the reimbursable compensation costs, the Universityalso engages in other transactions with these entities, which include providing certain facilities-related services,telephone, mailing, printing, and various other services, which are reimbursed at cost.


30

(b) UPMC provides support to the SOM for the school’s general academic mission, research, new programs, and facultyrecruitment; and to augment operating budgets for certain departments that do not generate sufficient revenues to meettheir academic and research costs. Additionally, UPMC provides financial support to the SOM through the Children’sHospital of Pittsburgh of UPMC (CHP), which supports pediatric research programs.

(c) The University signed an agreement with UPMC that included financial commitments designed to further the twoentities’ commitment to their interrelated teaching, research, clinical care, and community service missions. As part ofthe agreement, UPMC provides annual funding for the SOM.

(d) UPMC provides support payments to the UPMC Hillman Cancer Center (UHCC) for various subsidies, researchinitiatives, and general support.

(e) The University is involved in certain rental arrangements in which the University acts as both lessor or lessee withUPMC and its affiliates.

(f) In 2003, the University and UPMC created the Medical and Health Sciences Foundation (MHSF), a separate 501(c)(3)organization. The MHSF serves as a unified fundraising organization for the University’s schools of the health sciencesand UPMC. The arrangement calls for the cost of MHSF to be split between the University and UPMC.

(g) UPMC serves as the provider of health insurance coverage to all eligible University employees who enroll in the plan.The University is self-insured for these costs and reimburses UPMC for actual claims cost.

(h) The University has an arrangement with UPMC whereby certain research-related costs incurred by UPMC (primarilystaff compensation) in relation to WPIC and UHCC research awards are charged to such awards via an electronic billingand reimbursed to UPMC each month.

A lease arrangement exists between the University and the commonwealth for WPIC. Since 1949, the University has managed WPIC under an agreement between the University and the commonwealth whereby the University rents for a consideration of $1 per year the land, building, equipment, and other items that are used by WPIC. The agreement provides for continuing terms of 10 years each; however, this agreement is cancelable by either party on one year’s written notice. In 1992, the University subleased to UPMC the land, building,

equipment, and other items subject to the current lease arrangement between the commonwealth and the University. This sublease arrangement continued to be in effect during 2019 and 2018. Included in property, plant, and equipment is $181.4 million and $193.2 million at June 30, 2019 and 2018, respectively, related to the land, buildings, and equipment used by WPIC. Accumulated depreciation related to these assets totaled $156.9 million and $167.6 million at June 30, 2019 and 2018, respectively.

31

NOTE 15: COMMITMENTS AND CONTINGENCIES

At June 30, 2019 and 2018, the University had outstanding contractual commitments of $141.8 million and $66.1 million, respectively, for property, plant, and equipment expenditures.

The University engages in various leasing activities as both a lessor and lessee. Rental revenue from operating leases was $18.3 million and $18.4 million in 2019 and 2018, respectively. Rental expense for operating leases was $52.5 million in 2019 and $50.1 million in 2018. Minimum future rental revenue and expense under operating leases that have initial or remaining noncancelable lease terms or expected variable lease commitments for the years ended June 30 are as follows:

Rental Revenue

Rental Expense

(in thousands of dollars) 2020 $ 16,873 $ 54,391 2021 $ 16,140 $ 43,378 2022 $ 13,312 $ 37,678 2023 $ 11,523 $ 32,291 2024 $ 9,721 $ 30,054 Thereafter $ 7,617 $ 136,868

The University classifies certain lease transactions as capital leases. As of June 30, 2019 and 2018, assets recorded under capital leases were $42.6 million and $18.1 million, respectively, and accumulated depreciation recorded under capital leases was $13.7 million and $11.2 million, respectively. During 2019, the University acquired property and equipment under capital leases totaling $24.5 million. There was no property or equipment acquired under capital leases in 2018. As of June 30, 2019 and 2018, capital lease obligations included in other liabilities on the Consolidated Balance Sheets were $29.6 million and $6.7 million, respectively. Future minimum lease payments under non-cancellable capital leases in thousands of dollars for the years ended June 30 are as follows:

2020 $ 3,005 2021 2,861 2022 2,884 2023 2,908 2024 2,975 Thereafter 29,371 Total payments 44,004 Less: interest (14,419)Total $ 29,585

In May 2019, the University entered into a transaction with a third-party developer and its affiliates to develop a mixed-use facility consisting of commercial, laboratory, parking, and office space at 5051 Centre Avenue in Pittsburgh. The transaction calls for the University to lease portions of the property to the developer with the University leasing back a portion of the space for research and academic purposes once the development is completed in a few years. The transaction will be accounted for in accordance with ASU No. 2016-02, Leases, once the new accounting standard is adopted in 2020 (see Note 1 – Recent Accounting Pronouncements).

The University is a defendant in a number of legal actions seeking damages and other relief from the University. While the final outcome of each action cannot be determined at this time, legal counsel and University management are of the opinion that the liability, if any, in these legal actions will not have a material adverse effect on the University’s consolidated financial statements.

The University receives significant financial assistance from the federal government including the sponsorship of federal research projects. Research grants and contracts normally provide for the recovery of direct and indirect costs. Recovery of indirect costs is recorded at predetermined rates negotiated with the federal government. Indirect cost recovery rates from nonfederal sources may vary. Entitlement to these resources for the recovery of the applicable direct and related indirect costs is generally conditioned upon compliance with the terms and conditions of the grant or contract agreements and applicable federal regulations, including the expenditure of the resources for eligible purposes. Substantially all grants and contracts, and the University’s indirect cost rate, are subject to financial and compliance reviews and audits by the grantors. Funds received through federal sources are subject to audit each year in accordance with the Office of Management and Budget’s Uniform Guidance. In management’s opinion, the likelihood of a material adverse outcome on the University’s financial position from those reviews and audits is remote.

As part of ongoing operations, the University enters into utility contracts to secure electric and natural gas rates. These contracts are with various utility suppliers and some of the contracts cover multiple years. The University monitors the energy markets on an ongoing basis and will make commitments on new rates if deemed in the best interest of the University.


32

The University conducts a review of contracts and agreements that may contain guarantees, including loan guarantees such as standby letters of credit and indemnifications. In certain contracts, the University agrees to indemnify a third-party service provider under certain circumstances. Pursuant to its bylaws, the University provides indemnification to directors, officers,

and, in some cases, employees and agents against certain liabilities incurred as a result of service provided on behalf of or at the request of the University. The terms of indemnity vary from agreement to agreement, and the amount of indemnification, if any, cannot be reasonably determined.

NOTE 16: SUBSEQUENT EVENTS

The University has evaluated subsequent events through October 16, 2019, the date on which the consolidated financial statements were issued and determined that

there were no subsequent events requiring additional disclosure or adjustment to the consolidated financial statements.

33

MEMBERSHIP OF THE BOARD OF TRUSTEES FISCAL YEAR 2019

M E M B E R S

E X O F F I C I O ( N O N V O T I N G )

Tom W. Wolf, Governor

of the Commonwealth of Pennsylvania

Pedro A. Rivera, Secretary of Education of the Commonwealth of Pennsylvania

Rich Fitzgerald, Allegheny County Executive

William Peduto, Mayor of the City of Pittsburgh

2018 – 2022 Mary Ellen Callahan Vaughn S. Clagette James P. Covert Keith E. Schaefer

2019 – 2023 Douglas M. Browning Louis R. Cestello David C. Chavern Deborah J. Gillotti

A L U M N I T R U S T E E S

2016 – 2020 S. Jeffrey Kondis Jack D. Smith

2017 – 2021 Larry J. Merlo

2018 – 2022 Jane Bilewicz Allred Gary T. Brownlee

2019 – 2023 Michael G. Wells

E M E R I T U S T R U S T E E S

J. David BarnesSteven C. BeeringThomas G. BigleySuzanne W. BroadhurstJohn G. ConomikesGeorge A. Davidson Jr. Catherine D. DeAngelis Herbert P. Douglas Jr.D. Michael FisherE. Jeanne GleasonJ. Roger GluntEarl F. HordPaul E. LegoGeorge L. Miles Jr. Frank E. MosierAlfred L. MoyéThomas H. O’BrienAnthony J.F. O’ReillyRobert A. PaulJames C. RoddeyFarrell RubensteinRichard P. SimmonsCharles M. SteinerJohn A. SwansonBurton M. Tansky Dick Thornburgh Thomas J. Usher

M E M B E R

E X O F F I C I O

( V O T I N G )

Patrick Gallagher, Chancellor and Chief Executive Officer

S P E C I A L T R U S T E E S

2016 – 2020 Robert M. Hernandez Marlee S. Myers Shawndya L. Simpson Vacant

2017 – 2021 SaLisa L. Berrien Tamara M. Haddad Adam C. Walker Vacant

2018 – 2022

Sundaa Bridgett-Jones Wen-Ta Chiu David J. Morehouse Marna Cupp Whittington

2019 – 2023 Robert O. Agbede G. Nicholas Beckwith IIIEmil SpadaforeA. David Tilstone

C O M M O N W E A L T H

T R U S T E E S

G: Governor appointment H: House appointment S: Senate appointment

2015 – 2019 Jake Wheatley Jr. (G) Herbert S. Shear (H) Peter C. Varischetti (S)

2016 – 2020 Bradley J. Franc (G) Thomas O. Johnson II (H) Jay Costa Jr. (S)

2017 – 2021 Sy Holzer (G) Thomas VanKirk (H) William K. Lieberman (S)

2018 – 2022Vacant (G) John A. Maher III (H) John J. Verbanac (S)

T E R M T R U S T E E S

2016 – 2020 John A. Barbour Eva Tansky Blum Edward J. Grefenstette Patricia D. Horoho

John H. Pelusi Jr.

2017 – 2021 Ira J. Gumberg Dawne S. Hickton Roberta A. Luxbacher Thomas E. Richards

The consolidated financial statements have been reviewed and approved by the University’s Audit Committee. The Audit Committee is comprised of outside directors having requisite financial expertise and meets regularly with University management and both internal and external auditors to review internal accounting controls, audit issues, and financial reporting matters. The Committee meets with the external auditors in private sessions and is also responsible for approving the independent auditing firm retained each year. Nonvoting representatives on the Committee include members of the University’s administration as well as student, faculty, and staff representatives.

SCHEDULE OF EXPENDITURES OF FEDERAL AWARDS AND AUDITORS’ REPORT AS REQUIRED BY TITLE 2 U.S. CODE OF

FEDERAL REGULATIONS PART 200

UNIVERSITY OF PITTSBURGH OF THECOMMONWEALTH SYSTEM OF HIGHER EDUCATION

Schedule of Expenditures of Federal Awards


CFDA Direct Award or pass-through Passed Through FederalFederal Grantor/Pass Through Grantor/Program Title Number entity identifying number to Subrecipients Expenditures

I. RESEARCH & DEVELOPMENT CLUSTER:

Department of Health and Human Services:Administration for Children and Families:

Westat, Inc. 93.000 6469-01-S001 $ - $ 9,430 Westat, Inc. 93.000 6469-02-S001 - 80,538

Subtotal 93.000 - 89,968

Total Administration for Children and Families - 89,968

Administration for Community Living:ACL National Institute on Disability, Independent Living, and

Rehabilitation Research 93.433 Direct 713,134 4,906,739 Craig Hospital 93.433 UP001 - 5,343 Gallaudet University 93.433 0000023621 - 31,628 University of Alabama 93.433 000509854-002 - 19,706 University of Michigan 93.433 3004739336 - 68,193 University of Oklahoma 93.433 RS20181718-01 - 14,150

Subtotal 93.433 713,134 5,045,759

Other Administration for Community Living 93.000 Direct - 70,623 Total Administration for Community Living 713,134 5,116,382

Agency for Healthcare Research and Quality:Research on Healthcare Costs, Quality and Outcomes 93.226 Direct 529,550 2,779,333 Columbia University 93.226 2(GG014652-01) - 18,277 Commonwealth of Pennsylvania 93.226 4300572242 22,977 163,627 Commonwealth of Pennsylvania 93.226 OUD RURAL PA 46,689 436,959 Tufts University 93.226 HH5422 - 88,311 University of Arizona 93.226 455834 - 149,926 University of Illinois 93.226 16661 - 4,927 University of Massachusetts 93.226 OSP2017064 - 3,302 University of North Carolina 93.226 5111271 - 16,280 Vanderbilt University Medical Center 93.226 VUMC 67801 - 6,936

Subtotal 93.226 599,216 3,667,878

Total Agency for Healthcare Research and Quality 599,216 3,667,878

Centers for Disease Control and Prevention:Innovations in Applied Public Health Research 93.061 Direct 62,916 435,861 Gaia Medical Institute 93.061 SALIVA BIOMARKERS - 3,115

Subtotal 93.061 62,916 438,976

Baobab Health Trust 93.067 COAG 2 - 91,154 Prevention of Disease, Disability, and Death through

Immunization and Control of Respiratory and Related Diseases 93.083 Direct - 764,211

Commonwealth of Pennsylvania 93.094 4300557058 - 122 Commonwealth of Pennsylvania 93.094 4300596656 - 12,000 Commonwealth of Pennsylvania 93.094 4300616620 - 64,722

Subtotal 93.094 - 76,844

Centers for Research and Demonstration for HealthPromotion and Disease Prevention 93.135 Direct - 652,323

Injury Prevention and Control Research and Stateand Community Based Programs 93.136 Direct 95,150 177,173

Commonwealth of Pennsylvania 93.136 4300590165 - 190,382 Medical College of Wisconsin 93.136 EARLY AWARD - 120,196

Subtotal 93.136 95,150 487,751

Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects 93.185 Direct - 2,952,568

Occupational Safety and Health Program 93.262 Direct 299,233 1,573,090 CPWR The Center for Construction Research and Training 93.262 3001-817-01 NIOSH 73,709 139,301 Mount Sinai School of Medicine 93.262 0254-5765-4609 - 7,058 Mount Sinai School of Medicine 93.262 0254-5766-4609 - 23,156 Texas A&M Engineering Experiment Station 93.262 28-M1803757 - 56,073 University of Southern California 93.262 67526719 - 472

Subtotal 93.262 372,942 1,799,150

34





Rare Disorders: Research, Surveillance, Health Promotionand Education 93.315 Direct - 66,982

Spina Bifida Association 93.315 14-2635 - 29,572 Subtotal 93.315 - 96,554

Johns Hopkins University 93.317 204222200 - 108,524 Johns Hopkins University 93.317 2003961962 - 190,595

Subtotal 93.317 - 299,119

Commonwealth of Pennsylvania 93.336 4300584791 - (458) Commonwealth of Pennsylvania 93.336 4300584804 - 410,387 North Dakota Department of Health 93.336 PF17.086 - 201,337 North Dakota Department of Health 93.336 200388831 - 228,767

Subtotal 93.336 - 840,033

American Academy of Pediatrics 93.421 851111-PITT - 5,258 Commonwealth of Pennsylvania 93.426 4300609353 - 56,603 Johns Hopkins University 93.521 PHPA-G2650 - 1,267 Prevention and Public Health Fund (Affordable Care Act)

Enhanced Surveillance for New Vaccine Preventable Disease 93.533 Direct - 29,515 National Association of Chain Drug Stores Foundation 93.733 1H23 IP000985-01 - 1,505 Idaho Department of Health and Welfare 93.745 HC979800 - 107,900 Commonwealth of Pennsylvania 93.940 4300533540 - (3,627) Pennsylvania Pharmacists Association 93.945 4100065634 R2 - 24,574 Child Trends, Inc. 93.946 1372-00-002 - 1,736 Magee-Womens Research Institute & Foundation 93.991 EARLY AWARD - 59,270

Other Centers for Disease Control and Prevention 93.000 Direct - 570,881 RTI International 93.000 4-312-0215511-52924L - 7,070

Subtotal 93.000 - 577,951

Total Centers for Disease Control and Prevention 531,008 9,360,635

Centers for Medicare and Medicaid Services:University of North Carolina 93.610 5107360 - 7,897 Centers for Medicare and Medicaid Services (CMS) Research,

Demonstrations and Evaluations 93.779 Direct - 74,413 Allegheny County 93.000 EARLY AWARD - 42,251

Total Centers for Medicare and Medicaid Services - 124,561

Food and Drug Administration:Albert Einstein College of Medicine 93.103 679835 - 17,065 Carnegie Mellon University 93.103 1090569-408772 - 121,597 Children's Hospital of Philadelphia 93.103 ACTIVITY #3201480819 - 96,608 Duke University 93.103 207574/215728 - 40 Emory University 93.103 T447384 - 26,059 Magee-Womens Research Institute & Foundation 93.103 9144 - 23,308 Magee-Womens Research Institute & Foundation 93.103 9145 - 11,606 New England Pediatric Device Consortium 93.103 NEPDC-010 - 2,739 University of Florida 93.103 UFOCR00012071 - 9,871

Subtotal 93.103 - 308,893

Magee-Womens Research Institute & Foundation 93.000 9154 - 61,025 University of Southern California 93.000 94065140 - 3,380

Subtotal 93.000 - 64,405

Total Food and Drug Administration - 373,298

Health Resources and Services Administration:Health Research, Inc. 93.110 5606-01 - (6,335) Health Research, Inc. 93.110 5606-02 - 41,759 Massachusetts General Hospital 93.110 226858 - 29,545 Massachusetts General Hospital 93.110 226859 - 27,080 Massachusetts General Hospital 93.110 227146 - 20,515 Rand Corporation 93.110 9920160068 - 626

Subtotal 93.110 - 113,190

Research Institute at Nationwide Children's Hospital 93.127 710040-0818-00 - 28,540 Research Institute at Nationwide Children's Hospital 93.127 710040-0819-00 - 97,288

Subtotal 93.127 - 125,828

35





Grants to Increase Organ Donations 93.134 Direct 32,451 279,504

HIV-Related Training and Technical Assistance 93.145 Direct 1,889,247 2,908,198 Rutgers University 93.145 0759 19,058 28,068 Rutgers University 93.145 821743 9,288 8,831 University of Massachusetts 93.145 OSP2018085 - 61,944

Subtotal 93.145 1,917,593 3,007,041

National Research Service Award in Primary Care Medicine 93.186 Direct - 361,793 One Care of Southwest Virginia, Inc. 93.211 HRSA-18-116 - 39,528

University of North Carolina 93.300 5110180 - 15,486 University of North Carolina 93.300 5113256 - 17,307

Subtotal 93.300 - 32,793

Fulton County Family Partnership, Inc. 93.912 HRSA- 001 - 30,603

Hennepin Healthcare Research Institute 93.000 LIVING DONOR PROJECT - 68,767

Total Health Resources and Services Administration 1,950,044 4,059,047

National Institutes of Health:Family Smoking Prevention and Tobacco Control Act

Regulatory Research 93.077 Direct 16,665 333,581 Duke University 93.077 2036158 - 233,035 University of Southern California 93.077 98523373 - 21,306

Subtotal 93.077 16,665 587,922

Environmental Health 93.113 Direct 229,335 5,791,951 University of Cincinnati 93.113 010539-007 - 61,304 University of New Mexico 93.113 3RAV2 - 49,099 Wayne State University 93.113 WSU14055-A4 - 10,218

Subtotal 93.113 229,335 5,912,572

Oral Diseases and Disorders Research 93.121 Direct 2,444,378 8,832,306 Emory University 93.121 A059210 - 17,111 HealthPartners Institute for Education and Research 93.121 X1510700PITT - 38,883 International Agency for Research on Cancer 93.121 GEP/17/05 - 65,464 Johns Hopkins University 93.121 2003159250 - 801 Johns Hopkins University 93.121 2003323556 - 7,867 Massachusetts General Hospital 93.121 234245 - 4,491 NanoMAG, LLC 93.121 NANOMAG/PITT 2 - 16,331 Texas A&M University 93.121 M1802125 - 21,223 University of Michigan 93.121 3004741923 - 1,240,542 University of Michigan 93.121 SUBK00006151 - 304,312 University of Puerto Rico Medical Sciences Campus 93.121 ZIKA INFECTION - 34,684 University of Texas M.D. Anderson Cancer Center 93.121 EARLY AWARD - 67,677

Subtotal 93.121 2,444,378 10,651,692

Human Genome Research 93.172 Direct 484,619 1,712,079 Vanderbilt University Medical Center 93.172 UNIV41774 - 830

Subtotal 93.172 484,619 1,712,909

Research Related to Deafness and Communication Disorders 93.173 Direct 509,750 6,240,275 Arizona State University 93.173 13-945 - 49,202 CFD Research Corporation 93.173 20180353 - 20,422 Emory University 93.173 A100731 - 31,235 Neuro Kinetics, Inc. 93.173 NKI-CRHITV-02 - 78,809 Northwestern University 93.173 SP0044830PROJ0012558 - 10,118 Prentke Romich Company 93.173 5020 - 5,474 Stanford University 93.173 62078576-136940 - 85,716 University of Utah 93.173 10036512-03 - 46,373 University of Utah 93.173 10041913-007 - 5,499 Veterans Research Foundation of Pittsburgh 93.173 4503 - 34,598 Veterans Research Foundation of Pittsburgh 93.173 PRO07080061 - 12,000 Veterans Research Foundation of Pittsburgh 93.173 PRO09010491 - 5,790

Subtotal 93.173 509,750 6,625,511

36





Research and Training in Complementary andIntegrative Health 93.213 Direct 8,079 903,462

Carnegie Mellon University 93.213 1090513-385626 - 4,437 Carnegie Mellon University 93.213 1090513-385788 - 6,013 Carnegie Mellon University 93.213 1090513-386172 - 22,825 Carnegie Mellon University 93.213 1090541-397713 - 12,956 Carnegie Mellon University 93.213 1090552-404619 - 52,246 Carnegie Mellon University 93.213 1090552-404725 - 68,576 Carnegie Mellon University 93.213 1090552-404868 - 86,480 Case Western Reserve University 93.213 RES509358 - (196) Furanica, Inc. 93.213 R43AT009806-AGT01 - 80,629 Northwestern University 93.213 60047299 PITT - 291,075 Northwestern University 93.213 60050243 UP - 21,806 Palmer College Foundation 93.213 12270 - 28,687 University of Minnesota 93.213 P005878801 - 335,345 Veterans Research Foundation of Pittsburgh 93.213 FOOD POLYPHENOLS - 2,041 Veterans Research Foundation of Pittsburgh 93.213 TABER MASKREY WORK - 11,984 Washington State University 93.213 132418 G003792 - 354,572

Subtotal 93.213 8,079 2,282,938

National Center on Sleep Disorders Research 93.233 Direct - 842,463 Beth Israel Deaconess Medical Center 93.233 01028583 - (1,404) Magee-Womens Research Institute & Foundation 93.233 7005 - 309,787 Oregon Health & Science University 93.233 1012376_UPITT - 24,419 Rand Corporation 93.233 400075 - 5,825 Rand Corporation 93.233 9920150085 - 30,390

Subtotal 93.233 - 1,211,480

Mental Health Research Grants 93.242 Direct 3,298,411 42,186,588 Beth Israel Deaconess Medical Center 93.242 01028829 - (1,340) Brown University 93.242 00000707 - (165) Carnegie Mellon University 93.242 1090521-397548 - 114,543 Carnegie Mellon University 93.242 1090522-390404 - 65,184 Carnegie Mellon University 93.242 1090534-406558 - 25,823 Carnegie Mellon University 93.242 1090556-406675 - 160,822 Center for Social Innovation 93.242 5546-01-2018 - 7,871 Center for Social Innovation 93.242 EARLY AWARD - 28,164 Drexel University 93.242 860280 - 4,292 Florida International University 93.242 800008268-01UG - 38,930 Florida State University 93.242 R01915 - 40,447 Magee-Womens Research Institute & Foundation 93.242 5238 - 125,659 Mount Sinai School of Medicine 93.242 0255-0424-4609 - (1,784) Mount Sinai School of Medicine 93.242 0255-0426-4609 - 83,641 Mount Sinai School of Medicine 93.242 0255-1571-4609 - 14 Mount Sinai School of Medicine 93.242 0255-2001-4609 - 154,175 Mount Sinai School of Medicine 93.242 0255-5324-4609 - 56,834 NuRelm, Inc. 93.242 20181031-PITT - 39,311 Rand Corporation 93.242 9920170066 - 37,922 Research Foundation for Mental Hygiene, Inc. 93.242 26690 - 285,583 Stellenbosch University 93.242 S0003866 - 30,386 University of California at Berkeley 93.242 00008702 - 27,599 University of Chicago 93.242 FP052801 - (46,815) University of Chicago 93.242 FP062571-C - 13,630 University of Maryland, Baltimore 93.242 1600205 - 49,895 University of Michigan 93.242 3003272653 - 7,754 University of Michigan 93.242 3004134618 - 44,480 University of Michigan 93.242 3004654072 - 32,444 University of Nebraska Medical Center 93.242 34-5250-2007-001 - 120,238 University of Oregon 93.242 215770A - 444,954 University of Oregon 93.242 281450A - 168,289 University of Pennsylvania 93.242 571214 - (2,601) University of Pennsylvania 93.242 573873 - 26,535 University of Rochester 93.242 416630-G - 345,774 University of Southern California 93.242 82396976 - (12,057) University of Vermont 93.242 32146SUB52469 - 128,939 Vanderbilt University Medical Center 93.242 VUMC 66715 - 17,748 Wake Forest University 93.242 WFUHS 550833 - 15,632 Wake Forest University 93.242 WFUHS 551843 - 15,632 Washington University in St. Louis 93.242 WU-19-70 - 9,815 Yale University 93.242 GR100611-CON80000808 - 33,830

Subtotal 93.242 3,298,411 44,924,615

37





Alcohol Research Programs 93.273 Direct 1,084,470 8,013,683 Athersys, Inc. 93.273 STTR PHASE II - 99,832 Carnegie Mellon University 93.273 1090526-389745 - 19,181 Cleveland Clinic Lerner College of Medicine 93.273 1113-SUB - 12,406 Cleveland Clinic Lerner College of Medicine 93.273 906-SUB - 2,481 Pacific Institute for Research and Evaluation 93.273 0097.36.06 - 114,424 Pacific Institute for Research and Evaluation 93.273 0097.37.06 - 112,403 Pacific Institute for Research and Evaluation 93.273 0790 - 6,037 University of Washington 93.273 UWSC10629 - 18,752 Wayne State University 93.273 WSU18014 - 29,732 Yale University 93.273 GK000083 CON80000363 - 27,311 Yale University 93.273 GR101373CON-80001004 - 2,603 Yale University 93.273 GR104428CON-80001431 - 14,461

Subtotal 93.273 1,084,470 8,473,306

Drug Abuse and Addiction Research Programs 93.279 Direct 2,018,425 13,968,357 Boston Medical Center 93.279 0511501 - (373) Boston Medical Center 93.279 6161 - 2,926 Boston Medical Center 93.279 6161 - 6885 - 15,634 Carnegie Mellon University 93.279 1090517-387815 - 15,440 Carnegie Mellon University 93.279 1090553-404923 - 28,931 Duke University 93.279 2034171 - (431) Duke University 93.279 2037242 - 18,650 Emory University 93.279 T227715 - (7,888) Jackson Laboratory 93.279 210247-0418-09 - 125,665

Jackson Laboratory 93.279 PO 208935 - (4,819) Jackson Laboratory 93.279 EARLY AWARD - 27,293 Magee-Womens Research Institute & Foundation 93.279 6590 - 199,846 Magee-Womens Research Institute & Foundation 93.279 7421 - 23,576 Magee-Womens Research Institute & Foundation 93.279 8020 - (135) Magee-Womens Research Institute & Foundation 93.279 8099 - 132,205 Northwestern University 93.279 60050859 PITT - 13,277 Oregon Health & Science University 93.279 1006667_UPITT - 55,793 RTI International 93.279 888-11-16-02 - 252,951 Rutgers University 93.279 4731 - (2,265) SRI International 93.279 PO27396 - 54,909 Temple University 93.279 262474UPITT - 32,567 University of California San Diego 93.279 113950787 - 9,950 University of Florida 93.279 UFDSP00010884 - 10,700 University of Massachusetts 93.279 WA00458201OSP2017020 - 218,371 University of Miami 93.279 SPC-000239 - 17,776 University of Michigan 93.279 3004529158 - 2,725 University of Nebraska Medical Center 93.279 34-5250-2009-001 - 39,057 University of Utah 93.279 10050920-01 523 46,993 Yale University 93.279 GR101076 - 5,117 Yale University 93.279 GR104009-CON80001376 - 24,440

Subtotal 93.279 2,018,948 15,327,238

Discovery and Applied Research for TechnologicalInnovations to Improve Human Health 93.286 Direct 309,187 3,667,786

Carnegie Mellon University 93.286 1090514-390482 - 10,253 Carnegie Mellon University 93.286 1090530-395680 - 132,684 Carnegie Mellon University 93.286 1090550-405293 - 109,111 Case Western Reserve University 93.286 RES512641 - (5,033) Case Western Reserve University 93.286 RES513611 - 67,828 Children's Hospital of Los Angeles 93.286 RGF010339-B - 96,755 Illinois Institute of Technology 93.286 A19-0016-S001 - 19,360 Massachusetts General Hospital 93.286 233327 - 48,461 Sheehan Medical LLC 93.286 ULTRASOUND TRAINING - (2,533) University of North Carolina 93.286 5108992 - 70,248 University of Utah 93.286 10049378-UPITT - 9,820 Yale University 93.286 M14A11794 - 59,880

Subtotal 93.286 309,187 4,284,620

Minority Health and Health Disparities Research 93.307 Direct 742,198 2,597,603 Columbia University 93.307 2(GG012238) - 67,924 University of Arizona 93.307 462673 - 36,093 University of Chicago 93.307 FP064671-01 - 22,656 University of Iowa 93.307 1001859514 - 58,656

38





University of Maryland, Baltimore 93.307 1600101 - 38,542 University of Mississippi Medical Center 93.307 66106330216UP - 13,481 Virginia Commonwealth University 93.307 FP00000731_SA001 - 46,671

Subtotal 93.307 742,198 2,881,626

Trans-NIH Research Support 93.310 Direct 1,485,517 17,735,905 California State University, Northridge 93.310 A15-0012-S014 - 37,876 Carnegie Mellon University 93.310 1090565-407039 - 231,703 Case Western Reserve University 93.310 RES512402 - 106,517 Massachusetts General Hospital 93.310 229365 - 538 Massachusetts General Hospital 93.310 233284 - 3,116 Medical University of South Carolina 93.310 MUSC18-007-8C267 - 1,728 Micro-Leads, Inc. 93.310 1OT2OD024908-01-4908 - 72,179 Micro-Leads, Inc. 93.310 3OT2OD024908-01S1 - 77,192 Mount Sinai School of Medicine 93.310 0255-2442-4609 - 12,763 Mount Sinai School of Medicine 93.310 EARLY AWARD - 8,175 University of California at Los Angeles 93.310 1553 G VC502 - 46,990 University of Rochester 93.310 416982GURFAOGR510588 - 48,602 University of Rochester 93.310 417410GURFAOGR510838 - 129,375 University of Southern California 93.310 64859556 - 615 University of Toledo 93.310 F-2017-123 - (2,914) University of Toledo 93.310 F-2018-25 - 395,982 University of Washington 93.310 UWSC9410 - 5,911 University of Wisconsin 93.310 830K631 - 98,875 Vanderbilt University Medical Center 93.310 EARLY AWARD - 15,939

Subtotal 93.310 1,485,517 19,027,067

National Center for Advancing Translational Sciences 93.350 Direct 4,879,766 21,459,428 Allegheny Singer Research Institute 93.350 49801509 - 75,990 Duke University 93.350 203-7853 - 17,798 Massachusetts Institute of Technology 93.350 5710004148 - (303) University of Pennsylvania 93.350 571955 - 1,555 University of Texas Health Science Center at San Antonio 93.350 164073/164067 - 145,097

Vanderbilt University 93.350 UNIV60378 - 487,579 Washington University in St. Louis 93.350 WU-18-404 - 213 Washington University in St. Louis 93.350 WU-18-404-MOD-1 - 9,045

Subtotal 93.350 4,879,766 22,196,402

Research Infrastructure Programs 93.351 Direct 273,299 4,016,190 Carnegie Mellon University 93.351 1090520-394508 - 47,614 University of Michigan 93.351 3004884630 - 76,892

Subtotal 93.351 273,299 4,140,696

21st Century Cures Act - Beau Biden Cancer Moonshot 93.353 Direct 32,618 5,659,610 Fred Hutchinson Cancer Research Center 93.353 00009963491 - 8,316 Magee-Womens Research Institute & Foundation 93.353 6800 - 240,549

Subtotal 93.353 32,618 5,908,475

Nursing Research 93.361 Direct 1,234,681 5,463,537 Carnegie Mellon University 93.361 1090487-390359 - 34,647 Cornell University 93.361 84286-11030 - 256,937 Duke University 93.361 205859 - 18,067 Emory University 93.361 T792512 - (17,536) Emory University 93.361 T979384 - 86,326 Magee-Womens Research Institute & Foundation 93.361 7010 - 4,018 University of North Carolina 93.361 5106245 - 105,176 University of North Carolina 93.361 5112455 - 25,008

Subtotal 93.361 1,234,681 5,976,180

Cancer Cause and Prevention Research 93.393 Direct 830,576 8,560,007 Fred Hutchinson Cancer Research Center 93.393 0000920331 - 2,926 Fred Hutchinson Cancer Research Center 93.393 0000956670 - 15,595 Johns Hopkins University 93.393 2003599606 - 29,759 Northwestern University 93.393 60037274 UP - 62,803 Rand Corporation 93.393 9920190020 - 38,184 University of Pennsylvania 93.393 568654 - 24,795 University of Southern California 93.393 112322259 - 196,796 University of Southern California 93.393 87299989 - 30,010 University of Texas M.D. Anderson Cancer Center 93.393 3000991391 - 3,906 University of Texas M.D. Anderson Cancer Center 93.393 3001065589 - 47,218 University of Texas M.D. Anderson Cancer Center 93.393 3001216061 - 11,528

39





University of Texas M.D. Anderson Cancer Center 93.393 EARLY AWARD - 2,684 University of Virginia 93.393 GB10208 150461 - 82,533 University of Washington 93.393 UWSC7067 - (2,694) Wake Forest University 93.393 WFUHS 114040 - (26) Washington State University 93.393 130544-G003975 - 17,327

Subtotal 93.393 830,576 9,123,351

Cancer Detection and Diagnosis Research 93.394 Direct 1,828,398 5,628,680 Boston University 93.394 4500002272 - 95,554 Brigham & Women's Hospital 93.394 115580 - 231,159 Cernostics, Inc. 93.394 R44CA192416SA - 12,403 Children's Hospital of Boston 93.394 GENFD0001345545 - (6,484) Children's Hospital of Boston 93.394 GENFD0001457297 - 128,373 Duquesne University 93.394 G1400051 - 42,732 Ecog-Acrin Medical Research Foundation, Inc. 93.394 U24CA196172-01-PITT1 - 45,732 Fred Hutchinson Cancer Research Center 93.394 0000938543 - 12,086 Fred Hutchinson Cancer Research Center 93.394 00899671 - 4,029 Johns Hopkins University 93.394 2003087222 - 105 Johns Hopkins University 93.394 2003087222 - 45,771 Magee-Womens Research Institute & Foundation 93.394 5105 - 24,741 Massachusetts General Hospital 93.394 226786 - 101,884 NRG Oncology Foundation, Inc. 93.394 NRG BSB-PITT YR 1 48,926 61,539 NRG Oncology Foundation, Inc. 93.394 EARLY AWARD - 4,751 Stanford University 93.394 61960261-122878 - 151,326 University of Chicago 93.394 EARLY AWARD - 1,256,216 University of Washington 93.394 UWSC10500 - 23,543 Van Andel Institute 93.394 V544-CR1-2 - 65,499 Van Andel Institute 93.394 EARLY AWARD - 20,523

Subtotal 93.394 1,877,324 7,950,162

Cancer Treatment Research 93.395 Direct 6,942,335 19,643,859 Brigham & Women's Hospital 93.395 120624 - 240,624 Brigham & Women's Hospital 93.395 120627 - 105,529 Brigham & Women's Hospital 93.395 BWH ALLIANCE - 24,756 Cancer Targeted Technology, LLC 93.395 CTT-PITT09192018 - 26,316 Cedars-Sinai Medical Center 93.395 1524466 - 8,455 Children's Hospital of Philadelphia 93.395 9500080215-12C - 69,490 Children's Hospital of Philadelphia 93.395 9500080215-13C - 44,000 Children's Hospital of Philadelphia 93.395 9500080216-S7XX - 667

Children's Hospital of Philadelphia 93.395 FP00013560_SUB33_01 - 11,097 Children's Hospital of Philadelphia 93.395 FP00015221_SUB395_01 - 8,201 Children's Hospital of Philadelphia 93.395 FP00017458_SUB52_01 - 8,296 Children's Hospital of Philadelphia 93.395 FP00021561_SUB04_01 - (1,134) Children's Research Institute 93.395 30004166-04 - 14,412 Duke University 93.395 2037160 - 1,197 Ecog-Acrin Medical Research Foundation, Inc. 93.395 IND FED - 76,643 Ecog-Acrin Medical Research Foundation, Inc. 93.395 U10CA180820-01-PITT1 - 11,259 Ecog-Acrin Medical Research Foundation, Inc. 93.395 EARLY AWARD - (6,593) Fred Hutchinson Cancer Research Center 93.395 0000946743 - 9,742 Frontier Science & Technology Research Foundation 93.395 AMC CAN RES CTR - 24 Johns Hopkins University 93.395 ABTC 1301 - (2,910) Johns Hopkins University 93.395 ABTC 1302 - (673) Johns Hopkins University 93.395 ABTC 1401 - 4,602 Johns Hopkins University 93.395 ABTC 1603 - 3,811 Johns Hopkins University 93.395 ABTC 1604 - 2,760 Johns Hopkins University 93.395 ABTC1501BMSCA209-596 - 11,380 Magee-Womens Research Institute & Foundation 93.395 6804 - 150,330 Magee-Womens Research Institute & Foundation 93.395 6808 - (3,103) Mayo Clinic Rochester 93.395 ALLIANCE - 2,500 NRG Oncology Foundation, Inc. 93.395 FORTE01-SCHOEN - 4,517 NRG Oncology Foundation, Inc. 93.395 NRG FED - 6,586 NRG Oncology Foundation, Inc. 93.395 PITT SDMC-NCORP-01 1,455,522 3,007,257 NSABP Foundation, Inc. 93.395 Pitt - Yr.1 - 136,541 NSABP Foundation, Inc. 93.395 WASHU GY5 - NSABP - 9,713 NSABP Foundation, Inc. 93.395 YR4-NSABP-PITT SDMC - (21,872) Oncovir, Inc. 93.395 16-028 ONC2014-001 - 3,015 ReveraGen BioPharma, Inc. 93.395 Phase II VBP15 - 66 St. Jude Children's Research Hospital 93.395 110068190-7761462 - 117 St. Jude Children's Research Hospital 93.395 110068200-7815261 - 79,221 St. Jude Children's Research Hospital 93.395 PBTC-051 - 612 Texas State University 93.395 19022-83187-1 - 5,310 University of California at San Francisco 93.395 8985SC - 16,983 University of Illinois 93.395 16349 - 85,205

40





University of Michigan 93.395 3004687808 - 209,303 University of South Alabama 93.395 A17-0064-S002 - 37,733 University of South Alabama 93.395 A17-0064-S003 - 4,710 Washington University in St. Louis 93.395 WU-17-437 - 24,310

Subtotal 93.395 8,397,857 24,074,864

Cancer Biology Research 93.396 Direct 545,934 6,138,214 Aethlon Medical, Inc. 93.396 0001 - 53,979 Fred Hutchinson Cancer Research Center 93.396 0000940823 - 18,751 Fred Hutchinson Cancer Research Center 93.396 0000979569/215475 - 1,394 Love Research Foundation 93.396 PITT-CA189966 - 10,147 Magee-Womens Research Institute & Foundation 93.396 6807 - 165,953 Magee-Womens Research Institute & Foundation 93.396 6810 - 127,856 Nymirum, Inc. 93.396 MICRO RNAS - 26,384 Sage Bionetworks 93.396 CSBCPITT2017 - 7,219 Texas A&M University 93.396 23-M1802029 - 10,290 Texas A&M University 93.396 M1901199 - 47,098 University of Pennsylvania 93.396 568432 - 137,615 University of Texas M.D. Anderson Cancer Center 93.396 3001122307 - 8,052 Wistar Institute 93.396 29014-02-363 - 2,277 Wistar Institute 93.396 29016-02-363 - 71,274

Subtotal 93.396 545,934 6,826,503

Cancer Centers Support Grants 93.397 Direct 451,528 3,443,401 Dana Farber Cancer Institute 93.397 1289454 - 2,714 Health Research Inc. - Roswell Park Division 93.397 122-05 - 1,917 Northwestern University 93.397 60041626 UP - 5,615 Roswell Park Cancer Institute 93.397 122-06 - 211,603 Vanderbilt University Medical Center 93.397 VUMC 65484 - 5,828 Washington University in St. Louis 93.397 WU-18-212 - 943

Subtotal 93.397 451,528 3,672,021

Cancer Research Manpower 93.398 Direct - 2,018,220 Magee-Womens Research Institute & Foundation 93.398 6589 - 19,078 Magee-Womens Research Institute & Foundation 93.398 6592 - 101,776 University of Rochester 93.398 417083G - (6,564) University of Rochester 93.398 417346 - 86,509

Subtotal 93.398 - 2,219,019

Cardiovascular Diseases Research 93.837 Direct 2,049,373 28,935,472 All Children's Research Institute, Inc. 93.837 ACRI 13-001 - 8,349 Beth Israel Deaconess Medical Center 93.837 01028492 - 965 Brigham & Women's Hospital 93.837 113408 - (817)

Brigham & Women's Hospital 93.837 INVESTED - 3,921 Brown University 93.837 00000954 - 208,615 Brown University 93.837 00000960 - 306,839 Brown University 93.837 00001214 - 79,119 Children's Hospital of Philadelphia 93.837 3200170321 - 18,390 Cleveland Clinic Lerner College of Medicine 93.837 1022-SUB - 21,701 Cornell University 93.837 84545-11080 - 65,945 Duke University 93.837 2034246 - (25) Duke University 93.837 2034809 - (11,013) Duke University 93.837 2037350 - 129,521 Emory University 93.837 T962650 - 37,340 Emory University 93.837 T970333 - 68,531 Feinstein Institute for Medical Research 93.837 500736UOP - 77,170 Florida International University 93.837 800006875-01UG - 9,412 Henry M. Jackson Foundation 93.837 3735 - 332 Indiana University 93.837 IN-4688372-PIT - 29,322 Johns Hopkins University 93.837 2002379522 - (2,997) Kaiser Foundation Research Institute 93.837 OOS030150_UoP - 21,841 Magee-Womens Research Institute & Foundation 93.837 2221 - 10,241 Magee-Womens Research Institute & Foundation 93.837 5234 - 7,127 Massachusetts General Hospital 93.837 226586 - 28,914 Massachusetts General Hospital 93.837 230547 - 244,079 Massachusetts General Hospital 93.837 PS#225709 - 13,866 Medical College of Wisconsin 93.837 5R01 HL119747-05 - 2,210 Mount Sinai School of Medicine 93.837 0255-3108-4609 - 89,374 Mount Sinai School of Medicine 93.837 0255-A341-4605 - 29,481 New England Research Institutes 93.837 BEST-CLI - 932 New England Research Institutes 93.837 EXHIBIT A - 73,697 New England Research Institutes 93.837 HEART NETWORK SUBAWD - 21,272 New York University School of Medicine 93.837 15-A1-00-003412-01 - 50,554

41





Northwestern University 93.837 60039432 PITT - 36,208 Oregon Health & Science University 93.837 1011985_UPITT - 21,455 Rand Corporation 93.837 9920160072 - 96,587 Rand Corporation 93.837 9920180116 - 65,559 Seattle Children's Hospital 93.837 11302SUB - 7,588 University of Alabama 93.837 000506884-002 - 661 University of Alabama 93.837 000507361-009 - (102,696) University of Alabama 93.837 000509971-004 A02 - (4,654) University of Alabama 93.837 000518176-004 A03 - 2,920 University of Alabama 93.837 000518176-004 A05 - 23,868 University of California 93.837 2014-3107 - (2,074) University of California at Irvine 93.837 2014-3108 - (30) University of California at Los Angeles 93.837 1520 G WC256 - 28,312 University of California at San Francisco 93.837 10893SC - 52,599 University of Chicago 93.837 FP064434-B - 559,733 University of Delaware 93.837 45433 23,682 402,226 University of Illinois 93.837 16990 - 7,238 University of Michigan 93.837 3004174082 - 26,710 University of Minnesota 93.837 N005339702 - 11,677 University of Minnesota 93.837 N006187439 - 13,014 University of North Carolina 93.837 5108124 - 19,641 University of Pennsylvania 93.837 569052 - 3,409 University of Rochester 93.837 417044GURFAOGR500479 - 1,676 University of Rochester 93.837 417488GURFAOGR510850 - 491 University of Washington 93.837 UWSC8676 - 269,518 University of Washington 93.837 UWSC9052 - 82,966 University of Washington 93.837 UWSC9200 - 45,820 Vanderbilt University Medical Center 93.837 VUMC44131 - 4,382 Wayne State University 93.837 WSU15109-A1 - (596) Yale University 93.837 GR103769-CON80001340 - 78,132 Yale University 93.837 M17A12428CON80000838 - 2,061

Subtotal 93.837 2,073,055 32,334,081

Lung Diseases Research 93.838 Direct 5,113,187 31,555,528 Allegheny Health Network 93.838 49708209 - 84,434 Carnegie Mellon University 93.838 1090449-360690 - (6,692) Indiana University 93.838 IN4687826UP - 10,825 Johns Hopkins University 93.838 2003090748 - 89,650 Massachusetts General Hospital 93.838 224404 - 11,729 Massachusetts General Hospital 93.838 229886 4,583 62,084 Massachusetts General Hospital 93.838 229960 - PETAL 127,687 185,078 National Jewish Medical and Research Center 93.838 20072410 - 59,719 Pennsylvania State University 93.838 PITSCHL109086 - 62,987 Rhode Island Hospital 93.838 701-7137369 - 9,745 Scripps Research Institute 93.838 5-27245 - 45,758 Seattle Children's Hospital 93.838 11018SUB - 6,645 University of Alabama 93.838 000507361-006 - (67,257)

University of Alabama 93.838 000507361-009 A03 - 92,692 University of Alabama 93.838 000513913-001 - 47,199 University of California at San Francisco 93.838 8005SC - (525) University of Michigan 93.838 3004174082 - 113,731 University of Pennsylvania 93.838 565138 - 12,010 University of Vermont 93.838 33180SUB52703 - 27,547 Virginia Commonwealth University 93.838 FP00007971_SA002 - 20,911 Yale University 93.838 GK000130CON80000445 - 42,286

Subtotal 93.838 5,245,457 32,466,084

Blood Diseases and Resources Research 93.839 Direct 508,177 6,602,726 Blood Systems, Inc. 93.839 11685UP140 - 11,058 BloodCenter of Wisconsin, Inc. 93.839 0115-81148 - 5,634 BloodCenter of Wisconsin, Inc. 93.839 0116-81148 - (390) BloodCenter of Wisconsin, Inc. 93.839 0263-81148 - (116) Carnegie Mellon University 93.839 1090505-392431 - (14,796) Cornell University 93.839 84528-11104 - 206,731 Emory University 93.839 T781364 - 247,932 Emory University 93.839 T781393 - 19,120 Fred Hutchinson Cancer Research Center 93.839 0000907526 - (3,069) Fred Hutchinson Cancer Research Center 93.839 0000944540 - 42,347 Howard University 93.839 0008946-1000063891 - 28,684 IGI Technologies, Inc. 93.839 0004 - 23,218 Massachusetts Institute of Technology 93.839 5710003771 - (2,190) Medical College of Wisconsin 93.839 PO#6077365 - 23,598 Ohio State University 93.839 60058497 - 21,737

42





Oklahoma Medical Research Foundation 93.839 0240-04/UPITTCC - (7) Platelet Biogenesis, Inc. 93.839 5R44HL131050-SUPPLEM - 4,251 Platelet Biogenesis, Inc. 93.839 02 - 89,788 Rutgers University 93.839 0498 - 18,140 University of Miami 93.839 SPC-000237 - 4,438 University of Michigan 93.839 SUBK00009076 - 229,001 University of Michigan 93.839 SUBK00009081 - 679,587 University of Minnesota 93.839 N006919401 - 1,878 University of North Carolina 93.839 5112805 - 1,885 Washington University in St. Louis 93.839 WU-17-92 - 2,609 Washington University in St. Louis 93.839 WU-18-272 - 5,408

Subtotal 93.839 508,177 8,249,202

Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders 93.840 Direct - 366,911

Arthritis, Musculoskeletal & Skin Diseases Research 93.846 Direct 1,151,464 11,270,271 Baylor College of Medicine 93.846 7000000048 - 3,145 Berkeley Madonna, Inc. 93.846 001 - 16,845 Brigham & Women's Hospital 93.846 110647 - 14,670 Brigham & Women's Hospital 93.846 113296 - 8,088 Brigham & Women's Hospital 93.846 117004 - 75,573 Brigham & Women's Hospital 93.846 PS113296 - (59) Case Western Reserve University 93.846 RES510678 - (1,277) CFD Research Corporation 93.846 20180312 D.C - 3,484 Children's Research Institute 93.846 30000333-01 - 68,464 Columbia University 93.846 2(GG012460) - 45,231 Duke University 93.846 2832076 - 1,146 Duke University 93.846 A030249 - 1,146 Emory University 93.846 T801152 - 27,144 Johns Hopkins University 93.846 2003840289 - 35,110 Johns Hopkins University 93.846 STREAM - (46) Northwestern University 93.846 60036404 UP - 37,041 University of Arizona 93.846 249827 - 17,158 University of Massachusetts 93.846 OSP18811-00 - 9,297 University of Miami 93.846 SPC-000387 - 36,668 University of Michigan 93.846 3003826635-SF - 1,090 University of Pennsylvania 93.846 560224 - 18,034 University of Pennsylvania 93.846 572644 - 10,361 University of Pennsylvania 93.846 575155 - 41,837

Subtotal 93.846 1,151,464 11,740,421

Diabetes, Digestive, and Kidney Diseases Extramural Research 93.847 Direct 3,203,296 40,440,330 Actuated Medical, Inc. 93.847 5061-S01 - 17,856 Arbor Research Collaborative for Health 93.847 DLV - 7,606 Augusta University 93.847 30835-58 - 11,841 Beth Israel Deaconess Medical Center 93.847 01060021 - 7,631 Beth Israel Deaconess Medical Center 93.847 EARLY AWARD - 13,976 Carnegie Mellon University 93.847 1042382-334343 - 66,880 Carnegie Mellon University 93.847 1090523-396399 - 111,014 Carnegie Mellon University 93.847 1090558-406229 - 76,154

Case Western Reserve University 93.847 RES509468 - 7,443 Case Western Reserve University 93.847 RES512222 - 29 Case Western Reserve University 93.847 RES512837 - 23,777 Case Western Reserve University 93.847 RES512869 - 6,004 Case Western Reserve University 93.847 RES513282 - 122,501 Children's Hospital of Boston 93.847 GENFD0001512202 - 173,780 Cleveland Clinic Lerner College of Medicine 93.847 805-SUB - 60,535 Cleveland Clinic Lerner College of Medicine 93.847 871-SUB - 553 Cleveland Clinic Lerner College of Medicine 93.847 EARLY AWARD - 209,229 Columbia University 93.847 1(GG007740-01) - (131) Dartmouth College 93.847 R986 - 90,612 Emmes Corporation 93.847 CITR STUDY - 628 George Washington University 93.847 15-D15 - 7,209 George Washington University 93.847 16-D15 - 151,299 George Washington University 93.847 16-M79 - 6,519 George Washington University 93.847 EARLY AWARD - 14,107 Indiana University 93.847 IN-4687972-UP - 2,949 Johns Hopkins University 93.847 2004074834 - 7,110 Kaiser Foundation Health Plan of Washington 93.847 2017138477 - 2,526 Kaiser Foundation Health Plan of Washington 93.847 EARLY AWARD - 30,951 Kaiser Foundation Research Institute 93.847 RNG200279-07 - 54,324 Lipella Pharmaceuticals, Inc. 93.847 2R42DK108397 - 73,208

43





Lipella Pharmaceuticals, Inc. 93.847 2R44DK102247 - 104,661 Magee-Womens Research Institute & Foundation 93.847 1765 - 42,411 Massachusetts General Hospital 93.847 223615 - 14,918 Medical College of Wisconsin 93.847 1755216 - 2,363 Medical College of Wisconsin 93.847 PO #1757436 - 2,820 Medical College of Wisconsin 93.847 PO #6061883 - 50,647 Medical University of South Carolina 93.847 MUSC15-029 - 97,108 Medical University of South Carolina 93.847 MUSC16-093-8C281 - (2,837) Medical University of South Carolina 93.847 MUSC17-091-8C976 - 1,646 Medical University of South Carolina 93.847 MUSC18-087-8D377 - 146,049 Michigan State University 93.847 RC105482UOFPITT - 36,992 Mount Sinai School of Medicine 93.847 0255-2172-4609 - 2,916 Mount Sinai School of Medicine 93.847 0255-5137-4609 - 286,225 Mount Sinai School of Medicine 93.847 0255-A941-4609 - 4,256 Oregon Health & Science University 93.847 1004965_UPITT - 28,570 Oregon Health & Science University 93.847 1004965_UPITT_BELLE - 51,465 Pennsylvania State University 93.847 UPITTDK111667 - 73,924 Research Institute - McGill University Health Center 93.847 PO CC393 - 244,112 Sanford Research 93.847 SR-2019-203 - 24,985 State University of New York 93.847 1138946-77867 - 5,000 University of Bristol 93.847 69464 - 50 University of California 93.847 10749SC - 280,665 University of Chicago 93.847 FP052791-A - 76 University of Colorado 93.847 FY12.601.001 - 49,877 University of Colorado 93.847 FY18.896.005 - 12,313 University of Colorado 93.847 EARLY AWARD - 40,263 University of Illinois 93.847 087522-16458 - 15,681 University of Iowa 93.847 S00542-01 - 150 University of Iowa 93.847 W001038462 - 2,400 University of Kansas 93.847 ZAS00060 - 13,973 University of Kansas 93.847 ZAY00020 - 134,855 University of Michigan 93.847 3003895026 - 205 University of Michigan 93.847 3004635705 - 27,504 University of Michigan 93.847 SUBK00003528 - 8,830 University of Minnesota 93.847 N005115005 - 12,163 University of North Carolina 93.847 5033713 - 2,669 University of Pennsylvania 93.847 571237 - 18,703 University of Pennsylvania 93.847 571765 - 917 University of Pennsylvania 93.847 574238 - 14,368 University of South Florida 93.847 6163-1051-00-T - 17,994 University of South Florida 93.847 Clinic Site#14 - 286,121 University of Southern California 93.847 110873538 - 113,523 University of Texas Health Science Center at Houston 93.847 0013642A - 39,131 University of Texas Health Science Center at Houston 93.847 0013642B - 1,629 University of Texas M.D. Anderson Cancer Center 93.847 3000970743 - 51,235 University of Texas M.D. Anderson Cancer Center 93.847 3001128225 - 7,674 University of Washington 93.847 UWSC8791 - 30,665 Vanderbilt University Medical Center 93.847 VUMC 57451 - 19,880 Vanderbilt University Medical Center 93.847 VUMC 67777 - 290,528 Virginia Commonwealth University 93.847 PD302920-SC104230 - 86,098 Wake Forest University 93.847 WFUHS 113617 - 11,384 Washington University in St. Louis 93.847 WU-17-129 - (2,960) Washington University in St. Louis 93.847 WU-17-132 - (78)

Subtotal 93.847 3,203,296 44,605,167

Extramural Research Programs in the Neurosciencesand Neurological Disorders 93.853 Direct 3,235,649 32,007,464

Baylor College of Medicine 93.853 7000000742 - 92,357 Baylor College of Medicine 93.853 7000000812 - 26,252 Carnegie Mellon University 93.853 1090439-367147 - 48,647 Carnegie Mellon University 93.853 1090508-385128 - 309,115 Case Western Reserve University 93.853 RES510380 - 24,333 Children's Research Institute 93.853 30003963-19 - 449 Children's Research Institute 93.853 30003963-56 35,524 1,058,050 Cincinnati Children's Hospital Medical Center 93.853 137754 - 50,652 Cleveland Clinic Lerner College of Medicine 93.853 917-SUB - 59,319 Columbia University 93.853 15(GG010312-15) - (957) Columbia University 93.853 15(GG010312-21) - 750 Columbia University 93.853 5(GG013057-05) - 124,343 Duquesne University 93.853 G1900015 - 32,243 Emory University 93.853 61865510-125439 - 10,177 Harvard University 93.853 111178-5088520 - 36,466 Johns Hopkins University 93.853 2003044873 - 654

44





Massachusetts General Hospital 93.853 NN102 Sprint MS - (17,755) Massachusetts General Hospital 93.853 NN104 - 20,466 Massachusetts General Hospital 93.853 NN105 STAIR - 22,554 Massachusetts General Hospital 93.853 NN106 - 4,739 Massachusetts General Hospital 93.853 NN107 FX-LEARN - 742 Massachusetts General Hospital 93.853 SURE-PD3 - 27,429 Mayo Clinic Jacksonville 93.853 PIT-232483-03 - 1,346 Mayo Clinic Jacksonville 93.853 PMC-224063-01 - 40,343 Medical College of Wisconsin 93.853 5R01 NS070711-09 - 37,367 Northwestern University 93.853 60049288 PITT - 52,761 Oregon Health & Science University 93.853 1010846 UPITT - 97,903 ReveraGen BioPharma, Inc. 93.853 EARLY AWARD - 164,443 Seattle Children's Hospital 93.853 11839SUB - 43,213 Stanford University 93.853 60851347-44364-A - 20 Stanford University 93.853 T662055 - (1,188) University of California at San Francisco 93.853 10591SC - 3,010 University of California at San Francisco 93.853 11010SC - 31,080 University of California at San Francisco 93.853 7872sc - 240,755 University of California at San Francisco 93.853 9711sc - 51,175 University of Cincinnati 93.853 010785-119092 - 7,445 University of Miami 93.853 SPC-000708 - 136,651 University of Michigan 93.853 3002348500-SHN - 15,643 University of Michigan 93.853 3003713780 - 6 University of Michigan 93.853 3004674947-PNT - 2,790 University of Michigan 93.853 3004752207 - (1,027) University of Michigan 93.853 SUBK00005942 - 71,687 University of Michigan 93.853 SUBK00007466 - 275,618 University of Michigan 93.853 SUBK10299CSPR-002 - 10,242 University of Minnesota 93.853 N004037302 - 76,329 University of Southern California 93.853 85743790 - 9,181 University of Virginia 93.853 GB10094.157955 - 7,323 University of Wisconsin 93.853 670K106 - 72,871 University of Wisconsin 93.853 776K182 - 49,527

Subtotal 93.853 3,271,173 35,435,003

Allergy and Infectious Diseases Research 93.855 Direct 6,675,538 53,126,250 Aaron Diamond AIDS Research Center 93.855 A-13-100 AMBROSE - 16,146 Albany Medical College 93.855 515476-UPITT - 280,430 Albany Medical College 93.855 515484-UPITT-V.2 - 1,499 Albert Einstein College of Medicine 93.855 310592 - 7 Albert Einstein College of Medicine 93.855 311202/635752 - 8,226 Allegheny Singer Research Institute 93.855 49801609 - 30,076 Benaroya Research Institute at Virginia Mason 93.855 FY18ITN126 - 265,882 Benaroya Research Institute at Virginia Mason 93.855 FY18ITN154 - 56,944 Benaroya Research Institute at Virginia Mason 93.855 FY18ITN229 - 455 Benaroya Research Institute at Virginia Mason 93.855 FY18ITN260 - 2,647 Benaroya Research Institute at Virginia Mason 93.855 FY18ITN262 - 4,771 Benaroya Research Institute at Virginia Mason 93.855 FY19ITN154 - 56,583 Beth Israel Deaconess Medical Center 93.855 01029856 - 10,065 Beth Israel Deaconess Medical Center 93.855 01029857 - 8,348 Beth Israel Deaconess Medical Center 93.855 01029858 - 109 Beth Israel Deaconess Medical Center 93.855 01029859 - (130) Beth Israel Deaconess Medical Center 93.855 01060721 - 136,162 Beth Israel Deaconess Medical Center 93.855 01060722 - 60,722 Beth Israel Deaconess Medical Center 93.855 01060723 - 69,671 Beth Israel Deaconess Medical Center 93.855 01060736 - 46,848 Boston College 93.855 5103183-1 - 191,777 Brigham & Women's Hospital 93.855 109926 - 158,501 Brigham & Women's Hospital 93.855 109927 - 158,372

Brigham & Women's Hospital 93.855 110007 - 16,607 Brigham & Women's Hospital 93.855 110230 - 26,310 Brigham & Women's Hospital 93.855 110237 - 3,086 Brigham & Women's Hospital 93.855 110668 - 35,067 Brigham & Women's Hospital 93.855 110668 - A5345 LAB - 5,225 Brigham & Women's Hospital 93.855 111674 - 82,908 Brigham & Women's Hospital 93.855 112217 CLONAL EXPANS - 18,916 Brigham & Women's Hospital 93.855 112217 IVR/IUPM - 31,647 Brigham & Women's Hospital 93.855 112217 QPCR/IUPM - 5,276 Brigham & Women's Hospital 93.855 113818 - 6,970 Brigham & Women's Hospital 93.855 117360 - 25,981 Brigham & Women's Hospital 93.855 A5314 - 19,729 Brigham & Women's Hospital 93.855 A5315 - 13,587 Brigham & Women's Hospital 93.855 A5321 - 3,715 Brigham & Women's Hospital 93.855 A5342 - 7,861 Brigham & Women's Hospital 93.855 A5354 - 19,835 Brigham & Women's Hospital 93.855 ACTG PROTOCOL - 81,732

45





Brigham & Women's Hospital 93.855 EARLY AWARD - 25,965 Calder Biosciences, Inc. 93.855 1-R43-AI140941 - 90,089 Children's Hospital of Los Angeles 93.855 RGF010603-E - 24,359 Columbia University 93.855 08(GG011896-34) - 2,936 Columbia University 93.855 08(GG011896-49) - 40,973 Columbia University 93.855 1(GG013567-03) - 277,695 Columbia University 93.855 11(GG011896-34) - 91,239 Columbia University 93.855 11(GG011896-49) - 395,557 Columbia University 93.855 25(GG011896-49) - 132,391 Columbia University 93.855 3(GG011019-08) - 1,870 Cornell University 93.855 82337-10919 - 369,475 Duke University 93.855 189925/218470 - 18,747 Duke University 93.855 189925/235058 - 19,082 Duke University 93.855 203-7699 - 12,101 Duke University 93.855 6418 - 171,011 Duke University 93.855 A039043 - 16,942 Duke University 93.855 A039081 - 7,748 Duke University 93.855 SITE#0559 - 3,596 Emory University 93.855 A025496 - 36,884 Emory University 93.855 T772943 - 64,957 Family Health International 360 93.855 HPTN 083 280,011 280,011 Family Health International 360 93.855 PO18002625 - 64,185 George Washington University 93.855 17-M39 - (9,488) Harvard University 93.855 124022-5098759 - 10,085 Hospital for Sick Children 93.855 6610100131 - (108) Institute for Clinical Research Inc. 93.855 M44-PT-079-1101-4 - 125 Joan & Sanford I. Weill Medical College of Cornell University 93.855 183723-14 - 119,752 Johns Hopkins University 93.855 2002364878 - 155,426 Johns Hopkins University 93.855 2002367032 - 3,069 Johns Hopkins University 93.855 2002367033 - 47,096 Johns Hopkins University 93.855 2002740873 - 125,146 Johns Hopkins University 93.855 2004148022 - 2,210 Johns Hopkins University 93.855 2003649298 - 19,166 Magee-Womens Research Institute & Foundation 93.855 4675 - (23,858) Magee-Womens Research Institute & Foundation 93.855 4676 - (5,348) Magee-Womens Research Institute & Foundation 93.855 4677 - (14,803) Magee-Womens Research Institute & Foundation 93.855 4678 - (6,607) Magee-Womens Research Institute & Foundation 93.855 4679 - (5,565) Magee-Womens Research Institute & Foundation 93.855 4684 - 233,494 Magee-Womens Research Institute & Foundation 93.855 4685 - 271,336 Magee-Womens Research Institute & Foundation 93.855 4686 - 88,351 Magee-Womens Research Institute & Foundation 93.855 4687 - 74,681 Magee-Womens Research Institute & Foundation 93.855 5593 - 99,265 Magee-Womens Research Institute & Foundation 93.855 7311 - (21,377) Magee-Womens Research Institute & Foundation 93.855 9509 - 264,948 Magee-Womens Research Institute & Foundation 93.855 9540 - 121,949 Magee-Womens Research Institute & Foundation 93.855 9542 - 257,871 Magee-Womens Research Institute & Foundation 93.855 9543 - 107,089 Magee-Womens Research Institute & Foundation 93.855 9566 - 296,047 Magee-Womens Research Institute & Foundation 93.855 9569 - 104,942 Magee-Womens Research Institute & Foundation 93.855 9574 - 17,326 Magee-Womens Research Institute & Foundation 93.855 9576 - 353,309 Magee-Womens Research Institute & Foundation 93.855 9608 - 3,741 Magee-Womens Research Institute & Foundation 93.855 9609 - 16,234 Magee-Womens Research Institute & Foundation 93.855 9610 - 12,062 Magee-Womens Research Institute & Foundation 93.855 9611 - 6,960 Magee-Womens Research Institute & Foundation 93.855 9632 - 409,071 Magee-Womens Research Institute & Foundation 93.855 9634 - 124,950 Massachusetts General Hospital 93.855 225488 - 1,514 Massachusetts General Hospital 93.855 229712 - 4,942

New York University 93.855 F8802-02 - 16,756 Oregon Health & Science University 93.855 1011809-UPITT - 27,904 Rutgers University 93.855 0399 - 10,253 Stanford University 93.855 60819812-107582 - 13,529 State University of New York 93.855 R1001115 - 9,936 Tulane University 93.855 TUL-HSC-555655-17/18 - 17,897 University of Alabama 93.855 000518900-001 - 47,525 University of California 93.855 10737SC - 87,030 University of California 93.855 9306SC - 1,233 University of California 93.855 9337SC - 49,364 University of California 93.855 9471SC - 4,510 University of California at Berkeley 93.855 00009381 - 299,662 University of California at Los Angeles 93.855 1560 G WA740 - 8,639 University of California at Los Angeles 93.855 1560 G WA890 - 5,969 University of California at Los Angeles 93.855 1560 G WB676 - 15,196 University of California at Los Angeles 93.855 1650 G WA398 - 146,726

46





University of California at Los Angeles 93.855 EARLY AWARD - 393,473 University of California at San Francisco 93.855 10125SC - 29 University of California at San Francisco 93.855 10420SC - 64,575 University of California at San Francisco 93.855 7167SC - 73,146 University of California at San Francisco 93.855 8971SC - 69,663 University of California at San Francisco 93.855 9068SC - 155,720 University of California at San Francisco 93.855 9878SC - 18,212 University of Florida 93.855 UFDSP00011376 - 226,181 University of Louisville 93.855 ULRF 14-0588B5-01 - 97,126 University of Louisville 93.855 ULRF 14-0588D5-01 - 51,447 University of Louisville 93.855 ULRF-14-0588G4-01 - 4,813 University of Louisville 93.855 ULRF-14-0588G5-01 - 205,305 University of Maryland 93.855 55360-Z0082201 - 230,470 University of Maryland, Baltimore 93.855 1400243G - (162) University of Maryland, Baltimore 93.855 1701055 - 52,104 University of Michigan 93.855 3003868253 - 488,463 University of Missouri 93.855 C00056016-2 - 1,070 University of Pennsylvania 93.855 574339 - 67,368 University of Washington 93.855 UWSC10069 - 121,811 University of Wisconsin 93.855 686K405 - 23,130 Vanderbilt University Medical Center 93.855 VUMC40874 - 273,296 Washington University in St. Louis 93.855 WU-19-245 - 27,747

Subtotal 93.855 6,955,549 63,914,745

Biomedical Research and Research Training 93.859 Direct 5,381,794 32,584,407 Carnegie Mellon University 93.859 1090441-352542 - 42,891 Case Western Reserve University 93.859 RES512607 - 1,571 Fox Chase Chemical Diversity Center 93.859 R42GM112516-PITT - 98,245 Magee-Womens Research Institute & Foundation 93.859 3624 - 106,842 Magee-Womens Research Institute & Foundation 93.859 3625 - 186,534 MS2 Array, LLC 93.859 1383869690A1 - 31,684 North Carolina State University 93.859 2017-2356-02 - 66,100 Ohio State University 93.859 60057530 - 13,545 Ohio State University 93.859 60062579 - 21,385 Princeton University 93.859 SUB0000071 - 163,426 Princeton University 93.859 SUB0000140 - 158,178 Research Institute at Nationwide Children's Hospital 93.859 700006-0518-00 - (1,351) Stanford University 93.859 60831399-110802 - 6,184 State University of New York 93.859 1127906-72787 - 13,361 State University of New York 93.859 72787 - (2,044) Texas A&M University 93.859 06-M1703427 - 12,363 Trucode Gene Repair 93.859 5R44GM108187-04 - (7,430) Trucode Gene Repair 93.859 5R44GM108187-06 - 123,597 University of California 93.859 201302314-04 - 8,379 University of California at San Francisco 93.859 10503SC - 38,051 University of Cincinnati 93.859 011843-002 - 39,566 University of Colorado 93.859 FY15.652.001 - 218,514 University of Connecticut 93.859 122299 - 6,805 University of Maryland, Baltimore 93.859 1701462 - 1,637 University of Massachusetts 93.859 OSP2017045 - 177,950 University of Massachusetts 93.859 WA00473946OSO201704 - (21,005) University of Miami 93.859 SPC-000421 33,236 31,193 University of Pennsylvania 93.859 566256 - 5,491 University of Pennsylvania 93.859 569058 - 14 University of Wisconsin 93.859 881K252 - 25,979 Washington University in St. Louis 93.859 WU-16-84 - (12)

Subtotal 93.859 5,415,030 34,152,050

Child Health and Human Development Extramural Research 93.865 Direct 966,503 8,507,018 Albert Einstein Healthcare Network 93.865 4934 - 15,713 Arizona State University 93.865 14-453 - 55,263

Arizona State University 93.865 17-014 - 68,849 Baebies, Inc. 93.865 RESEARCH AGREEMENT - 54,776 California Pacific Medical Center Research Institute 93.865 280201015-S220 - 1,057,534 California Pacific Medical Center Research Institute 93.865 EARLY AWARD - 24,836 Carnegie Mellon University 93.865 109500-379459 - 69,162 Children's Hospital of Philadelphia 93.865 3210610519 - 15,823 Cornell University 93.865 16091646-UTAH - (4,638) Cornell University 93.865 182878 - 4,010 Gaia Medical Institute 93.865 SALIVA NCDT - 71,550 George Washington University 93.865 S-MFM1718-JB15 100,264 137,202 George Washington University 93.865 S-MFM1819-JB15 - 32,118 Indiana University 93.865 IN4685314UPITT - 14,586 Magee-Womens Research Institute & Foundation 93.865 1419 - (251) Magee-Womens Research Institute & Foundation 93.865 1420 - 1,108 Magee-Womens Research Institute & Foundation 93.865 1421 - (5,063)

47





Magee-Womens Research Institute & Foundation 93.865 1422 - 92,882 Magee-Womens Research Institute & Foundation 93.865 1423 - 79,291 Magee-Womens Research Institute & Foundation 93.865 1424 - 221,961 Magee-Womens Research Institute & Foundation 93.865 1426 - 179,835 Magee-Womens Research Institute & Foundation 93.865 2616 - 167,025 Magee-Womens Research Institute & Foundation 93.865 2623 - (17,881) Magee-Womens Research Institute & Foundation 93.865 2624 - 197,308 Magee-Womens Research Institute & Foundation 93.865 2627 - 36,802 Magee-Womens Research Institute & Foundation 93.865 2628 - 18,385 Magee-Womens Research Institute & Foundation 93.865 2638 - 3,104 Magee-Womens Research Institute & Foundation 93.865 2639 - 162,308 Magee-Womens Research Institute & Foundation 93.865 2640 - (15,886) Magee-Womens Research Institute & Foundation 93.865 2645 - 9,284 Magee-Womens Research Institute & Foundation 93.865 2649 - 167,064 Magee-Womens Research Institute & Foundation 93.865 2651 - 6,240 Magee-Womens Research Institute & Foundation 93.865 3485 - (3,409) Magee-Womens Research Institute & Foundation 93.865 3490 - 29,045 Magee-Womens Research Institute & Foundation 93.865 3495 - 238,311 Magee-Womens Research Institute & Foundation 93.865 3499 - 79,720 Magee-Womens Research Institute & Foundation 93.865 3503 - 203,276 Magee-Womens Research Institute & Foundation 93.865 3618 - (59,307) Magee-Womens Research Institute & Foundation 93.865 3622 - 82,126 Magee-Womens Research Institute & Foundation 93.865 3640 - 2,767 Magee-Womens Research Institute & Foundation 93.865 3641 - 11,013 Magee-Womens Research Institute & Foundation 93.865 3642 - 15,860 Magee-Womens Research Institute & Foundation 93.865 3643 - 10,185 Magee-Womens Research Institute & Foundation 93.865 3646 - 41,271 Magee-Womens Research Institute & Foundation 93.865 3647 - 123,498 Magee-Womens Research Institute & Foundation 93.865 3648 - 124,901 Magee-Womens Research Institute & Foundation 93.865 3649 - 84,041 Magee-Womens Research Institute & Foundation 93.865 4017 - 16,846 Magee-Womens Research Institute & Foundation 93.865 4022 - 3,162 Magee-Womens Research Institute & Foundation 93.865 4023 - (588) Magee-Womens Research Institute & Foundation 93.865 4027 - 20,397 Magee-Womens Research Institute & Foundation 93.865 4028 - 105,682 Magee-Womens Research Institute & Foundation 93.865 4029 - 107,998 Magee-Womens Research Institute & Foundation 93.865 4034 - 21,256 Magee-Womens Research Institute & Foundation 93.865 4111 - 175,803 Magee-Womens Research Institute & Foundation 93.865 4709 - 806 Magee-Womens Research Institute & Foundation 93.865 5251 - (126) Magee-Womens Research Institute & Foundation 93.865 5259 - 74,733 Magee-Womens Research Institute & Foundation 93.865 5261 - 33,098 Magee-Womens Research Institute & Foundation 93.865 5570 - 7,431 Magee-Womens Research Institute & Foundation 93.865 5588 - 21,269 Magee-Womens Research Institute & Foundation 93.865 6214 - 237,386 Magee-Womens Research Institute & Foundation 93.865 6223 - 31,636 Magee-Womens Research Institute & Foundation 93.865 6353 - (19,183) Magee-Womens Research Institute & Foundation 93.865 6370 - 135,585 Magee-Womens Research Institute & Foundation 93.865 6929 - 56,475 Magee-Womens Research Institute & Foundation 93.865 7024 - 91,564 Magee-Womens Research Institute & Foundation 93.865 7532 - 176,104 Magee-Womens Research Institute & Foundation 93.865 8848 - (49,054) Magee-Womens Research Institute & Foundation 93.865 8849 - (3,061) Medical University of South Carolina 93.865 MUSC16-062-88465 - (270) Medical University of South Carolina 93.865 MUSC18-064-8B463 - 9,133 New York University 93.865 F4320-01 - 449,274 Next Health, Inc. 93.865 R44HD085702 - 75,377 NuRelm, Inc. 93.865 1R41HD090813-01-1 - 39,879 Oregon Health & Science University 93.865 9009028_UPitt - 677 Oregon State University 93.865 P0446A-B - 20,708 Research Institute at Nationwide Children's Hospital 93.865 700171-0719-00 - 19,936 Seattle Children's Hospital 93.865 11116SUB - 31,744

Seattle Children's Hospital 93.865 11456SUB - 194 Simbex, LLC 93.865 SIMBEX-008 - 46,717 University of Alabama 93.865 000509380-SP004-006 - 21,939 University of Chicago 93.865 FP059400-A - 19,524 University of Michigan 93.865 3004685879 - 56,783 University of Minnesota 93.865 P006341401 - 4,746 University of Nebraska Medical Center 93.865 34-5321-2003-009 - 718 University of Nebraska Medical Center 93.865 34-5321-2003-010 - 1,455 University of Texas Southwestern Medical Center 93.865 GMO 190901 - 21,463 University of Utah 93.865 10035609-UPMC - 23,278 Washington University in St. Louis 93.865 WU-17-283 - 13,714 Washington University in St. Louis 93.865 WU-18-171 - 2,379 Washington University in St. Louis 93.865 WU-19-131 - 11,513 Yale University 93.865 M14A11869(A09764) - 34,554

48





Subtotal 93.865 1,066,767 14,561,270

Aging Research 93.866 Direct 6,208,806 45,796,261 Albert Einstein College of Medicine 93.866 311225/P0675432 - 6,726 Boston University 93.866 4500002667 - 111,095 Brigham & Women's Hospital 93.866 111014 - 117,036 California Pacific Medical Center Research Institute 93.866 280201009-S197 - 17,543 California Pacific Medical Center Research Institute 93.866 280201018-S234 - 10,762 California Pacific Medical Center Research Institute 93.866 280201019-S226 - 21,781 Columbia University 93.866 2(GG010390-14) - 41,340 Columbia University 93.866 7(GG012955-01) - (8,312) Columbia University 93.866 7(GG012955-02) - 61,373 Crossroads Consulting, LLC 93.866 NIHSBIR2-01 - 292,179 Dartmouth College 93.866 R1031 - 38,954 Hennepin Healthcare Research Institute 93.866 APREE CLINICAL - 44,181 Hennepin Healthcare Research Institute 93.866 XT-1715-02 - 12,115 Indiana University 93.866 IN-4687304-UP - 2,131 Indiana University 93.866 EARLY AWARD - 35,177 Joan & Sanford I. Weill Medical College of Cornell University 93.866 183997 - 37,137 Johns Hopkins University 93.866 2003451222 - 5,356 Johns Hopkins University 93.866 2003469191 - 65,225 Johns Hopkins University 93.866 2003658576 - 16,127 Magee-Womens Research Institute & Foundation 93.866 5246_PITT - 62,627 Magee-Womens Research Institute & Foundation 93.866 6591 - 177,546 Massachusetts General Hospital 93.866 232963 - 37,770 Massachusetts Institute of Technology 93.866 S4692-PO-271461 - 13,417 Northern California Institute for Research and Education 93.866 WEI2015-09 - 68,185 Northwestern University 93.866 60040682UP - 41,008 Northwestern University 93.866 60048330 PITT - 57,810 Northwestern University 93.866 EARLY AWARD - 6,490 Rand Corporation 93.866 9920180009 - 19,804 Scripps Research Institute 93.866 527018/527019/527021 - (202) St. Joseph's Hospital and Medical Center 93.866 32144PITT - 113,027 University of California at San Francisco 93.866 10480SC - 176,630 University of Delaware 93.866 51725 - 203,436 University of Florida 93.866 UFDSP00010686 - 4,581 University of Florida 93.866 UFDSP00011846 - 17,806 University of Illinois 93.866 17218 - 42,789 University of Kansas 93.866 ZAN00000 - 85,190 University of Maryland, Baltimore 93.866 1100627A REQUEST1904 - 22,999 University of Massachusetts 93.866 OSP2018118 - 6,246 University of Miami 93.866 SPC-000423 - 6,755 University of Michigan 93.866 SUBK00003635 - 103,034 University of Michigan 93.866 SUBK00003641 - 3,010 University of Minnesota 93.866 P007422502 - 18,079 University of New South Wales 93.866 RG172507 - 28,991 University of Southern California 93.866 105715756 - 12,026 University of Southern California 93.866 75682029/50699687 - 26,044 University of Southern California 93.866 79635068 - 100,766 University of Utah 93.866 10042502-14 - (521) University of Washington 93.866 BPO32906 - 23,415 University of Washington 93.866 UWSC10962 - 4,804 University of Washington 93.866 UWSC11052 - 5,991 University of Washington 93.866 EARLY AWARD - 71,913 Wake Forest University 93.866 WFUHS 552702 - 102,742 Washington University in St. Louis 93.866 WU-15-187-MOD-3 - 144,084

Subtotal 93.866 6,208,806 48,532,479

Vision Research 93.867 Direct 486,741 7,770,241 Carnegie Mellon University 93.867 1090413-371445 - 51,797 Carnegie Mellon University 93.867 1090458-398342 - 26,774 Carnegie Mellon University 93.867 1090501-380395 - 22,415 Children's Hospital of Boston 93.867 GENFD0001490474 - 16,693 Children's Hospital of Philadelphia 93.867 3209850817 - 79 Columbia University 93.867 1(GG013023-01) - 40,280 Columbia University 93.867 1(GG02175-01) - 10 JAEB Center for Health Research, Inc. 93.867 PEDIG - 563 Johns Hopkins University 93.867 2003070657 - (6,431) Johns Hopkins University 93.867 2003816234 - 37,428 New York University 93.867 17-A0-00-006701-01 - 117,147 Schepens Eye Research Institute 93.867 533027 - 13,507 Tufts University 93.867 HH4034 - 31,146 University of California San Diego 93.867 86728016 - (9,504) University of Mississippi Medical Center 93.867 66663150316UP - 38,158 University of Southern California 93.867 100927092 - 141,198 University of Texas at Austin 93.867 UTA17-001015 - 38,068

49





West Virginia University 93.867 13-215-UP - 10,579 Yale University 93.867 GR104143-CON80001549 - 45,931

Subtotal 93.867 486,741 8,386,079

Medical Library Assistance 93.879 Direct 632,201 5,090,494 Brigham & Women's Hospital 93.879 111377 - 47,072 Indiana University 93.879 IN4688956PITT - 14,670 University of Utah 93.879 10039576-10 - 7,000

Subtotal 93.879 632,201 5,159,236

International Research and Research Training 93.989 Direct 9,202 849,127

Other National Institutes of Health:Allergy and Infectious Diseases 93.000 Direct 253,741 841,431 Cancer 93.000 Direct - 46,192 Child Health 93.000 Direct - 24,680 Clinical Center 93.000 Direct - 18,242 Drug Abuse 93.000 Direct 4,127 1,463,131 Heart, Lung & Blood 93.000 Direct - 103,370

Aethlon Medical, Inc. 93.000 0055757 - 29,018 Boston University 93.000 4500002653 - 15,601 Cancer Targeted Technology, LLC 93.000 CTT-UPITT09302015 - 983 Children's Hospital of Philadelphia 93.000 20026676-RSUB - 5,535 Children's Hospital of Philadelphia 93.000 962265 - RSUB - 17,163 Children's Hospital of Philadelphia 93.000 962543 - RSUB - 74,983 Children's Hospital of Philadelphia 93.000 962687 - 756,103 Duke University 93.000 SITE#UPT99 - 10,150 Ecog-Acrin Medical Research Foundation, Inc. 93.000 EARLY AWARD - 6,285 Emmes Corporation 93.000 AREDS2 - 13,194 Fred Hutchinson Cancer Research Center 93.000 EARLY AWARD - 1,257 Institute for Transfusion Medicine 93.000 HHSN26800003 - 89,878 Leidos Biomedical Research, Inc. 93.000 12XS547 - 426,883 Leidos Biomedical Research, Inc. 93.000 16X018 - 145,162 Leidos Biomedical Research, Inc. 93.000 16X116 - 1,407,904 Leidos Biomedical Research, Inc. 93.000 16X162Q TASK 01 - 23,465 Magee-Womens Research Institute & Foundation 93.000 4537 - 1,605 Magee-Womens Research Institute & Foundation 93.000 4538 - 5,257 Magee-Womens Research Institute & Foundation 93.000 5523 - 38,835 Magee-Womens Research Institute & Foundation 93.000 5595 - 207,683 Magee-Womens Research Institute & Foundation 93.000 6753 - 22,953 Magee-Womens Research Institute & Foundation 93.000 9153 - 69,245 Mayo Clinic Rochester 93.000 MCR-0105-CPN - 13,812 Mayo Clinic Rochester 93.000 MCR-0125-CPN - 4,962 Mayo Clinic Rochester 93.000 MCR-0135-CPN - 15,696 Mayo Clinic Rochester 93.000 MCR-0138-CPN - 126,000 Mimetas US, Inc. 93.000 0058588 - 247,373 Northwestern University 93.000 SP0016040 60050361 - 3,474 Northwestern University 93.000 SP0016040 60050362 - 9,681 Northwestern University 93.000 SP0033779 60044358 - 7,301 Northwestern University 93.000 SP0033779 60047201 - 42,488 Northwestern University 93.000 SP003377960044358CHP - 15,573 NSABP Foundation, Inc. 93.000 EARLY AWARD - 5,028 Obatala Sciences, Inc. 93.000 UPITT01 - 9,492 Ohio State University 93.000 60062134 - 83,917 Rockland Immunochemicals, Inc. 93.000 G1051 - (909) Social & Scientific Systems, Inc. 93.000 CRB-SSS-S-15-004662 - 15,781 Social & Scientific Systems, Inc. 93.000 PHR-SSS-S-16-005010 - 1,050 University of Alabama 93.000 000406190-010 - 4,435 University of Alabama 93.000 000406257-027 - 4,027 University of Alabama 93.000 000406291-007 - 96,750 University of Alabama 93.000 000500918-T011-008 - 37,511 University of Alabama 93.000 000500918-T018-002 - 3,771 University of Alabama 93.000 000500918-T013-009 - 16,125 University of Alabama 93.000 000500918-T016-006 - 1,354 University of Alabama 93.000 000509729-002 - 4,475 University of Michigan 93.000 3001890361 - 6,717 University of Michigan 93.000 3002796441 - (2,598) University of Michigan 93.000 SUBK-C1487 - 64,056 University of Minnesota 93.000 N006462001 - 224,657 Vanderbilt University Medical Center 93.000 VUMC56485 - (50,370) Vanderbilt University Medical Center 93.000 VUMC65662 - 275,346 Westat, Inc. 93.000 6426-S08 - 6,868 Westat, Inc. 93.000 6473-03-S002 - 1,964

Subtotal 93.000 257,868 7,161,995

Total National Institutes of Health 67,639,926 563,905,019

50





Substance Abuse and Mental Health Services Administration:Allegheny County 93.104 211450 - 122,901 Luzerne County 93.104 CARE INITIATIVE - 101,856 Luzerne County 93.104 SYSTEM OF CARE - 34,938

Subtotal 93.104 - 259,695

University of Wisconsin 93.239 877K866 - 11,774

Allegheny Singer Research Institute 93.243 45100609 - 81,403 CMSU Counties of Central Pennsylvania 93.243 1H79 TI081289-01 - 57,661 Commonwealth of Pennsylvania 93.243 4300534203 - 537 Westmoreland Drug and Alcohol Commission, Inc. 93.243 0001 - 148,220

Subtotal 93.243 - 287,821

Other Substance Abuse and Mental Health ServicesAdministration 93.000 Direct - 19,613

University of Pittsburgh Medical Center 93.000 4100079078 - 47,165 Subtotal 93.000 - 66,778

Total Substance Abuse and Mental Health Services Administration - 626,068

DHHS Other:Other DHHS 93.000 Direct - 56,538 Johns Hopkins University 93.088 2002798111 - 1,510

Total DHHS Other - 58,048

Total Department of Health and Human Services 71,433,328 587,380,904

Department of Defense:Advanced Research Projects Agency:

Rutgers University 12.431 8178 46,926 333,466 HRL Laboratories, LLC 12.910 12105-301700-DS - 2

Other Advanced Research Projects Agency 12.000 Direct - 295,709 University of Notre Dame 12.000 208063UP - 426

Subtotal 12.000 - 296,135

Total Advanced Research Projects Agency 46,926 629,603

Defense Health Agency:MD Consulting, LLC. 12.000 HT0014-16-C-0013 - 55,534

Total Defense Health Agency - 55,534

Defense Threat Reduction Agency:Scientific Research - Combating Weapons of Mass

Destruction 12.351 Direct 391,807 2,589,948 University of Texas at Austin 12.351 UTA15-000015 - 161,267 Washington University in St. Louis 12.351 WU-15-243 - 138,008

Subtotal 12.351 391,807 2,889,223

Total Defense Threat Reduction Agency 391,807 2,889,223

Department of the Air Force:Basic and Applied Scientific Research 12.300 Direct - 312

Air Force Defense Research Sciences Program 12.800 Direct 112,221 478,687 Carnegie Mellon University 12.800 1150141-357109 - 243,607 Washington University in St. Louis 12.800 WU-17-190 - 49,947

Subtotal 12.800 112,221 772,241

Booz Allen Hamilton Inc. 12.000 S900447BAH - 226,384 Engineering Research and Consulting, Inc. 12.000 PS170061 - 43,318 National Center for Defense Manufacturing & Machining 12.000 20150276 6,988 (35,327) Triton Systems, Inc. 12.000 TSI-2470-16-104758 - 43,553 Triton Systems, Inc. 12.000 TSI-2482-16-105706 - 33,017

Subtotal 12.000 6,988 310,945

Total Department of the Air Force 119,209 1,083,498

Department of the Army:Research on Chemical and Biological Defense 12.360 Direct - 1,080,389

51





Military Medical Research and Development 12.420 Direct 2,761,661 18,203,908 Brigham & Women's Hospital 12.420 112798 - 19,261 Case Western Reserve University 12.420 RES512532 - 117,687 Children's Hospital of Boston 12.420 W81XWH-17-1-0532 - 8,878 Duquesne University 12.420 G1700020 - 14,179 Georgia Institute of Technology 12.420 RJ092-G1 - 48,425 Henry M. Jackson Foundation 12.420 2506 - 32,589 Henry M. Jackson Foundation 12.420 4312 - 117,438 Johns Hopkins University 12.420 PAIN STUDY - 358 Magee-Womens Research Institute & Foundation 12.420 6216 - 39,411 Magee-Womens Research Institute & Foundation 12.420 6806 - 69,620 Maine Medical Center 12.420 111233-01OXBURGH DOD - 29,541 Memorial Sloan Kettering Cancer Center 12.420 BD525373 - 16,100 Minnesota Veterans Medical Research and Education Foundation 12.420 MVMREF-2017-001 - 2,135 Ohio State University 12.420 60065096 - 17,759 Oregon Health & Science University 12.420 1005470_UPITT - 83,021 Oregon Health & Science University 12.420 1008339_UPITT - 283 St. Joseph's Hospital and Medical Center 12.420 32689PITT - 482,913 TheraNova, LLC 12.420 CRD-01-1150 - 47,729 University of Alabama 12.420 000507860-006 - 77,802 University of California at San Francisco 12.420 10043sc - 161,759 University of Cincinnati 12.420 010376-002 - 57,607 University of Colorado 12.420 FY18.576.003 - 22,421 University of Michigan 12.420 3003179986 - 109,762 University of Michigan 12.420 3005327478 - 21,277 University of Michigan 12.420 EARLY AWARD - 19,413 University of New Mexico 12.420 3RDE3 - 34,209 University of Pittsburgh Medical Center (UPMC) 12.420 19641 - 24,509 University of Virginia 12.420 GG12134.159875 - 93,663 Wake Forest University 12.420 WFUHS 440109 - 1,901 Wake Forest University 12.420 WFUHS 440271 188,138 188,138 Wake Forest University 12.420 WFUHS 441000B GU-00 - 91,746 Wake Forest University 12.420 WFUHS 441022 SR-12 - 71,323 Wake Forest University 12.420 WFUHS 441037 CTA-07 62,098 103,164 Wake Forest University 12.420 WFUHS 441053 ER-03 - 132,051 Wake Forest University 12.420 WFUHS 441055 ER-05 - 40,428 Wake Forest University 12.420 WFUHS 441056 ER-06 - 88,128 Wake Forest University 12.420 WFUHS 441063 ER-13 - 145,365 Wake Forest University 12.420 WFUHS 441075 CF-05 77,618 141,605 Wake Forest University 12.420 WFUHS 441077 CF-07 - 268,012 Wake Forest University 12.420 WFUHS 441079 CF-09 123,772 251,733 Wake Forest University 12.420 WFUHS 441083 CF-13 - 12,067

Subtotal 12.420 3,213,287 21,509,318

Basic Scientific Research 12.431 Direct 1,096,523 2,209,556 Carnegie Mellon University 12.431 1130208-378915 - 148,722 Carnegie Mellon University 12.431 1130220-399314 - 5,163 Princeton University 12.431 SUB0000081 - 264,963 University of California at Santa Barbara 12.431 KK1714 - 191,273 University of Michigan 12.431 3004628718 - 228,040

Subtotal 12.431 1,096,523 3,047,717

Research and Technology Development 12.910 Direct 182,405 1,030,218

Other Department of the Army 12.000 Direct 4,913,560 8,179,532 Abzyme Therapeutics LLC 12.000 PO AB1281 - 90,654 BAE Systems 12.000 1001524 - 731,646 Battelle Memorial Institute 12.000 712468 - 878,845 Carnegie Mellon University 12.000 1042673-379177 - (5,835) Chromologic LLC 12.000 MSA-162000 - 34,984 Intelligent Automation, Inc. 12.000 2375-1 - 30,000 Johns Hopkins University 12.000 2002233422 - 7,941 Johns Hopkins University 12.000 2004207953 - 15,070 Johns Hopkins University 12.000 W81XWH-17-2-0032 - 2,771 Lynntech, Inc. 12.000 ARM-080 - 239,820

Materials Sciences Corporation 12.000 12291-SD44 - 15,000 Materials Sciences Corporation 12.000 12530-SD45 - 67,365 Materials Sciences Corporation 12.000 9691-SD36 - 119,070 University of California at San Francisco 12.000 11291SC - 191,746 University of California at Santa Barbara 12.000 KK1815 - 84,533 University of Cincinnati 12.000 010580-002 - (1,866) Vivonics, Inc. 12.000 2128-S008 - 12,877

Subtotal 12.000 4,913,560 10,694,153

Total Department of the Army 9,405,775 37,361,795

52





Department of the Navy:Basic and Applied Scientific Research 12.300 Direct 171,281 3,488,803 Carnegie Mellon University 12.300 1141302-385701 - 128,648 University of California at Los Angeles 12.300 0980 G SB337 - 436 University of Virginia 12.300 GG11737 146385 - (16,440) University of Virginia 12.300 GG11764 146900 - 118,824

Subtotal 12.300 171,281 3,720,271

Research and Technology Development 12.910 Direct - 84,081

Other Department of the Navy 12.000 Direct 50,000 770,090 Directed Vapor Technologies International, Inc. 12.000 D0149-02 - 8,739 KCF Technologies, Inc. 12.000 SBIR PHASE I - 10,000 Materials Sciences Corporation 12.000 12985-AR01 - 33,843

Subtotal 12.000 50,000 822,672

Total Department of the Navy 221,281 4,627,024

Space and Naval Warfare Systems Command:Johns Hopkins University 12.910 2004129650 - 302,593 Paradromics Inc. 12.000 NESD-001 - 352,806

Total Space and Naval Warfare Systems Command - 655,399

Total Department of Defense 10,184,998 47,302,076

Other Agencies:Agency for International Development:

JSI Research & Training Institute, Inc. 98.001 APC-GM-0068 - (8,163) JSI Research & Training Institute, Inc. 98.001 APC-GM-0107 - 387,108

Subtotal 98.001 - 378,945

Other Agency for International Development 98.000 Direct 424,347 944,189 Magee-Womens Research Institute & Foundation 98.000 5599 - (2) Magee-Womens Research Institute & Foundation 98.000 7317 - (4,625) Magee-Womens Research Institute & Foundation 98.000 7530 - 3,772 National Opinion Research Center 98.000 7554.UPITT.01-048 - 3,032 RTI International 98.000 3-312-0214177-51820L - 51,426

Subtotal 98.000 424,347 997,792

Total Agency for International Development 424,347 1,376,737

Department of Agriculture:US Civilian Research & Development Foundation 10.001 DAA2-15-61217-1 - (2,644) University of Michigan 10.310 SUBK00008917 - 19,207

Total Department of Agriculture - 16,563

Department of Commerce:Cluster Grants 11.020 Direct 13,645 135,191 Science, Technology, Business and/or Education Outreach 11.620 Direct - 15,119

Total Department of Commerce 13,645 150,310

Department of Education:International Research and Studies 84.017 Direct - 94,186

Education Research, Development and Dissemination 84.305 Direct 115,819 741,793 Harvard University 84.305 108129-5076562 - 82,042 Pennsylvania State University 84.305 5513-UP-IES-0403 - 76,610 Purdue University 84.305 19100064-008 - 78,611 Temple University 84.305 259589-PITT - 23,807 University of North Carolina 84.305 5107775 - 54,819 University of Oregon 84.305 224810B - 183,494

Subtotal 84.305 115,819 1,241,176

University of North Carolina 84.334 9012343-119 - 76,083 Allegheny Intermediate Unit 84.366 PDE MSP TITLE IIB - 11,926

Total Department of Education 115,819 1,423,371

Department of Energy:Office of Science Financial Assistance Program 81.049 Direct 287,350 3,294,119 Central Michigan University 81.049 F63460 - 242,122 Electroninks Inc. 81.049 DOE2018-2019 - 87,277 Harvard University 81.049 167974-5106940 - 111,482

53





Luna Innovations Incorporated 81.049 3495.02/PITT - 1,079 Northwestern University 81.049 SP0027267PROJ0007139 - 112,338 University of Minnesota 81.049 A007230201 - 58,037 UT-Battelle, LLC 81.049 4000074247 - (19,673)

Subtotal 81.049 287,350 3,886,781

Conservation Research and Development 81.086 Direct - 535,489

Giner, Inc. 81.087 Membrane Fuel Cells - 176,421 Rapid Advancement Process Intensification Deployment Manufact Instit 81.087 05.8 - 320,477 Rapid Advancement Process Intensification Deployment Manufact Instit 81.087 06-7 - 114,039 Rapid Advancement Process Intensification Deployment Manufact Instit 81.087 6.1 - 60,664 University of Central Florida 81.087 16226073-UP - 6,622 University of Central Florida 81.087 16226104-09 - 58,566

Subtotal 81.087 - 736,789

Fossil Energy Research and Development 81.089 Direct 227,346 1,180,599 Gas Technology Institute 81.089 AGREEMENT NO. S876 - 124,705 Pennsylvania State University 81.089 5955-UP-DOE-6825 - 36,953 Pennsylvania State University 81.089 5957-UP-DOE-6825 - 48,771 Pennsylvania State University 81.089 5987-UP-DOE-6825 - 7,912

Subtotal 81.089 227,346 1,398,940

Nuclear Energy Research, Development and Demonstration 81.121 Direct 47,544 325,155 University of Houston 81.121 R-19-0010 - 29,155 Utah State University 81.121 200658-604 - 418,015 Westinghouse Electric Company, LLC 81.121 4500666345 - (547)

Subtotal 81.121 47,544 771,778

Clarkson University 81.122 100906-1 - 51,017

AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 204 - (5,765) AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 205 - 366 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 209 - 6,951 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 210 - 6,780 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 211 - 68,512 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 212U - 27,915 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 213 - 10,829 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 214 - 47,543 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 216 - 26,636 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 217 - 33,750 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 218 - 31,050 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 220 - 51,116 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 221 - 15,000 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 222 - 12,591 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 223 - 12,992 AECOM Energy and Construction, Incorporated 81.000 TASK RELEASE NO 224 - 8,200 Battelle Energy Alliance, LLC 81.000 0207637 - 129,654 Battelle Energy Alliance, LLC 81.000 191828 - 118,640 Battelle Energy Alliance, LLC 81.000 206932 - 63,981 Battelle Energy Alliance, LLC 81.000 211001 - 59,634 Battelle Energy Alliance, LLC 81.000 213209 - 23,927 Battelle Energy Alliance, LLC 81.000 215245 - 39,146 Battelle Memorial Institute 81.000 338678 - 40,026 Battelle Memorial Institute 81.000 455499 - 4,500 Battelle Memorial Institute 81.000 734574 - 25,607 Brookhaven Science Associates, LLC 81.000 293354 - 5,033 Brookhaven Science Associates, LLC 81.000 359437 - 25,435 Fermi Research Alliance, LLC 81.000 653793 - 20,421 Fluor Marine Propulsion, LLC 81.000 128753 - 102,031 KeyLogic Systems, Inc. 81.000 5000-017 - 6,215 Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 1 - 34,256 Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 10 - 27,015 Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 11 - 502 Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 12 - 49,129 Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 13 - 27,405 Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 14 - 5,006

Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 2 - 6,851 Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 3 - 10,002 Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 5 - 17,874 Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 6 - 10,005 Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 7 - 10,005 Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 8 - 21,881 Leidos Biomedical Research, Inc. 81.000 P010220918 TASK 9 - 9,163 Los Alamos National Security, LLC 81.000 329287 - 646 Rapid Advancement Process Intensification Deployment Manufact Instit 81.000 EARLY AWARD - 104,664

54





REMADE Institute 81.000 SA-19-05 - 4,350 Sandia Corporation, a subsidiary of Lockheed Martin 81.000 1967875 - 6,000 Triad National Security, LLC 81.000 439301 - 160,829 UChicago Argonne, LLC 81.000 9F-60178 - 15,085 University of California 81.000 7374238 - 57,966

Subtotal 81.000 - 1,597,350

Total Department of Energy 562,240 8,978,144

Department of Housing and Urban Development:Municipality of Penn Hills 14.218 PH STABILIZATION - 3,790

Total Department of Housing and Urban Development - 3,790

Department of the Interior:Commonwealth of Pennsylvania 15.250 4400011482 47,227 242,025 Pennsylvania State University 15.805 5890-UP-USGS-0079 - 18,350 U.S. Geological Survey Research and Data Collection 15.808 Direct - 8,471

Total Department of the Interior 47,227 268,846

Department of Justice:National Institute of Justice Research, Evaluation, and

Development Project Grants 16.560 Direct 230,216 802,619 Criminal Justice Research and Development Graduate

Research Fellowships 16.562 Direct - 11,863 PA Commission on Crime and Delinquency 16.738 2014/16-JG98/SS28121 - 77,631 PA Commission on Crime and Delinquency 16.812 SR/DP-04/ST-27520 - 21,863

Total Department of Justice 230,216 913,976

Department of Transportation:National Academy of Sciences 20.200 HR 01-58 10,121 54,403 University of Cincinnati 20.200 010507-003 - 10,248

Subtotal 20.200 10,121 64,651

Commonwealth of Pennsylvania 20.205 4300455471/ WO 009 - 17,409 Commonwealth of Pennsylvania 20.205 4400011482/ WO 013 - (10) Commonwealth of Pennsylvania 20.205 4400011482/ WO 014 - 60,770 Commonwealth of Pennsylvania 20.205 4400011482/ WO 015 - 87,117 Commonwealth of Pennsylvania 20.205 4400018535/WO 016 - 179,054 Commonwealth of Pennsylvania 20.205 4400018535/WO 018 - 48,236 Commonwealth of Pennsylvania 20.205 4400018535/WO 019 - 101,473

Subtotal 20.205 - 494,049

Minnesota Department of Transportation 20.000 1003327 WORK ORDER 2 - 11,777 Minnesota Department of Transportation 20.000 1003327 WORK ORDER 3 - 32,054 National Academy of Sciences 20.000 TRANSIT-86 - 22,604 National Association of EMS 20.000 SUB-DTNH2215C00029 - 78,626 Pathway Accessibility Solutions, Inc. 20.000 ACCESSPATH - 475 Thornton Tomasetti, Inc. 20.000 TTWAS17.01-PITT - 8,906

Subtotal 20.000 - 154,442

Total Department of Transportation 10,121 713,142

Department of Veterans Affairs:Specially Adapted Housing Assistive Technology

Grant Program 64.051 Direct - 66,259

Other Department of Veterans Affairs 64.000 Direct - 5,767,267 Western Interstate Commission for Higher Education 64.000 SUICIDE PREVENTION - 43,287

Subtotal 64.000 - 5,810,554

Total Department of Veterans Affairs - 5,876,813

Environmental Protection Agency:Vanderbilt University 66.509 UNIV58986 - 235,022

Drexel University 66.511 860305 - 9,251 Other Environmental Protection Agency 66.000 Direct - 58,939

Total Environmental Protection Agency - 303,212

Executive Office of the President:Executive Office of the President 95.000 Direct - 105,946

Total Executive Office of the President - 105,946

55





Institute of Museum and Library Services:National Leadership Grants 45.312 Direct - 145,190 Laura Bush 21st Century Librarian Program 45.313 Direct - 11,949

Total Institute of Museum and Library Services - 157,139

N.A.S.A.:Aerospace Education Services Program:

NNX14AQ96G 43.001 Direct - 24,180 NNX15AM03G 43.001 Direct 10,832 70,548 NNX15AQ72H 43.001 Direct - 7,015 NNX15AU50G 43.001 Direct - 54,820 NNX17AC43G 43.001 Direct - (39) 80NSSC17K0445 43.001 Direct - 44,967 80NSSC17K0460 43.001 Direct - 43,631 80NSSC17K0388 43.001 Direct - 39,847 80NSSC18K1001 43.001 Direct 666 91,563 80NSSC19K0547 43.001 Direct - 36,715 80NSSC19K0588 43.001 Direct - 47,296

Arizona State University 43.001 09-193 - 71,393 California Institute of Technology 43.001 1619866 - 41,032 Directed Vapor Technologies International, Inc. 43.001 PROTECTIVE COATINGS - (43,725) Lowell Observatory 43.001 2018-81420-UP - 21,657 Smithsonian Astrophysical Observatory 43.001 TM8-19004X - 5,653 University of Maryland 43.001 47162-Z6125002 - 38,780

Subtotal 43.001 11,498 595,333

Aeronautics 43.002 Direct - 26,118

Pennsylvania State University 43.008 5240-UP-NASA-K06H - 31,012 Pennsylvania State University 43.008 5497-UP-NASA-K06H - 8,533 Pennsylvania State University 43.008 5999-UP-NASA-K06H - 12,250

Subtotal 43.008 - 51,795

Space Technology 43.012 Direct - 190,188

Center for the Advancement of Science in Space 43.000 GA-2016-236 57,047 120,951 Emergent Space Technologies, Inc 43.000 UNPIT001 - 12,000 Georgia Institute of Technology 43.000 RH809-G2 - 163,095 QuesTek Innovations LLC 43.000 PO# 1918 - 58,484 Space Telescope Science Institute 43.000 HST-AR-14568.001-A - 26,938 Space Telescope Science Institute 43.000 HST-GO-13781.002-A - 3,129 Space Telescope Science Institute 43.000 HST-GO-14476.002-A - 4,010 Space Telescope Science Institute 43.000 HST-GO-14683.002-A - 7,426 Space Telescope Science Institute 43.000 HST-GO-15436.006-A - 11,184 Wyle Laboratories, Inc 43.000 T804051 - 38,533

Subtotal 43.000 57,047 445,750

Total N.A.S.A. 68,545 1,309,184

National Endowment for the Humanities:Promotion of the Humanities Division of Preservation and Access 45.149 Direct - 83,626 Promotion of the Humanities Teaching and Learning Resources

and Curriculum Development 45.162 Direct - 43,750 Promotion of the Humanities Office of Digital Humanities 45.169 Direct - 8,405

Total National Endowment for the Humanities - 135,781

National Science Foundation:Engineering Grants 47.041 Direct 130,467 4,703,188 APO Technologies, Inc. 47.041 1 - 15,662 Carnegie Mellon University 47.041 1123333-407865 - 26,390 North Carolina A & T State University 47.041 260116A - 458,674 Rice University 47.041 R3G221 - (388) SpIntellx, Inc. 47.041 UPITT-NSF1843825 - 6,187 University of Tennessee 47.041 A17-1367-S001 - 8,808 Virginia Tech University 47.041 479852-19442 - 140,169

Subtotal 47.041 130,467 5,358,690

Mathematical and Physical Sciences 47.049 Direct 633,954 6,614,860 Associated Universities, Inc. 47.049 SOSPA5-010 - 8,783 Association of Universities for Research in Astronomy, Inc. 47.049 N72572C - 78,017 Carnegie Mellon University 47.049 1122343-351111 - 111,572 Research Foundation - State University of New York 47.049 76749/1136652/2 - 172,969 University of California at Irvine 47.049 2014-3124 - 340,874

Subtotal 47.049 633,954 7,327,075

56





Geosciences 47.050 Direct 67,910 671,493 University of Arizona 47.050 125166 - 937

Subtotal 47.050 67,910 672,430

Computer and Information Science and Engineering 47.070 Direct 58,246 4,690,371 Boise State University 47.070 6282-PO124442 - 6,377 Carnegie Mellon University 47.070 1122353-399022 - 26,935 Research Foundation - State University of New York 47.070 R1146532 - 17,318 University of Tennessee 47.070 A16-1316-S001 - 6,994 University of Utah 47.070 10047390-UPITT - 9,820 Virginia Tech University 47.070 479590-19442 - 35,991

Subtotal 47.070 58,246 4,793,806

Biological Sciences 47.074 Direct 27,013 2,501,662 Baylor University 47.074 32050279-01 - 30,433 Carnegie Mellon University 47.074 1122469-369793 - 25,622 Duquesne University 47.074 G1600031 - 941 Oregon Health & Science University 47.074 1011004_UPITT - 19,988 University of Dayton 47.074 RSC16079 - 126,787

Subtotal 47.074 27,013 2,705,433 Social, Behavioral, and Economic Sciences 47.075 Direct - 700,638 Carnegie Mellon University 47.075 1122300-352752 - 72,425 National Bureau of Economic Research 47.075 34-3619-000797327700 - 2,295 University of California 47.075 KK1708 - 19,842 University of North Carolina 47.075 20170087-02-UOP - 41,516

Subtotal 47.075 - 836,716

Education and Human Resources 47.076 Direct 259,107 3,873,596 Community College of Allegheny County 47.076 1400575-PITT - 3,735 Educational Development Center 47.076 11717 - 16,871 Fred Rogers Company 47.076 PEG+CAT - 30,773 University of Montana 47.076 G196-19-W7292 - 9,381 University of South Florida 47.076 2015-1126-00-A - 26,968 University of Wisconsin 47.076 847K383 - 9,324

Subtotal 47.076 259,107 3,970,648

Office of International Science and Engineering 47.079 Direct 301,456 905,947 Office of Integrative Activities 47.083 Direct - 111,230 Other National Science Foundation 47.000 Direct - (1)

Total National Science Foundation 1,478,153 26,681,974

Nuclear Regulatory Commission:U.S. Nuclear Regulatory Commission Scholarship and

Fellowship Program 77.008 Direct - 169,552 Total Nuclear Regulatory Commission - 169,552

Total Other Agencies 2,950,313 48,584,480

TOTAL RESEARCH & DEVELOPMENT CLUSTER 84,568,639 683,267,460

II. STUDENT FINANCIAL ASSISTANCE CLUSTER:

Department of Education:Federal Supplemental Educational Opportunity Grants 84.007 Direct - 1,573,377 Federal Work-Study Program 84.033 Direct - 2,740,946 Federal Pell Grant Program 84.063 Direct - 22,724,561 Federal Perkins Loan Program 84.038 Direct - 24,368,893 Direct Student Loans Program 84.268 Direct - 241,266,937

Total Department of Education - 292,674,714

Health Resources and Services Administration:Nursing Faculty Loan Program 93.264 Direct - 538,682

Health Professions Student Loan Program:Medicine 93.342 Direct - 116,327Dentistry 93.342 Direct - 5,311,777 Pharmacy 93.342 Direct - 1,626,554 Subtotal 93.342 - 7,054,658

Disadvantaged Student Loan Program:Dentistry 93.342 Direct - 141,000 Medicine 93.342 Direct - 267,678 Subtotal 93.342 - 408,678

57





Nursing Student Loan Program:Baccalaureate 93.364 Direct - 1,835,376

Nursing Faculty Loan Program - ARRA 93.408 Direct - 88,736 Total Health Resources and Services Administration - 9,926,130

TOTAL STUDENT FINANCIAL ASSISTANCE CLUSTER - 302,600,844

III. TRIO CLUSTER:

Department of Education:TRIO - Student Support Services 84.042 Direct - 726,052

Total Department of Education - 726,052

TOTAL TRIO CLUSTER - 726,052

IV. HEAD START CLUSTER:

Administration for Children and Families:Head Start 93.600 Direct 3,453,140 4,344,427

Total Administration for Children and Families 3,453,140 4,344,427

TOTAL HEAD START CLUSTER 3,453,140 4,344,427

V. CHILD NUTRITION CLUSTER:

Department of Agriculture:Commonwealth of Pennsylvania 10.559 SFSP - 11,849


TOTAL CHILDREN NUTRITION CLUSTER - 11,849

VI. OTHER PROGRAMS:

Department of Health and Human Services:Administration for Children and Families:

Commonwealth of Pennsylvania 93.643 4100081112 - 373,369

Research Foundation - State University of New York 93.648 8-82905 - 8,117

Commonwealth of Pennsylvania 93.658 4100064360 10,982 390,618 Commonwealth of Pennsylvania 93.658 4100066356 - 9,947,146 Commonwealth of Pennsylvania 93.658 4100081112 39,955 11,380,525

Subtotal 93.658 50,937 21,718,289

Commonwealth of Pennsylvania 93.669 4100064360 - 16,672 Commonwealth of Pennsylvania 93.669 4100081112 - 132,625

Subtotal 93.669 - 149,297

Commonwealth of Pennsylvania 93.674 4100064360 - 21,837 Commonwealth of Pennsylvania 93.674 4100081112 - 773,010

Subtotal 93.674 - 794,847

Total Administration for Children and Families 50,937 23,043,919

Administration for Community Living:ACL National Institute on Disability, Independent Living, and

Rehabilitation Research 93.433 Direct 54,229 101,875

Total Administration for Community Living 54,229 101,875

Centers for Disease Control and Prevention:Birth Defects and Developmental Disabilities - Prevention

and Surveillance 93.073 Direct 37,500 106,817 Louisiana Department of Health 93.074 2000311156 - 9,993

Injury Prevention and Control Research and State and Community Based Programs 93.136 Direct - 127,976

Commonwealth of Pennsylvania 93.354 430061116 - 52,718 Oregon Health Authority 93.354 159701 - 17,999

Subtotal 93.354 - 70,717

ChangeLab Solutions 93.421 CDC7055-0-0109-1 - 35,386 ChangeLab Solutions 93.424 CDC7043-0-0109-1A1 - 5,542 Pennsylvania Pharmacists Association 93.426 4100082224-1815 - 25,211

58





Commonwealth of Pennsylvania 93.758 4100066456 4,034 24,357 District of Columbia 93.817 CW61684 - 67,359 Commonwealth of Pennsylvania 93.940 4300533540 - 292 Commonwealth of Pennsylvania 93.977 4300587825 - 1,446,330 Commonwealth of Pennsylvania 93.991 4100081647 - 161,682

Commonwealth of Pennsylvania 93.000 4400018535 - 57,838 Total Centers for Disease Control and Prevention 41,534 2,139,500

Centers for Medicare and Medicaid Services:Allegheny County 93.778 193520 - (3,267)

Total Centers for Medicare and Medicaid Services - (3,267)

Health Resources and Services Administration:Training in General, Pediatric, and Public Health Dentistry 93.059 Direct - 460,337 Eastcentral Pennsylvania Area Health Education Center 93.107 EC UP6111 - 5,499 Maternal & Child Health Federal Consolidated Programs 93.110 Direct - 618,744 Nurse Anesthetist Traineeships 93.124 Direct - 126,208 Substance Abuse and Mental Health Services Projects of

of Regional and National Significance 93.243 Direct - 1,680 Leadership in Public Health Social Work Education Grant

Program 93.330 Direct - 57,270 Public Health Training Centers Program 93.516 Direct 280,262 972,368 Sadler Health Center Corporation 93.527 3 H80CS29025-03-02 - 4,855

Mental and Behavioral Health Education and Training Grants 93.732 Direct - 451,180 Chatham University 93.732 01 - 7,523 Chatham University 93.732 BHWET 01 - 5,591

Subtotal 93.732 - 464,294

Grants for Primary Care Training and Enhancement 93.884 Direct - 95,888 PPHF Geriatric Education Centers 93.969 Direct 226,588 829,173

Total Health Resources and Services Administration 506,850 3,636,316

Substance Abuse and Mental Health Services Administration:CMSU Counties of Central Pennsylvania 93.104 6U79 SM062468-04M001 - 57,226 CMSU Counties of Central Pennsylvania 93.104 SM062468-03 - 18,665 Commonwealth of Pennsylvania 93.104 4100078411 - 518,007 Commonwealth of Pennsylvania 93.104 SAP #4100078411 - 217,120

Subtotal 93.104 - 811,018

Substance Abuse and Mental Health Services Projects of Regional and National Significance 93.243 Direct 47,094 1,464,023

Allegheny County 93.243 174565 - 377,502 Allegheny County 93.243 211641 - 7,419 Allegheny Singer Research Institute 93.243 49247209 - 14,369 Allegheny Singer Research Institute 93.243 49247909 - 45,046 Chatham University 93.243 1 - 54,264 Commonwealth of Pennsylvania 93.243 4300566877 - 76,183 Commonwealth of Pennsylvania 93.243 4300600269 - 218,852 Commonwealth of Pennsylvania 93.243 SAP 4100068678 - 264,003 Morehouse School of Medicine 93.243 128-01 - 33,265 University of the Sciences in Philadelphia 93.243 121-129102801 - 62,441 University of Utah 93.243 10041723-PITT - 29,635

Subtotal 93.243 47,094 2,647,002

Pennsylvania State University 93.788 6007-UP-SAMHSA-1889 - 8,334

Total Substance Abuse and Mental Health Services Administration 47,094 3,466,354

DHHS Other:Futures Without Violence 93.088 2835 - 9,500

Total DHHS Other - 9,500

Total Department of Health and Human Services 700,644 32,394,197

Department of Defense:National Security Agency:

Language Grant Program 12.900 Direct - 110,487 Total National Security Agency - 110,487

DoD Other:Institute of International Education 12.357 1801PITT20PGO051PO1 - 374,041 Institute of International Education 12.357 2603PITT14GO-051-PO4 - 195,714

Subtotal 12.357 - 569,755

59





University of California at Los Angeles 12.000 2000 P UG248 - 79,007 Total DoD Other - 648,762

Total Department of Defense - 759,249

Other Agencies:Appalachian Regional Commission:

Innovation Works 23.002 ARC POWER - 70,138 Innovation Works 23.002 SWPA Coal-Impact - 35,875

Total Appalachian Regional Commission - 106,013

Corporation for National and Community Services:Jumpstart for Young Children, Inc. 94.006 JS-SITE #09 - 193,392 National Service and Civic Engagement Research Competition 94.026 Direct 14,646 58,170

Total Corporation for National and Community Services 14,646 251,562

Department of Agriculture:Commonwealth of Pennsylvania 10.558 300-02-961-3 - 23,023


Department of Commerce:Catalyst Connection 11.307 PO00003070 - 4,341

Total Department of Commerce - 4,341

Department of Education:National Resource Centers Program for Foreign Language and

and Area Studies or Foreign Language and InternationalStudies Program and Foreign Language and Area Studies Fellowship Program 84.015 Direct - 1,078,009

Undergraduate International Studies and Foreign Language Programs 84.016 Direct - 41,089

Higher Education Institutional Aid 84.031 Direct - 482,095 Santa Fe College 84.031 T001 - 6,808

Subtotal 84.031 - 488,903

Commonwealth of Pennsylvania 84.126 FC4000007735 - 711,414 Graduate Assistance in Areas of National Need 84.200 Direct - 192,925 Homewood Children's Village 84.215 HCV/PACS - 4,215 Pennsylvania State University 84.229 6023-UP-USDE-0009 - 8,465 Special Education - Personnel Development to Improve

Services and Results for Children with Disabilities 84.325 Direct - 484,699 Salus University 84.325 PITT 88403 17-18 - 2,000 Salus University 84.325 PITT 88404 FALL2018 - 27,426 Salus University 84.325 PITT 88404A 1819 - 31,765

Subtotal 84.325 - 545,890

National Writing Project Corporation 84.367 92-PA09-SEED17-CRWPP - 12,527

Total Department of Education - 3,083,437

Department of Interior:National Writing Project Corporation 15.954 92-PA09-NPS2018 - 3,500

Total Department of Interior - 3,500

Department of Justice:Commonwealth of Pennsylvania 16.754 4300548899 - (14,832) Commonwealth of Pennsylvania 16.000 4300548943 - 6,452

Total Department of Justice - (8,380)

Department of Labor:Commonwealth of Pennsylvania 17.245 TAA0249.14 - - Commonwealth of Pennsylvania 17.245 TAA0249.17 - 102,000

Total Department of Labor - 102,000

Department of Treasury:Low-Income Taxpayer Clinics 21.008 Direct - 84,687

Total Department of Treasury - 84,687

Institute of Museum and Library Services:Pennsylvania School Librarians Association 45.310 001 - 44,352 Pennsylvania School Librarians Association 45.310 002 - 36,015

Total Institute of Museum and Library Services - 80,367

60





National Endowment for the Humanities:Promotion of the Humanities Challenge Grants 45.130 Direct - 12,080 Promotion of the Humanities Office of Digital Humanities 45.169 Direct - 165,243

Total National Endowment for the Humanities - 177,323

Nuclear Regulatory Commission:U.S. Nuclear Regulatory Commission Scholarship and

Fellowship Program 77.008 Direct - 66,000 Total Nuclear Regulatory Commission - 66,000

Peace Corps:Other Peace Corps 08.000 Direct - 23,160

Total Peace Corps - 23,160

Small Business Administration:Kutztown University 59.037 SBA20180714 - 137,633

Kutztown University 59.000 EARLY AWARD - 210,008 University of Pennsylvania 59.000 5-73387 - 10,251 University of Pennsylvania 59.000 573568-J - 2,498

Subtotal 59.000 - 222,757

Total Small Business Administration - 360,390

Total Other Agencies 14,646 4,357,423

TOTAL OTHER PROGRAMS 715,290 37,510,869

GRAND TOTAL - FEDERAL AWARDS AND GRANTS $ 88,737,069 $ 1,028,461,501

See accompanying notes to schedule of expenditures of federal awards and independent auditors' reports.

61


Notes to Schedule of Expenditures of Federal Awards Year ended June 30, 2019

62 (Continued)

(1) Basis of Presentation and Significant Accounting PoliciesThe accompanying schedule of expenditures of federal awards (the Schedule) includes all grants,contracts, and similar agreements of the University of Pittsburgh – Of the Commonwealth System of HigherEducation (the University), which have been received from the U.S. federal government for the year endedJune 30, 2019. The federal award information is presented in accordance with the requirements of Title 2U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, andAudit Requirements for Federal Awards (Uniform Guidance).

For the purposes of the Schedule, federal awards have been classified in two types:

• Direct federal awards, and

• Pass-through funds received from nonfederal organizations made under federally sponsored programsconducted by those organizations.

The Schedule also presents expenditures passed through from the University to other nonfederal subrecipient organizations. Since the Schedule presents only a selected portion of the activities of the University, it is not intended to and does not present either the financial position, changes in net assets, or cash flows of the University. The Schedule is prepared on the accrual basis of accounting. Negative expenditures detailed in the Schedule result from current year adjustments to prior year award amounts.

Expenditures for federal awards (excluding student financial assistance) are determined using the administrative requirements as set forth in OMB Circular A-110, Uniform Administrative Requirements for Grants and Agreements with Institutions of Higher Education, Hospitals, and Other Non-Profit Organizations or the administrative and cost principles contained in the Uniform Guidance, and the cost accounting principles and procedures set forth in OMB Circular A-21, Cost Principles for Educational Institutions, as applicable. Under these administrative requirements and cost principles, certain expenditures are not allowable or are limited as to reimbursement.

Expenditures for student financial assistance are recognized as incurred and include the federal share of students’ Federal Supplemental Educational Opportunity Grants program and Federal Work-Study program earnings, Pell grants, loan disbursements and loan outstanding balances, and administrative cost allowances, where applicable.

(2) Reimbursement of Facilities and Administrative CostsSponsored grants and contracts normally provide for the recovery of direct costs and facilities andadministrative costs (F&A costs). Recovery of the related F&A costs is generally recorded at predeterminedrates negotiated with the federal government. Entitlement to these resources for the recovery of theapplicable direct and related F&A costs is generally conditioned upon compliance with the terms andconditions of the grant agreements and applicable federal regulations, including the expenditure of theresources for eligible purposes. Substantially all grants and the University’s F&A cost rate are subject tofinancial and compliance reviews and audits by the grantors. In management’s opinion, the likelihood of anadverse material outcome upon the University’s financial position from those reviews and audits is remote.On June 10, 2015, the Department of Health and Human Services approved F&A cost recovery rateseffective from July 1, 2015 through June 30, 2019. The University has elected not to use the 10-percent deminimis indirect cost rate as allowed under the Uniform Guidance.


Notes to Schedule of Expenditures of Federal Awards Year ended June 30, 2019

63

(3) Federal Loan ProgramsThe University administers the following federal loan programs with an outstanding loan balance as ofJune 30, 2019:

FederalCFDA Outstanding

Federal grant and program title number loan balance

Department of Education – Federal Perkins Loan Program 84.038 $ 20,067,314

Department of Health and Human Services – Public Service:Health Professions Student Loan Program:

Medicine 93.342 $ 97,027Dentistry 93.342 4,693,172Pharmacy 93.342 1,372,472

Nursing Student Loan Program – Baccalaureate 93.364 1,480,389Nursing Faculty Loan Program:

Nursing Faculty Loan ARRA 93.408 77,285Nursing Faculty Loan 93.264 486,135

Disadvantaged Student Loan Program:Medicine 93.342 260,387Dentistry 93.342 132,170

The Perkins and Department of Health and Human Services Public Service Loan Programs are administered directly by the University, and balances and transactions relating to these programs are included in the University’s consolidated financial statements. The amounts included in the Schedule of Expenditures under the Perkins and Department of Health and Human Services Public Service Loan Programs include the balance of the respective loan program as of June 30, 2018, administrative costs, if any, and new loans issued during fiscal 2019.

(4) Department of Education Direct Loan ProgramsThe University is responsible only for the performance of certain administrative duties with respect to theDirect Loans; accordingly, these loans are not included in the University’s consolidated financial statementsand it is not practical to determine the balance of loans outstanding to students and former students of theUniversity under these programs.

(5) Student Financial Assistance ProgramFor the year ended June 30, 2019, administrative costs on the Student Financial Assistance Program wereclaimed under the Federal Work Study Program in the amount of $243,387.

(6) Vendor RelationshipsThe Special Education Program (CFDA #84.027) constitutes a vendor relationship with the University inaccordance with Uniform Guidance. This project is being excluded from the Schedule, although itrepresents federal funds of $3,654,501 for the year ended June 30, 2019.

Independent Auditors’ Report on Internal Control Over Financial Reporting and on Compliance and Other Matters Based on an Audit of Financial Statements Performed in Accordance With Government

Auditing Standards

The Board of Trustees University of Pittsburgh – Of the Commonwealth System of Higher Education:

We have audited, in accordance with the auditing standards generally accepted in the United States of America and the standards applicable to financial audits contained in Government Auditing Standards, issued by the Comptroller General of the United States, the consolidated financial statements of the University of Pittsburgh – Of the Commonwealth System of Higher Education (the University), which comprise the consolidated balance sheet as of June 30, 2019, and the related consolidated statements of activities, and cash flows for the year then ended, and the related notes to the consolidated financial statements, and have issued our report thereon dated October 16, 2019, which included an emphasis of matter paragraph for the University’s adoption of Accounting Standards Update (ASU) 2016-14, Presentation of Financial Statements of Not-for-Profit Entities; ASU 2014-09, Revenue from Contracts with Customers (Topic 606), as amended; ASU 2018-08, Clarifying the Scope and the Accounting Guidance for Contributions Received and Contributions Made; and ASU 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost.

Internal Control Over Financial Reporting In planning and performing our audit of the consolidated financial statements, we considered the University’s internal control over financial reporting (internal control) to determine the audit procedures that are appropriate in the circumstances for the purpose of expressing our opinion on the consolidated financial statements, but not for the purpose of expressing an opinion on the effectiveness of the University’s internal control. Accordingly, we do not express an opinion on the effectiveness of the University’s internal control.

A deficiency in internal control exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent, or detect and correct, misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control, such that there is a reasonable possibility that a material misstatement of the entity’s financial statements will not be prevented, or detected and corrected on a timely basis. A significant deficiency is a deficiency, or a combination of deficiencies, in internal control that is less severe than a material weakness, yet important enough to merit attention by those charged with governance.

Our consideration of internal control was for the limited purpose described in the first paragraph of this section and was not designed to identify all deficiencies in internal control that might be material weaknesses or significant deficiencies. Given these limitations, during our audit we did not identify any deficiencies in internal control that we consider to be material weaknesses. However, material weaknesses may exist that have not been identified.



64

Compliance and Other Matters As part of obtaining reasonable assurance about whether the University’s consolidated financial statements are free from material misstatement, we performed tests of its compliance with certain provisions of laws, regulations, contracts, and grant agreements, noncompliance with which could have a direct and material effect on the determination of financial statement amounts. However, providing an opinion on compliance with those provisions was not an objective of our audit, and accordingly, we do not express such an opinion. The results of our tests disclosed no instances of noncompliance or other matters that are required to be reported under Government Auditing Standards.

Purpose of this Report The purpose of this report is solely to describe the scope of our testing of internal control and compliance and the results of that testing, and not to provide an opinion on the effectiveness of the University’s internal control or on compliance. This report is an integral part of an audit performed in accordance with Government Auditing Standards in considering the University’s internal control and compliance. Accordingly, this communication is not suitable for any other purpose.

Pittsburgh, PennsylvaniaOctober 16, 2019

65



66

Independent Auditors’ Report on Compliance for Each Major Federal Program; Report on Internal Control Over Compliance; and Report on Schedule of Expenditures

of Federal Awards Required by the Uniform Guidance

The Board of Trustees of the University of Pittsburgh – Of the Commonwealth System of Higher Education:

Report on Compliance for Each Major Federal Program We have audited the University of Pittsburgh – Of the Commonwealth System of Higher Education’s (the University) compliance with the types of compliance requirements described in the OMB Compliance Supplement that could have a direct and material effect on each of the University’s major federal programs for the year ended June 30, 2019. The University’s major federal programs are identified in the summary of auditors’ results section of the accompanying schedule of findings and questioned costs.

Management’s Responsibility

Management is responsible for compliance with federal statutes, regulations, and the terms and conditions of its federal awards applicable to its federal programs.

Auditors’ Responsibility

Our responsibility is to express an opinion on compliance for each of the University’s major federal programs based on our audit of the types of compliance requirements referred to above. We conducted our audit of compliance in accordance with auditing standards generally accepted in the United States of America; the standards applicable to financial audits contained in Government Auditing Standards, issued by the Comptroller General of the United States; and the audit requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Those standards and the Uniform Guidance require that we plan and perform the audit to obtain reasonable assurance about whether noncompliance with the types of compliance requirements referred to above that could have a direct and material effect on a major federal program occurred. An audit includes examining, on a test basis, evidence about the University’s compliance with those requirements and performing such other procedures as we considered necessary in the circumstances.

We believe that our audit provides a reasonable basis for our opinion on compliance for each major federal program. However, our audit does not provide a legal determination of the University’s compliance.

Opinion on Each Major Federal Program

In our opinion, the University complied, in all material respects, with the types of compliance requirements referred to above that could have a direct and material effect on each of its major federal programs identified in the summary of auditors’ results section of the accompanying schedule of findings and questioned costs for the year ended June 30, 2019.

Report on Internal Control Over Compliance Management of the University is responsible for establishing and maintaining effective internal control over compliance with the types of compliance requirements referred to above. In planning and performing our audit of compliance, we considered the University’s internal control over compliance with the types of requirements

67

that could have a direct and material effect on each major federal program to determine the auditing procedures that are appropriate in the circumstances for the purpose of expressing an opinion on compliance for each major federal program and to test and report on internal control over compliance in accordance with the Uniform Guidance, but not for the purpose of expressing an opinion on the effectiveness of internal control over compliance. Accordingly, we do not express an opinion on the effectiveness of the University’s internal control over compliance.

A deficiency in internal control over compliance exists when the design or operation of a control over compliance does not allow management or employees, in the normal course of performing their assigned functions, to prevent, or detect and correct, noncompliance with a type of compliance requirement of a federal program on a timely basis. A material weakness in internal control over compliance is a deficiency, or a combination of deficiencies, in internal control over compliance, such that there is a reasonable possibility that material noncompliance with a type of compliance requirement of a federal program will not be prevented, or detected and corrected, on a timely basis. A significant deficiency in internal control over compliance is a deficiency, or a combination of deficiencies, in internal control over compliance with a type of compliance requirement of a federal program that is less severe than a material weakness in internal control over compliance, yet important enough to merit attention by those charged with governance.

Our consideration of internal control over compliance was for the limited purpose described in the first paragraph of this section and was not designed to identify all deficiencies in internal control over compliance that might be material weaknesses or significant deficiencies. We did not identify any deficiencies in internal control over compliance that we consider to be material weaknesses. However, material weaknesses may exist that have not been identified.

The purpose of this report on internal control over compliance is solely to describe the scope of our testing of internal control over compliance and the results of that testing based on the requirements of the Uniform Guidance. Accordingly, this report is not suitable for any other purpose.

Report on Schedule of Expenditures of Federal Awards Required by the Uniform Guidance We have audited the consolidated financial statements of the University as of and for the year ended June 30, 2019, and have issued our report thereon dated October 16, 2019, which contained an unmodified opinion on those financial statements. Our audit was conducted for the purpose of forming an opinion on the consolidated financial statements as a whole. The accompanying schedule of expenditures of federal awards is presented for purposes of additional analysis as required by the Uniform Guidance and is not a required part of the consolidated financial statements. Such information is the responsibility of management and was derived from and relates directly to the underlying accounting and other records used to prepare the consolidated financial statements. The information has been subjected to the auditing procedures applied in the audit of the consolidated financial statements and certain additional procedures, including comparing and reconciling such information directly to the underlying accounting and other records used to prepare the consolidated financial statements or to the consolidated financial statements themselves, and other additional procedures in accordance with auditing standards generally accepted in the United States of America. In our opinion, the schedule of expenditures of federal awards is fairly stated in all material respects in relation to the consolidated financial statements as a whole.

Pittsburgh, Pennsylvania March 10, 2020


Schedule of Findings and Questioned Costs Year ended June 30, 2019

68

(1) Summary of Auditors’ Results(a) Type of report issued on whether the consolidated financial statements were prepared in accordance

with generally accepted accounting principles: Unmodified

(b) Internal control deficiencies over financial reporting disclosed by the audit of the consolidated financialstatements:

• Material weaknesses: No• Significant deficiencies: None reported

(c) Noncompliance material to the financial statements: No

(d) Internal control deficiencies over major programs disclosed by the audit:

• Material weaknesses: No• Significant deficiencies: None reported

(e) Type of report issued on compliance for major programs: Unmodified - CFDA #93.658 Foster CareProgram and Unmodified – Research and Development Cluster

(f) Audit findings that are required to be reported in accordance with 2 CFR 200.516(a): No

(g) Major programs:

• Research and Development Cluster – various CFDA numbers

• Foster Care Program - CFDA #93.658

(h) Dollar threshold used to distinguish between Type A and Type B programs: $3,085,079

(i) Auditee qualified as a low-risk auditee: Yes

(2) Findings Relating to the Financial Statements Reported in Accordance with Government AuditingStandardsNone

(3) Findings and Questioned Costs Relating to Federal AwardsNone

UNIVERSITY OF PITTSBURGH – OF THE COMMONWEALTH … · CONSOLIDATED FINANCIAL STATEMENTS The accompanying notes are an integral part of these consolidated financial statements. 1

Documents